	Disease	Major category	Subcategory	Inheritance	OMIM	Gene	UpdatedGene	GeneID	Associated features	T cell count	B cell count	Immunoglobulin levels	Neutrophil count	Other affected cells	KEGG_drug	KEGG_pathway	HPOs
CD3d deficiency_CD3D_AR	CD3d deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR	186790	CD3D	CD3D	915	nan	Very low	Normal	Low	Normal	No g/d T cells	['Antithymocyte immunoglobulin (rabbit): D09190<JP/US>', 'Blinatumomab: D09325<JP/US>', 'Catumaxomab: D09207', 'Flotetuzumab: D11306', 'Muromonab-CD3: D05092', 'Otelixizumab: D08959', 'Tebentafusp: D12296<US>', 'Teplizumab: D09013', 'Visilizumab: D06314']	['hsa04640  Hematopoietic cell lineage', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa05142  Chagas disease', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05340  Primary immunodeficiency']	['HP:0005403', 'HP:0000007', 'HP:0002715', 'HP:0004313']
CD3e deficiency_CD3E_AR	CD3e deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR	186830	CD3E	CD3E	916	nan	Very low	Normal	Low	Normal	No g/d T cells	['Acapatamab: D12121', 'Antithymocyte immunoglobulin (rabbit): D09190<JP/US>', 'Blinatumomab: D09325<JP/US>', 'Catumaxomab: D09207', 'Cevostamab: D11984', 'Cibisatamab: D11489', 'Duvortuxizumab: D11372', 'Elranatamab: D12058', 'Epcoritamab: D12368', 'Flotetuzumab: D11306', 'Glofitamab: D11833', 'Mosunetuzumab: D11463', 'Muromonab-CD3: D05092', 'Odronextamab: D11534', 'Otelixizumab: D08959', 'Pavurutamab: D11992', 'Plamotamab: D11686', 'Runimotamab: D12236', 'Talquetamab: D12180', 'Tarlatamab: D12234', 'Tebentafusp: D12296<US>', 'Teclistamab: D12177<US>', 'Teplizumab: D09013', 'Tidutamab: D11845', 'Ubamatamab: D12007', 'Vibecotamab: D11841', 'Visilizumab: D06314']	['hsa04640  Hematopoietic cell lineage', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa05142  Chagas disease', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05340  Primary immunodeficiency']	['HP:0005403', 'HP:0000007', 'HP:0002715', 'HP:0004313']
CD3z deficiency_CD247_AR	CD3z deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR	Â 186780	CD3Z	CD247	919	nan	Very low	Normal	Low	Normal	No g/d T cells	[]	['hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa05142  Chagas disease', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer']	['HP:0005403', 'HP:0000007', 'HP:0002715', 'HP:0004313']
Coronin-1A deficiency_CORO1A_AR	Coronin-1A deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR	605000	CORO1A	CORO1A	11151	Detectable thymus, EBV	Very low	Normal	Low	Normal	nan	[]	['hsa04145  Phagosome', 'hsa05152  Tuberculosis']	['HP:0005403', 'HP:0000007', 'HP:0002715', 'HP:0004313']
gc deficiency (common gamma chain SCID, CD132 deficiency)_IL2RG_XL	gc deficiency (common gamma chain SCID, CD132 deficiency)	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	XL	308380	IL2RG	IL2RG	3561	nan	Very low	Normal to high	Low	Normal	Low NK	['Aldesleukin: D00748<US>', 'Celmoleukin: D02743', 'Rezpegaldesleukin: D12328', 'Teceleukin: D02749<JP>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04144  Endocytosis', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05321  Inflammatory bowel disease', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0005404', 'HP:0004313', 'HP:0001417', 'HP:0005403']
IL7Ra deficiency_IL7R_AR	IL7Ra deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR	146661	IL7R	IL7R	3575	nan	Very low	Normal to high	Low	Normal	nan	['Lusvertikimab: D12479']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04068  FoxO signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04640  Hematopoietic cell lineage', 'hsa05200  Pathways in cancer', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0005404', 'HP:0000007', 'HP:0004313', 'HP:0005403']
ITPKB deficiency_ITPKB_AR	ITPKB deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR		ITPKB	ITPKB	3707	FTT	Very low	Normal	Low	Normal to low	Low Hb, low platelets, low neutrophils	[]	['hsa00562  Inositol phosphate metabolism', 'hsa01100  Metabolic pathways', 'hsa04020  Calcium signaling pathway', 'hsa04070  Phosphatidylinositol signaling system']	['HP:0001508', 'HP:0002715', 'HP:0000007', 'HP:0001875', 'HP:0004313', 'HP:0005403']
JAK3 deficiency_JAK3_AR	JAK3 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR	600173	JAK3	JAK3	3718	nan	Very low	Normal to high	Low	Normal	Low NK	['Decernotinib: D10585', 'Delgocitinib: D11046<JP>', 'Filgotinib (DG01991): D11106<JP>', 'Gusacitinib (DG03080): D11676 D11677', 'Nezulcitinib: D12118', 'Peficitinib (DG01853): D10653 D10721<JP>', 'Ritlecitinib tosilate: D11970', 'Tofacitinib (DG00742): D09783<JP/US> D09970', 'Tuspetinib: D12476']	['hsa04062  Chemokine signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04217  Necroptosis', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05223  Non-small cell lung cancer', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0005404', 'HP:0000007', 'HP:0004313', 'HP:0005403']
LAT deficiency_LAT_AR	LAT deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR	602354	LAT	LAT	27040	Adenopathy, splenomegaly, recurrent infections, autoimmunity	Nl to low number	Nl to low	High	Normal	nan	[]	['hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa05135  Yersinia infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer']	['HP:0010702', 'HP:0002715', 'HP:0002960', 'HP:0002719', 'HP:0000007', 'HP:0005403', 'HP:0001744']
PAX1 deficiency_PAX1_AR	PAX1 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR		PAX1	PAX1	5075	Athymia, otofaciocervical syndrome	Very low	Normal	Low	Normal	nan	[]	[]	['HP:0002715', 'HP:0000007', 'HP:0005359', 'HP:0004313', 'HP:0005403']
CD45 deficiency_PTPRC_AR	CD45 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR	151460	PTPRC	PTPRC	5788	nan	Very low	Normal	Low	Normal	nan	[]	['hsa04514  Cell adhesion molecules', 'hsa04660  T cell receptor signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa05132  Salmonella infection', 'hsa05340  Primary immunodeficiency']	['HP:0005403', 'HP:0000007', 'HP:0002715', 'HP:0004313']
SLP76 deficiency_LCP2_AR	SLP76 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 1 T-B+ SCID	AR		SLP76	LCP2	3937	nan	Low T cells- mainly TEMRA and oligoconal	Normal	Low	Normal but dysfunctional	Reduced NK degranulation, platelet dysfunction	[]	['hsa04015  Rap1 signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04611  Platelet activation', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04660  T cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa05135  Yersinia infection']	['HP:0002715', 'HP:0000007', 'HP:0004313', 'HP:0005403', 'HP:0011993']
Adenosine deaminase (ADA) deficiency_ADA_AR	Adenosine deaminase (ADA) deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AR	608958	ADA	ADA	100	Low NK, bone defects, may have pulmonary alveolar proteinosis, cognitive defects	Very low	Low, decreasing	Low	Normal	Low NK	['Elapegademase: D11017<JP/US>', 'Pentostatin: D00155<JP/US>']	['hsa00230  Purine metabolism', 'hsa01100  Metabolic pathways', 'hsa01232  Nucleotide metabolism', 'hsa05340  Primary immunodeficiency']	['HP:0006517', 'HP:0002715', 'HP:0000007', 'HP:0004313', 'HP:0005403', 'HP:0100543']
Reticular dysgenesis_AK2_AR	Reticular dysgenesis	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AR	103020	AK2	AK2	204	Deafness	Very low	Nl to low	Low	Low	nan	[]	['hsa00230  Purine metabolism', 'hsa00730  Thiamine metabolism', 'hsa01100  Metabolic pathways', 'hsa01232  Nucleotide metabolism', 'hsa01240  Biosynthesis of cofactors']	['HP:0002715', 'HP:0000365', 'HP:0000007', 'HP:0001875', 'HP:0004313', 'HP:0005403']
DCLRE1C (Artemis) deficiency_DCLRE1C_AR	DCLRE1C (Artemis) deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AR	605988	DCLRE1C	DCLRE1C	64421	Radiation sensitive	Very low	Very low	Low	Normal	nan	[]	['hsa03450  Non-homologous end-joining', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0005365', 'HP:0000007', 'HP:0011133', 'HP:0004313', 'HP:0005403']
DNA ligase IV deficiency_LIG4_AR	DNA ligase IV deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AR	601837	LIG4	LIG4	3981	Radiation sensitive, microcephaly	Very low	Very low	Low	Normal	nan	[]	['hsa03450  Non-homologous end-joining']	['HP:0002715', 'HP:0005365', 'HP:0000007', 'HP:0000252', 'HP:0011133', 'HP:0004313', 'HP:0005403']
Cernunnos/XLF deficiency_NHEJ1_AR	Cernunnos/XLF deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AR	611290	NHEJ1	NHEJ1	79840	Radiation sensitive, microcephaly	Very low	Very low	Low	Normal	nan	[]	['hsa03450  Non-homologous end-joining']	['HP:0002715', 'HP:0005365', 'HP:0000007', 'HP:0000252', 'HP:0011133', 'HP:0004313', 'HP:0005403']
DNA PKcs deficiency_PRKDC_AR	DNA PKcs deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AR	176977	PRKDC	PRKDC	5591	Radiation sensitive	Very low	Very low	Variable	Normal	nan	[]	['hsa03450  Non-homologous end-joining', 'hsa04110  Cell cycle']	['HP:0002715', 'HP:0005365', 'HP:0000007', 'HP:0011133', 'HP:0005403']
Activated RAC2 defect_RAC2_AD GOF	Activated RAC2 defect	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AD GOF	602049	RAC2	RAC2	5880	Reticular dysgenesis	Very low	Very low	Low	Low	nan	[]	['hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04071  Sphingolipid signaling pathway', 'hsa04310  Wnt signaling pathway', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04510  Focal adhesion', 'hsa04520  Adherens junction', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04670  Leukocyte transendothelial migration', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05135  Yersinia infection', 'hsa05163  Human cytomegalovirus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05210  Colorectal cancer', 'hsa05212  Pancreatic cancer', 'hsa05231  Choline metabolism in cancer', 'hsa05415  Diabetic cardiomyopathy', 'hsa05416  Viral myocarditis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0002715', 'HP:0005365', 'HP:0001875', 'HP:0004313', 'HP:0005403']
RAG1 deficiency_RAG1_AR	RAG1 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AR	179615	RAG1	RAG1	5896	nan	Very low	Very low	Low	Normal	nan	[]	['hsa04068  FoxO signaling pathway', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0005365', 'HP:0000007', 'HP:0004313', 'HP:0005403']
RAG2 deficiency_RAG2_AR	RAG2 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 2 T-B- SCID	AR	179616	RAG2	RAG2	5897	nan	Very low	Very low	Low	Normal	nan	[]	['hsa04068  FoxO signaling pathway', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0005365', 'HP:0000007', 'HP:0004313', 'HP:0005403']
MHC class I deficiency_B2M_AR	MHC class I deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	109700	B2M	B2M	567	Sinopulmonary infections, cutaneous granulomas. Absent Î²2m associated proteins MHC-I, CD1a, CD1b, CD1c	Low CD8, Nl CD4, absent MHC I on lymphocytes	Normal	Normal	nan	nan	[]	['hsa04612  Antigen processing and presentation', 'hsa05163  Human cytomegalovirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection']	['HP:0002715', 'HP:0000007', 'HP:0005415', 'HP:0032252', 'HP:0005403']
BCL10 deficiency_BCL10_AR	BCL10 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	616098	BCL10	BCL10	8915	Recurrent bacterial and viral infections, candidiasis, gastroenteritis	Nl number, low memory T and Treg cells, poor antigen and anti-CD3 proliferation	Nl number, decreased memory and switched B cells	nan	nan	nan	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa05131  Shigellosis', 'hsa05152  Tuberculosis']	['HP:0005403', 'HP:0000007', 'HP:0002715']
CARD11 deficiency (LOF)_CARD11_AR	CARD11 deficiency (LOF)	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	615206	CARD11	CARD11	84433	Pneumocystis jirovecii pneumonia, bacterial and viral infections	Nl number, predominant naÃ¯ve T-cells, poor proliferation	Normal, transitional B cell predominance	nan	nan	nan	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway']	['HP:0002715', 'HP:0000007', 'HP:0002090', 'HP:0020102', 'HP:0005403']
CD3g deficiency_CD3G_AR	CD3g deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	186740	CD3G	CD3G	917	nan	Nl number, but low TCR expression	Normal	Nl	nan	nan	['Antithymocyte immunoglobulin (rabbit): D09190<JP/US>', 'Blinatumomab: D09325<JP/US>', 'Catumaxomab: D09207', 'Flotetuzumab: D11306', 'Muromonab-CD3: D05092', 'Otelixizumab: D08959', 'Tebentafusp: D12296<US>', 'Teplizumab: D09013', 'Visilizumab: D06314']	['hsa04640  Hematopoietic cell lineage', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa05142  Chagas disease', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer']	['HP:0005403', 'HP:0000007', 'HP:0002715']
CD40 deficiency_CD40_AR	CD40 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	109535	CD40 (TNFRSF5)	CD40	958	Thrombocytopenia, hemolytic anemia, opportunistic infections, biliary tract and liver disease, Cryptosporidium infections	Normal	sIgM+, IgD+ cells present, absent sIgG+, IgA+ and IgE+ cells	IgM nl or high low IgG, IgA	Variable	nan	['Bleselumab: D11357', 'Dacetuzumab: D08896', 'Iscalimab: D11610', 'Lucatumumab: D08942', 'Ravagalimab: D11597', 'Selicrelumab: D11491', 'Sotigalimab: D12178', 'Teneliximab: D06071']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04064  NF-kappa B signaling pathway', 'hsa04514  Cell adhesion molecules', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04672  Intestinal immune network for IgA production', 'hsa05144  Malaria', 'hsa05145  Toxoplasmosis', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05310  Asthma', 'hsa05320  Autoimmune thyroid disease', 'hsa05322  Systemic lupus erythematosus', 'hsa05330  Allograft rejection', 'hsa05340  Primary immunodeficiency', 'hsa05416  Viral myocarditis', 'hsa05417  Lipid and atherosclerosis']	['HP:0002715', 'HP:0001903', 'HP:0002720', 'HP:0000007', 'HP:0003496', 'HP:0001392', 'HP:0001873', 'HP:0004313', 'HP:0005403', 'HP:0031690', 'HP:0001878']
CD40 ligand deficiency (CD154)_CD40LG_XL	CD40 ligand deficiency (CD154)	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	XL	300386	CD40LG (TNFSF5)	CD40LG	959	Thrombocytopenia, hemolytic anemia, opportunistic infections, biliary tract and liver disease, Cryptosporidium infections	Nl to low	sIgM+, IgD+ cells present, absent sIgG+, IgA+ and IgE+ cells	IgM nl or high low IgG, IgA	Variable	nan	['Letolizumab: D11122', 'Ruplizumab: D05777', 'Toralizumab: D06193']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04064  NF-kappa B signaling pathway', 'hsa04514  Cell adhesion molecules', 'hsa04660  T cell receptor signaling pathway', 'hsa04672  Intestinal immune network for IgA production', 'hsa05144  Malaria', 'hsa05145  Toxoplasmosis', 'hsa05310  Asthma', 'hsa05320  Autoimmune thyroid disease', 'hsa05322  Systemic lupus erythematosus', 'hsa05330  Allograft rejection', 'hsa05340  Primary immunodeficiency', 'hsa05416  Viral myocarditis', 'hsa05417  Lipid and atherosclerosis']	['HP:0002715', 'HP:0001903', 'HP:0002720', 'HP:0003496', 'HP:0001392', 'HP:0001873', 'HP:0004313', 'HP:0001417', 'HP:0005403', 'HP:0031690', 'HP:0001878']
CD8 deficiency_CD8A_AR	CD8 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	186910	CD8A	CD8A	925	Recurrent infections, may be asymptomatic	Absent CD8, nl CD4	Normal	Nl	nan	nan	['Antithymocyte immunoglobulin (rabbit): D09190<JP/US>', 'Tucidinostat: D10993<JP>']	['hsa04514  Cell adhesion molecules', 'hsa04612  Antigen processing and presentation', 'hsa04640  Hematopoietic cell lineage', 'hsa04660  T cell receptor signaling pathway', 'hsa05135  Yersinia infection', 'hsa05340  Primary immunodeficiency']	['HP:0005403', 'HP:0000007', 'HP:0002719', 'HP:0002715']
CHUK deficiency_CHUK_AR	CHUK deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR		CHUK	CHUK	1147	"Combined immunodeficiency, recurrent infections (Staphylococcus aureus, mucocutaneous candidiasis, epidermodysplasia verruciformis due to HPV).
Absent secondary lymphoid tissues, lymphocytic infiltration of intestine and liver. Skeletal abnormalities, failure to thrive.Normal T cell proliferation, reduced NK function"	Normal T, NK cell numbers.  Accumulation of immature NK cells	B cell lymphopenia	Pan-hypogammaglobulinemia	nan	nan	[]	['hsa01523  Antifolate resistance', 'hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04150  mTOR signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05212  Pancreatic cancer', 'hsa05215  Prostate cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0002728', 'HP:0001508', 'HP:0010976', 'HP:0002719', 'HP:0002721', 'HP:0000007', 'HP:0000924', 'HP:0005387', 'HP:0002726', 'HP:0004432']
MHC class II deficiency group A_CIITA_AR	MHC class II deficiency group A	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	600005	CIITA	CIITA	4261	Respiratory and gastrointestinal infections, liver/biliary tract disease	"Low CD4 cells
Absent MHC II expression on lymphocytes"	Normal	Normal to low	nan	nan	[]	['hsa04612  Antigen processing and presentation', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05164  Influenza A', 'hsa05340  Primary immunodeficiency']	['HP:0004798', 'HP:0002715', 'HP:0000007', 'HP:0004313', 'HP:0005403']
COPG1 deficiency_COPG1_AR	COPG1 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR		COPG1	COPG1	22820	"recurrent pneumonia, viral respiratory infections, bronchiectasis, chronic EBV, CMV viremia.  Failure to thrive
impaired T and B cell function in vitro"	T cell lymphopenia, mostly CD4	normal slightly reduced	"near-normal levels of serum IgM, G, A
â¢ poor/absent Ig responses to vaccines"	nan	nan	[]	[]	['HP:0001508', 'HP:0011947', 'HP:0000007', 'HP:0002110', 'HP:0002090', 'HP:0006532', 'HP:0020071']
DOCK2 deficiency_DOCK2_AR	DOCK2 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	603122	DOCK2	DOCK2	1794	Nl NK cells, but defective function. Poor interferon responses in hematopoietic and non-hematopoietic cells	Low	Normal	Low	Normal	nan	[]	['hsa04062  Chemokine signaling pathway']	['HP:0005403', 'HP:0000007', 'HP:0002715', 'HP:0004313']
DOCK8 deficiency_DOCK8_AR	DOCK8 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	243700	DOCK8	DOCK8	81704	Low NK cells with poor function, eosinophilia, recurrent infections, cutaneous viral, fungal and staphylococcal infections, severe atopy, cancer diathesis	Low, poor proliferation, few, poorly functioning Treg	Low, low CD27+ memory B cells Poor peripheral B cell tolerance.	Low IgM, normal to high IgG and IgA, high IgE	nan	Low NK	[]	[]	['HP:0003237', 'HP:0001880', 'HP:0002715', 'HP:0002664', 'HP:0002719', 'HP:0000007', 'HP:0003212', 'HP:0002850', 'HP:0003261', 'HP:0005403']
FCHO1 deficiency_FCHO1_AR	FCHO1 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	613437	FCHO1	FCHO1	23149	Recurrent infections, lymphoproliferation, increased activation-induced T-cell death, defective clathrin-mediated endocytosis	Low	Normal	Normal	nan	nan	[]	[]	['HP:0005403', 'HP:0000007', 'HP:0002719', 'HP:0002715']
ICOS deficiency_ICOS_AR	ICOS deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	604558	ICOS	ICOS	29851	Recurrent infections, autoimmunity, gastroenteritis, granulomas	Normal	Normal	Low	nan	nan	['Acazicolcept: D12300', 'Feladilimab: D11996', 'Izuralimab: D12195', 'Vopratelimab: D11433']	['hsa04514  Cell adhesion molecules', 'hsa04660  T cell receptor signaling pathway', 'hsa04672  Intestinal immune network for IgA production', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0002960', 'HP:0002719', 'HP:0000007', 'HP:0004313', 'HP:0032252', 'HP:0005403']
ICOLG deficiency_ICOSLG_AR	ICOLG deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	605717	ICOSLG	ICOSLG	23308	Recurrent bacterial and viral infections	Low	Low	Low	Low	nan	['Rozibafusp alfa: D11907']	['hsa04514  Cell adhesion molecules', 'hsa04672  Intestinal immune network for IgA production']	['HP:0010976', 'HP:0002715', 'HP:0000007', 'HP:0001875', 'HP:0004313', 'HP:0005403']
IKBKB deficiency_IKBKB_AR	IKBKB deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	615592	IKBKB	IKBKB	3551	Recurrent bacterial, viral, fungal infections, opportunistic infections	Nl number, absent Treg and g/d T cells, impaired TCR activation	Nl number, poor function	nan	nan	nan	['Ertiprotafib: D04050']	['hsa01523  Antifolate resistance', 'hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04150  mTOR signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04910  Insulin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04930  Type II diabetes mellitus', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05212  Pancreatic cancer', 'hsa05215  Prostate cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0005403', 'HP:0031690', 'HP:0000007', 'HP:0002715']
Ikaros deficiency_IKZF1_AD DN	Ikaros deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AD DN		IKZF1	IKZF1	10320	Recurrent sinopulmonary infections, pneumocystis early CID onset	No memory T cells	No memory B cells	Low	nan	nan	[]	[]	['HP:0000006', 'HP:0005425', 'HP:0002715', 'HP:0002721', 'HP:0005387', 'HP:0004313', 'HP:0005403']
IKZF2 deficiency_IKZF2_AD	IKZF2 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AD		IKZF2	IKZF2	22807	"combined immunodeficiency, recurrent upper respiratory infections/pneumonia, thrush, mucosal ulcers, chronic lymphadenopathy, SLE, ITP, Evanâs syndrome.
EBV-associated HLH, lymphoma"	"Increased activated/ exhausted T cells. Increased  production pro-inflammatory cytokines by T cells.  Increased MAIT, Tfh cells, NK cells.
Normal Treg"	normal B cell numbers, but low switched memory. dysregulated germinal centers	hypogammaglobulinemia with low/normal IgG vaccine responses	nan	nan	[]	[]	['HP:0000006', 'HP:0032140', 'HP:0030374', 'HP:0002721', 'HP:0005387', 'HP:0002665', 'HP:0004313', 'HP:0002716']
IKZF2 deficiency_IKZF2_AR	IKZF2 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR		IKZF2	IKZF2	22807	"combined immunodeficiency, recurrent upper respiratory infections/pneumonia, thrush, mucosal ulcers, chronic lymphadenopathy, SLE, ITP, Evanâs syndrome.
EBV-associated HLH, lymphoma"	"Increased activated/ exhausted T cells. Increased  production pro-inflammatory cytokines by T cells.  Increased MAIT, Tfh cells, NK cells.
Normal Treg"	normal B cell numbers, but low switched memory. dysregulated germinal centers	hypogammaglobulinemia with low/normal IgG vaccine responses	nan	nan	[]	[]	['HP:0032140', 'HP:0030374', 'HP:0002721', 'HP:0000007', 'HP:0005387', 'HP:0002665', 'HP:0004313', 'HP:0002716']
IL-21 deficiency_IL21_AR	IL-21 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	615767	IL21	IL21	59067	Severe early onset colitis, recurrent sinopulmonary infections	Nl number, nl/low function	Low	nan	nan	nan	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04630  JAK-STAT signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa05321  Inflammatory bowel disease']	['HP:0005425', 'HP:0002583', 'HP:0002715', 'HP:0010976', 'HP:0000007', 'HP:0005403']
IL-21R deficiency_IL21R_AR	IL-21R deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	615207	IL21R	IL21R	50615	Recurrent infections, Pneumocystis jiroveci, Cryptosporidium infections and liver disease	Nl number, low cytokine production, poor antigen proliferation	Normal	nan	nan	nan	['Denenicokin: D09332']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04630  JAK-STAT signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa05321  Inflammatory bowel disease']	['HP:0002715', 'HP:0002719', 'HP:0000007', 'HP:0001392', 'HP:0005403']
ITK deficiency_ITK_AR	ITK deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	186973	ITK	ITK	3702	EBV associated B cell lymphoproliferation, lymphoma	Progressive decrease	Normal	Variable	nan	nan	[]	['hsa04062  Chemokine signaling pathway', 'hsa04660  T cell receptor signaling pathway', 'hsa04670  Leukocyte transendothelial migration']	['HP:0002715', 'HP:0020072', 'HP:0000007', 'HP:0002665', 'HP:0005403']
LCK deficiency_LCK_AR	LCK deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	615758	LCK	LCK	3932	Recurrent infections, immune dysregulation, autoimmunity	Low CD4+, low Treg, restricted T cell repertoire, poor TCR signaling	Normal	nan	nan	nan	['Dasatinib (DG00714): D03658<JP> D06414<JP/US>']	['hsa04064  NF-kappa B signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa05135  Yersinia infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0002960', 'HP:0002719', 'HP:0000007', 'HP:0005403', 'HP:0002958']
MALT1 deficiency_MALT1_AR	MALT1 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	615468	MALT1	MALT1	10892	Bacterial, fungal and viral infections	Nl number, poor proliferation	Normal	nan	nan	nan	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa05131  Shigellosis', 'hsa05152  Tuberculosis']	['HP:0005403', 'HP:0000007', 'HP:0002715']
MAN2B2 deficiency_MAN2B2_AR	MAN2B2 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR		MAN2B2	MAN2B2	23324	Developmental delay, congenital disorder of glycosylation, microcephaly, vasculitis, arthritis, FTT	Low T cells and TRECs	Low	Normal IgM, low IgA, high IgE	nan	nan	[]	['hsa00511  Other glycan degradation']	['HP:0001508', 'HP:0002715', 'HP:0010976', 'HP:0002720', 'HP:0000007', 'HP:0001263', 'HP:0003212', 'HP:0000252', 'HP:0001369', 'HP:0005403', 'HP:0002633']
NIK deficiency_MAP3K14_AR	NIK deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	604655	MAP3K14	MAP3K14	9020	Recurrent bacterial, viral and Cryptosporidium infections	Nl number, poor proliferation to antigen	Low, low switched memory B cells	nan	nan	Low NK	[]	['hsa04010  MAPK signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04210  Apoptosis', 'hsa04380  Osteoclast differentiation', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04660  T cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04672  Intestinal immune network for IgA production', 'hsa04936  Alcoholic liver disease', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05208  Chemical carcinogenesis - reactive oxygen species']	['HP:0010976', 'HP:0002715', 'HP:0030374', 'HP:0000007', 'HP:0005403']
Moesin deficiency_MSN_XL	Moesin deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	XL	300988	MSN	MSN	4478	Recurrent infections with bacteria, varicella	Nl number, defective migration, proliferaton	Low number	nan	Low	nan	[]	['hsa04530  Tight junction', 'hsa04670  Leukocyte transendothelial migration', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05162  Measles', 'hsa05205  Proteoglycans in cancer']	['HP:0002715', 'HP:0002719', 'HP:0001875', 'HP:0001417', 'HP:0005403']
Polymerase d 1 deficiency_POLD1_AR	Polymerase d 1 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	174761	POLD1	POLD1	5424	Recurrent respiratory tract infections, skin infections, warts and molluscum, short stature, intellectual disability	Low CD4 T cells	Low	Low	nan	nan	[]	['hsa03030  DNA replication', 'hsa03410  Base excision repair', 'hsa03420  Nucleotide excision repair', 'hsa03430  Mismatch repair', 'hsa03440  Homologous recombination']	['HP:0004322', 'HP:0002715', 'HP:0010976', 'HP:0011947', 'HP:0032218', 'HP:0100658', 'HP:0000007', 'HP:0001249', 'HP:0200043', 'HP:0004313', 'HP:0005403']
Polymerase d 2 deficiency_POLD2_AR	Polymerase d 2 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	600815	POLD2	POLD2	5425	Recurrent respiratory tract infections, skin infections, warts and molluscum, short stature, intellectual disability	Low CD4 T cells	Low	Low	nan	nan	[]	['hsa03030  DNA replication', 'hsa03410  Base excision repair', 'hsa03420  Nucleotide excision repair', 'hsa03430  Mismatch repair', 'hsa03440  Homologous recombination']	['HP:0004322', 'HP:0002715', 'HP:0010976', 'HP:0011947', 'HP:0032218', 'HP:0100658', 'HP:0000007', 'HP:0001249', 'HP:0200043', 'HP:0004313', 'HP:0005403']
c-Rel deficiency_REL_AR	c-Rel deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	164910	REL	REL	5966	Recurrent infections with bacteria, mycobacteria, salmonella and opportunistic infections	Normal	Low	Low	nan	nan	[]	['hsa04014  Ras signaling pathway', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05203  Viral carcinogenesis']	['HP:0002715', 'HP:0010976', 'HP:0002719', 'HP:0000007', 'HP:0004313', 'HP:0005403', 'HP:0031690']
RelA haplosufficiency_RELA_AD	RelA haplosufficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AD	618287	RELA	RELA	5970	Mucosal ulceration, impaired NFkB activation	Normal	Normal	Normal	nan	nan	['Edasalonexent: D12181']	['hsa01523  Antifolate resistance', 'hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04071  Sphingolipid signaling pathway', 'hsa04137  Mitophagy - animal', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04211  Longevity regulating pathway', 'hsa04218  Cellular senescence', 'hsa04380  Osteoclast differentiation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04917  Prolactin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04926  Relaxin signaling pathway', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05030  Cocaine addiction', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05134  Legionellosis', 'hsa05135  Yersinia infection', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05146  Amoebiasis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05212  Pancreatic cancer', 'hsa05215  Prostate cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0005403', 'HP:0000006', 'HP:0002715']
RelB deficiency_RELB_AR	RelB deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	604758	RELB	RELB	5971	Recurrent infections	Nl number, poor diversity, poor function	nan	nan	nan	nan	[]	['hsa04010  MAPK signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05169  Epstein-Barr virus infection']	['HP:0005403', 'HP:0000007', 'HP:0002719', 'HP:0002715']
MHC class II deficiency group C_RFX5_AR	MHC class II deficiency group C	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	601863	RFX5	RFX5	5993	Respiratory and gastrointestinal infections, liver/biliary tract disease	Low CD4 cells	Normal	Normal to low	nan	nan	[]	['hsa04612  Antigen processing and presentation', 'hsa05152  Tuberculosis', 'hsa05340  Primary immunodeficiency']	['HP:0004798', 'HP:0002715', 'HP:0032218', 'HP:0000007', 'HP:0004313', 'HP:0005403']
MHC class II deficiency group B_RFXANK_AR	MHC class II deficiency group B	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	603200	RFXANK	RFXANK	8625	Respiratory and gastrointestinal infections, liver/biliary tract disease	Low CD4 cells	Normal	Normal to low	nan	nan	[]	['hsa04612  Antigen processing and presentation', 'hsa05152  Tuberculosis', 'hsa05340  Primary immunodeficiency']	['HP:0004798', 'HP:0002715', 'HP:0032218', 'HP:0000007', 'HP:0004313', 'HP:0005403']
MHC class II deficiency group D_RFXAP_AR	MHC class II deficiency group D	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	601861	RFXAP	RFXAP	5994	Respiratory and gastrointestinal infections, liver/biliary tract disease	Low CD4 cells	Normal	Normal to low	nan	nan	[]	['hsa04612  Antigen processing and presentation', 'hsa05152  Tuberculosis', 'hsa05340  Primary immunodeficiency']	['HP:0004798', 'HP:0002715', 'HP:0032218', 'HP:0000007', 'HP:0004313', 'HP:0005403']
Rhoh Deficiency_RHOH_AR	Rhoh Deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	602037	RHOH	RHOH	399	HPV infection, lung granulomas, molluscum contagiosum, lymphoma	Nl number, low naÃ¯ve T cells, restricted repertoire, poor proliferation to CD3	Normal	nan	nan	nan	[]	['hsa04670  Leukocyte transendothelial migration', 'hsa05132  Salmonella infection']	['HP:0002715', 'HP:0000007', 'HP:0002665', 'HP:0032252', 'HP:0005403', 'HP:0032163']
SASH3 deficiency_SASH3_XL	SASH3 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	XL		SASH3	SASH3	54440	"Combined immunodeficiency and immune dysregulation, recurrent sinopulmonary, cutaneous and mucosal infections, refractory autoimmune cytopenias. increased levels of pro-inflammatory biomarkers, consistent with immune dysregulation.
Low TCR-induced T cell signaling, proliferation/cell cycle progression, hi apoptosis"	"CD4+ T cell, NK cell lymphopenia
low naÃ¯ve CD4 and CD8 T cells"	"B cell lymphopenia
hi  BM plasmablasts"	"low serum IgG, IgA 
reduced specific Ab responses"	nan	nan	[]	[]	['HP:0002960', 'HP:0010976', 'HP:0002721', 'HP:0005387', 'HP:0001417', 'HP:0002958']
MST1 deficiency_STK4_AR	MST1 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	614868	STK4	STK4	6789	Intermittent neutropenia, bacterial, viral (HPV), candidal infections, EBV lymphoproliferation, autoimmune cytopenias, lymphoma, congenital heart disease	Low, low terminal differentiated  effector memory (TEMRA) cells, low naÃ¯ve T cells, poor proliferation	Low	nan	nan	nan	[]	['hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa05200  Pathways in cancer', 'hsa05223  Non-small cell lung cancer']	['HP:0002715', 'HP:0002960', 'HP:0010976', 'HP:0000007', 'HP:0001875', 'HP:0002665', 'HP:0005403']
MHC class I deficiency_TAP1_AR	MHC class I deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	170260	TAP1	TAP1	6890	Vasculitis, pyoderma gangrenosum	Low CD8, Nl CD4, absent MHC I on lymphocytes	Normal	Normal	nan	nan	[]	['hsa02010  ABC transporters', 'hsa04145  Phagosome', 'hsa04612  Antigen processing and presentation', 'hsa05163  Human cytomegalovirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05340  Primary immunodeficiency']	['HP:0025452', 'HP:0002715', 'HP:0000007', 'HP:0005415', 'HP:0005403', 'HP:0002633', 'HP:0000999']
MHC class I deficiency_TAP2_AR	MHC class I deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	170261	TAP2	TAP2	6891	Vasculitis, pyoderma gangrenosum	Low CD8, Nl CD4, absent MHC I on lymphocytes	Normal	Normal	nan	nan	[]	['hsa02010  ABC transporters', 'hsa04145  Phagosome', 'hsa04612  Antigen processing and presentation', 'hsa05163  Human cytomegalovirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05340  Primary immunodeficiency']	['HP:0025452', 'HP:0002715', 'HP:0000007', 'HP:0005415', 'HP:0005403', 'HP:0002633', 'HP:0000999']
MHC class I deficiency_TAPBP_AR	MHC class I deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	601962	TAPBP	TAPBP	6892	Vasculitis,pyoderma gangrenosum	Low CD8, Nl CD4, absent MHC I on lymphocytes	Normal	Normal	nan	nan	[]	['hsa04612  Antigen processing and presentation', 'hsa05163  Human cytomegalovirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection']	['HP:0025452', 'HP:0002715', 'HP:0000007', 'HP:0005415', 'HP:0005403', 'HP:0002633', 'HP:0000999']
TFRC deficiency_TFRC_AR	TFRC deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	616740	TFRC	TFRC	7037	Recurrent infections, thrombocytopenia	Nl number, poor proliferation	Nl number, low memory B cells	nan	Low	nan	['Pabinafusp alfa: D11812<JP>']	['hsa04066  HIF-1 signaling pathway', 'hsa04144  Endocytosis', 'hsa04145  Phagosome', 'hsa04216  Ferroptosis', 'hsa04640  Hematopoietic cell lineage']	['HP:0002715', 'HP:0030374', 'HP:0002719', 'HP:0000007', 'HP:0001875', 'HP:0001873', 'HP:0005403']
OX40 deficiency_TNFRSF4_AR	OX40 deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	615593	TNFRSF4	TNFRSF4	7293	Impaired immunity to HHV8, Kaposiâs sarcoma	Nl numbers, low antigen specific memory CD4+	Nl numbers, low memory B cells	nan	nan	nan	['Tavolimab: D11301', 'Vonlerolizumab: D11268']	['hsa04060  Cytokine-cytokine receptor interaction']	['HP:0100726', 'HP:0002715', 'HP:0000007', 'HP:0100242', 'HP:0005403']
TCRÎ± deficiency_TRAC_AR	TCRÎ± deficiency	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	615387	TRAC	TRAC	28755	Recurrent viral, bacterial, fungal infections, immune dysregulation and autoimmunity, diarrhea	Absent TCRÎ±Î², all T cells are Î³Î´, poor proliferation	Normal	nan	nan	nan			['HP:0002715', 'HP:0002960', 'HP:0002014', 'HP:0000007', 'HP:0005403', 'HP:0002958']
ZAP-70 deficiency (ZAP70 LOF)_ZAP70_AR	ZAP-70 deficiency (ZAP70 LOF)	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR	176947	ZAP70	ZAP70	7535	May have immune dysregulation, autoimmunity	Low CD8, Nl CD4 number but poor function	Normal	Nl	nan	nan	[]	['hsa04014  Ras signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa05135  Yersinia infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0002960', 'HP:0000007', 'HP:0005403', 'HP:0002958']
ZAP70 combined hypomorphic GOF_ZAP70_AR LOF/GOF	ZAP70 combined hypomorphic GOF	Table 1 Immunodeficiencies affecting cellular and humoral immunity	Subtable 3 Combined Immunodeficiencies Generally Less Profound than Severe Combined Immunodeficiency	AR LOF/GOF	176947	ZAP70	ZAP70	7535	Severe autoimmunity	Decreased CD8, normal or decreased CD4 cells	Normal or decreased	nan	nan	nan	[]	['hsa04014  Ras signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa05135  Yersinia infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05340  Primary immunodeficiency']	['HP:0000006', 'HP:0002715', 'HP:0002960', 'HP:0000007', 'HP:0005403']
ARPC1B deficiency_ARPC1B_AR	ARPC1B deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 1 Immunodeficiency with Congenital Thrombocytopenia	AR	604223	ARPC1B	ARPC1B	10095	Mild thrombocytopenia with normal sized platelets, recurrent invasive infections, colitis, vasculitis, autoantibodies (ANA, ANCA), eosinophilia, defective Arp2/3, filament branching	Normal	Normal Numbers	High IgE	nan	nan	[]	['hsa04144  Endocytosis', 'hsa04530  Tight junction', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05100  Bacterial invasion of epithelial cells', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection']	['HP:0001880', 'HP:0002583', 'HP:0002715', 'HP:0000007', 'HP:0003212', 'HP:0001873', 'HP:0005403', 'HP:0002633']
Wiskott-Aldrich syndrome (WAS LOF)_WAS_XL	Wiskott-Aldrich syndrome (WAS LOF)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 1 Immunodeficiency with Congenital Thrombocytopenia	XL	Â 300392	WAS	WAS	7454	Thrombocytopenia with small platelets, recurrent bacterial and viral infections, bloody diarrhea,  eczema, lymphoma, autoimmune disease, IgA nephropathy, vasculitis. XL thrombocytopenia is a mild form of WAS	Progressive decrease in numbers,  Abnormal lymphocyte responses to anti-CD3	Normal numbers	High IgE, low IgM	nan	nan	[]	['hsa04062  Chemokine signaling pathway', 'hsa04520  Adherens junction', 'hsa04530  Tight junction', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa05135  Yersinia infection', 'hsa05231  Choline metabolism in cancer']	['HP:0000964', 'HP:0002715', 'HP:0002960', 'HP:0002014', 'HP:0000112', 'HP:0003212', 'HP:0002665', 'HP:0001873', 'HP:0002850', 'HP:0001417', 'HP:0005403', 'HP:0002633', 'HP:0000794', 'HP:0005537', 'HP:0025085']
WIP deficiency_WIPF1_AR	WIP deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 1 Immunodeficiency with Congenital Thrombocytopenia	AR	602357	WIPF1	WIPF1	7456	Thrombocytopenia with or without small platelets, recurrent bacterial and viral infections, eczema, bloody diarrhea, WAS protein absent	Reduced, defective lymphocyte responses to anti-CD3	Normal or low	High IgE	nan	nan	[]	['hsa04144  Endocytosis', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05135  Yersinia infection']	['HP:0000964', 'HP:0002715', 'HP:0002014', 'HP:0000007', 'HP:0003212', 'HP:0001873', 'HP:0005403', 'HP:0005537', 'HP:0025085']
Ataxia-telangiectasia_ATM_AR	Ataxia-telangiectasia	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	607585	ATM	ATM	472	Ataxia, telangiectasia, pulmonary infections, lymphoreticular and other malignancies, increased alpha fetoprotein,  increased radiosensitivity, chromosomal instability and chromosomal translocations	Progressive decrease, abnormal proliferation to mitogens	Normal	Variable	nan	nan	[]	['hsa01524  Platinum drug resistance', 'hsa03440  Homologous recombination', 'hsa04064  NF-kappa B signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04110  Cell cycle', 'hsa04115  p53 signaling pathway', 'hsa04210  Apoptosis', 'hsa04218  Cellular senescence', 'hsa05131  Shigellosis', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05206  MicroRNAs in cancer']	['HP:0002715', 'HP:0001251', 'HP:0000007', 'HP:0006532', 'HP:0005403', 'HP:0001009']
Bloom Syndrome_BLM_AR	Bloom Syndrome	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	604610	BLM               (RECQL3)	BLM	641	Short stature, dysmorphic facies, sun-sensitive erythema, marrow failure, leukemia, lymphoma, chromosomal instability	Normal	Normal	Low	nan	nan	[]	['hsa03440  Homologous recombination', 'hsa03460  Fanconi anemia pathway']	['HP:0004322', 'HP:0002715', 'HP:0001999', 'HP:0000007', 'HP:0001909', 'HP:0004313', 'HP:0002665', 'HP:0010783', 'HP:0005403']
Immunodeficiency with centromeric instability and facial anomalies, ICF3_CDCA7_AR	Immunodeficiency with centromeric instability and facial anomalies, ICF3	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	609937	CDCA7	CDCA7	83879	Facial dysmorphic features, macroglossia, bacterial/opportunistic infections, malabsorption, cytopenias, malignancies,  multiradial configurations of chromosomes 1, 9, 16	responses to PHA may be decreased	Decreased or normal	Variably low IgG, IgA	nan	nan	[]	[]	['HP:0002715', 'HP:0001999', 'HP:0010976', 'HP:0002720', 'HP:0000007', 'HP:0002024', 'HP:0000158', 'HP:0004313', 'HP:0005403']
Immunodeficiency with centromeric instability and facial anomalies, ICF1_DNMT3B_AR	Immunodeficiency with centromeric instability and facial anomalies, ICF1	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	602900	DNMT3B	DNMT3B	1789	Facial dysmorphic features, developmental delay, macroglossia, bacterial/opportunistic infections, malabsorption, cytopenias, malignancies,  multiradial configurations of chromosomes 1, 9, 16	Decreased or normal, responses to PHA may be decreased	Decreased or normal	Variably low IgG, IgA	nan	nan	['Azacitidine: D03021<JP/US>', 'Decitabine: D03665<US>']	['hsa00270  Cysteine and methionine metabolism', 'hsa01100  Metabolic pathways', 'hsa05206  MicroRNAs in cancer']	['HP:0002715', 'HP:0001999', 'HP:0010976', 'HP:0002720', 'HP:0000007', 'HP:0001263', 'HP:0002024', 'HP:0000158', 'HP:0004313', 'HP:0005403']
GINS1 deficiency_GINS1_AR	GINS1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	610608	GINS1	GINS1	9837	IUGR	Low or normal	Low or normal	High IgA, low IgM and IgG	Low	Low NK	[]	[]	['HP:0002715', 'HP:0010976', 'HP:0000007', 'HP:0001510', 'HP:0001875', 'HP:0002850', 'HP:0003261', 'HP:0001511', 'HP:0005403', 'HP:0004315']
Immunodeficiency with centromeric instability and facial anomalies, ICF4_HELLS_AR	Immunodeficiency with centromeric instability and facial anomalies, ICF4	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	603946	HELLS	HELLS	3070	Facial dysmorphic features, macroglossia, bacterial/opportunistic infections, malabsorption, cytopenias, malignancies,  multiradial configurations of chromosomes 1, 9, 16	Decreased or normal,	Decreased or normal	Variably low IgG, IgA	nan	nan	[]	[]	['HP:0002715', 'HP:0001999', 'HP:0010976', 'HP:0002720', 'HP:0000007', 'HP:0002024', 'HP:0000158', 'HP:0004313', 'HP:0005403']
Ligase I deficiency_LIG1_AR	Ligase I deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	126391	LIG1	LIG1	3978	Recurrent respiratory infections,  growth retardation, sun sensitivity, lymphoma, radiation sensitivity	Lymphopenia, decreased mitogen response	Normal	Low, poor function	nan	nan	[]	['hsa03030  DNA replication', 'hsa03410  Base excision repair', 'hsa03420  Nucleotide excision repair', 'hsa03430  Mismatch repair']	['HP:0002715', 'HP:0011947', 'HP:0000992', 'HP:0000007', 'HP:0001510', 'HP:0002665', 'HP:0002205', 'HP:0004313', 'HP:0005403']
MCM10 deficiency_MCM10_AR	MCM10 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR		MCM10	MCM10	55388	CMV, HLH-like, phenocopies GINS1 and MCM4	Mild lymphopenia with decreased CM, EM T cells	Low	Slightly low IgG	nan	VERY low NK, absent CD56dim, poor NK function	[]	[]	['HP:0010976', 'HP:0002715', 'HP:0000007', 'HP:0005403', 'HP:0004315']
MCM4 deficiency_MCM4_AR	MCM4 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	602638	MCM4	MCM4	4173	Viral infections (EBV, HSV, VZV),  short stature, B cell lymphoma, adrenal failure	Normal	Normal	Normal	nan	Low NK	[]	['hsa03030  DNA replication', 'hsa04110  Cell cycle']	['HP:0004322', 'HP:0002715', 'HP:0012191', 'HP:0000007', 'HP:0002665', 'HP:0005403']
Nijmegen breakage syndrome_NBN_AR	Nijmegen breakage syndrome	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	602667	NBS1	NBN	4683	Microcephaly, dysmorphic facies, lymphomas, solid tumors, increased radiosensitivity, chromosomal instability	Progressive decrease	Variably reduced	Variable	nan	nan	[]	['hsa03440  Homologous recombination', 'hsa04218  Cellular senescence']	['HP:0002715', 'HP:0001999', 'HP:0002664', 'HP:0000007', 'HP:0002665', 'HP:0000252', 'HP:0005403']
NSMCE3 deficiency_NSMCE3_AR	NSMCE3 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	608243	NSMCE3	NSMCE3	56160	Severe lung disease (possibly viral), thymic hypoplasia, Chromosomal breakage, radiation sensitivity	Number decreased, poor response to mitogens and antigens	Normal	Normal IgG, IgA, normal to elevated IgM; decreased antibody responses to PPS	nan	nan	[]	[]	['HP:0002088', 'HP:0002715', 'HP:0000778', 'HP:0000007', 'HP:0003496', 'HP:0040012', 'HP:0410299', 'HP:0005403']
PMS2 Deficiency_PMS2_AR	PMS2 Deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	600259	PMS2	PMS2	5395	Recurrent infections, cafÃ©-au-lait spots, lymphoma, colorectal carcinoma, brain tumors	Normal	Low B cells, switched and non-switched	Low IgG and IgA, high IgM, abnormal antibody responses	nan	nan	[]	['hsa03430  Mismatch repair', 'hsa03460  Fanconi anemia pathway']	['HP:0031404', 'HP:0002715', 'HP:0030731', 'HP:0010976', 'HP:0002664', 'HP:0002719', 'HP:0002720', 'HP:0000007', 'HP:0003496', 'HP:0002665', 'HP:0030692', 'HP:0005403', 'HP:0004315']
X-linked reticulate pigmentary disorder-POLA1_POLA1_XL	X-linked reticulate pigmentary disorder-POLA1	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	XL	301220	POLA1	POLA1	5422	Hyperpigmentation, characteristic facies, lung and GI involvement	nan	nan	nan	nan	nan	['Clofarabine: D03546<JP/US>']	['hsa03030  DNA replication']	['HP:0001417', 'HP:0005403', 'HP:0002715']
POLE1 (Polymerase Îµ subunit 1) deficiency (FILS syndrome)_POLE_AR	POLE1 (Polymerase Îµ subunit 1) deficiency (FILS syndrome)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	174762	POLE1	POLE	5426	Recurrent respiratory infections, meningitis, facial dysmorphism, livido, short stature	Decreased T cell proliferation	Low memory B cells	nan	nan	nan	[]	['hsa03030  DNA replication', 'hsa03410  Base excision repair', 'hsa03420  Nucleotide excision repair']	['HP:0004322', 'HP:0002715', 'HP:0001999', 'HP:0011947', 'HP:0030374', 'HP:0000007', 'HP:0033832', 'HP:0002205', 'HP:0001287', 'HP:0005403']
POLE2 (Polymerase Îµ subunit 2) deficiency_POLE2_AR	POLE2 (Polymerase Îµ subunit 2) deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	602670	POLE2	POLE2	5427	Recurrent infections, disseminated BCG infections, autoimmunity (type 1 diabetes, hypothyroidism, facial dysmorphism	Lymphopenia, lack of TRECS, absent proliferation in response to antigens	Very low	nan	nan	nan	[]	['hsa03030  DNA replication', 'hsa03410  Base excision repair', 'hsa03420  Nucleotide excision repair']	['HP:0000821', 'HP:0002715', 'HP:0002960', 'HP:0001999', 'HP:0005365', 'HP:0100651', 'HP:0002719', 'HP:0000007', 'HP:0005403']
RNF168 deficiency (Radiosensitivity, Immune Deficiency, Dysmorphic features, Learning difficulties [RIDDLE] Syndrome)_RNF168_AR	RNF168 deficiency (Radiosensitivity, Immune Deficiency, Dysmorphic features, Learning difficulties [RIDDLE] Syndrome)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	612688	RNF168	RNF168	165918	Short stature, mild defect of motor control to ataxia, normal intelligence to learning difficulties, mild facial dysmorphism to microcephaly,  increased radiosensitivity	Normal	Normal	Low IgG or IgA	nan	nan	[]	[]	['HP:0004322', 'HP:0002715', 'HP:0001999', 'HP:0002720', 'HP:0001251', 'HP:0000007', 'HP:0000252', 'HP:0005403', 'HP:0004315']
Immunodeficiency with centromeric instability and facial anomalies, ICF2_ZBTB24_AR	Immunodeficiency with centromeric instability and facial anomalies, ICF2	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 2 DNA Repair Defects other than those listed in Table 1	AR	614064	ZBTB24	ZBTB24	9841	Facial dysmorphic features, macroglossia, bacterial/opportunistic infections, malabsorption, cytopenias, malignancies,  multiradial configurations of chromosomes 1, 9, 16	Decreased or normal	Decreased or normal	Variably low IgG, IgA	nan	nan	[]	[]	['HP:0002715', 'HP:0001999', 'HP:0010976', 'HP:0002720', 'HP:0000007', 'HP:0002024', 'HP:0000158', 'HP:0004313', 'HP:0005403']
Chromosome 11q deletion syndrome (Jacobsen syndrome)_11q23del_AD	Chromosome 11q deletion syndrome (Jacobsen syndrome)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 3 Thymic Defects with Additional Congenital Anomalies	AD	147791	11q23del	11q23del	11q23del	Recurrent respiratory infections, multiple warts, facial dysmorphism, growth retardation	Variably low	Decreased numbers of B cells and switched memory B cells	Variably low	Normal	nan			['HP:0000006', 'HP:0002715', 'HP:0001999', 'HP:0011947', 'HP:0001510', 'HP:0200043', 'HP:0002205', 'HP:0004313', 'HP:0005403']
CHARGE syndrome due to CHD7 deficiency_CHD7_AD	CHARGE syndrome due to CHD7 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 3 Thymic Defects with Additional Congenital Anomalies	AD	608892	CHD7	CHD7	55636	Coloboma, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies, CNS malformation, some are SCID-like and have low TRECs	Decreased or normal, response to PHA may be decreased	Normal	Normal or decreased	Normal	nan	[]	[]	['HP:0000453', 'HP:0000006', 'HP:0002715', 'HP:0001249', 'HP:0000598', 'HP:0004313', 'HP:0005403', 'HP:0000589']
Chromosome 10p13-p14 deletion Syndrome (10p13-p14DS)_Del10p13-p14_AD	Chromosome 10p13-p14 deletion Syndrome (10p13-p14DS)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 3 Thymic Defects with Additional Congenital Anomalies	AD	601362	Del10p13-p14	Del10p13-p14	Del10p13-p14	Hypoparathyroidism, renal disease, deafness, growth retardation, facial dysmorphism, cardiac defects may be present, recurrent infections +/-	Normal, rarely lymphopenia and decreased lymphoproliferation to mitogens and antigens, hypolastic thymus may be present	Normal	Normal	Normal	nan			['HP:0000006', 'HP:0000829', 'HP:0002715', 'HP:0001999', 'HP:0000365', 'HP:0002719', 'HP:0001510', 'HP:0005403']
Winged helix FOXN1 deficiency (Nude SCID)_FOXN1_AR	Winged helix FOXN1 deficiency (Nude SCID)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 3 Thymic Defects with Additional Congenital Anomalies	AR	600838	FOXN1	FOXN1	8456	Severe infections,  abnormal thymic epithelium, immunodeficiency, congenital alopecia, nail dystrophy,  neural tube defect	Very low	Normal	Low	Normal	nan	[]	[]	['HP:0032169', 'HP:0002715', 'HP:0001596', 'HP:0000007', 'HP:0002721', 'HP:0008404', 'HP:0045005', 'HP:0004313', 'HP:0005403']
FOXN1 Haplosufficiency_FOXN1_AD	FOXN1 Haplosufficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 3 Thymic Defects with Additional Congenital Anomalies	AD	618806	FOXN1	FOXN1	8456	Recurrent, viral and bacterial respiratory tract infections; skin involvement (eczema, dermatitis), nail dystropyhy	Severe T cell lymphopenia at birth, nomrmalised by adulthood	Normal or low	nan	Normal	nan	[]	[]	['HP:0000006', 'HP:0000964', 'HP:0002715', 'HP:0011947', 'HP:0008404', 'HP:0005403', 'HP:0011123']
Chromosome 22q11.2 deletion Syndrome (22q11.2DS) (AKA DiGeorge/velocardiofacial syndrome)_Large (3Mb) deletion of 22q11.2_AD	Chromosome 22q11.2 deletion Syndrome (22q11.2DS) (AKA DiGeorge/velocardiofacial syndrome)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 3 Thymic Defects with Additional Congenital Anomalies	AD	602054	Large (3Mb) deletion of 22q11.2	22q11.2	22q11.2	Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability	5% have < 1500 CD3T cells/uL in neonatal period	Normal numbers in childhood usually	Normal or decreased	Normal	nan			['HP:0000006', 'HP:0000829', 'HP:0002715', 'HP:0001249', 'HP:0004313', 'HP:0005403']
CHARGE syndrome due to SEMA3E deficiency_SEMA3E_AD	CHARGE syndrome due to SEMA3E deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 3 Thymic Defects with Additional Congenital Anomalies	AD	608166	SEMA3E	SEMA3E	9723	Coloboma, heart anomaly, choanal atresia, intellectual retardation, genital and ear anomalies, CNS malformation, some are SCID-like and have low TRECs	Decreased or normal, response to PHA may be decreased	Normal	Normal or decreased	Normal	nan	[]	['hsa04360  Axon guidance']	['HP:0000453', 'HP:0000006', 'HP:0002715', 'HP:0000598', 'HP:0004313', 'HP:0005403', 'HP:0000589']
TBX1 deficiency_TBX1_AD	TBX1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 3 Thymic Defects with Additional Congenital Anomalies	AD	602054	TBX1	TBX1	6899	Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability	Decreased or normal	Normal	Normal or decreased	Normal	nan	[]	[]	['HP:0000006', 'HP:0000829', 'HP:0002715', 'HP:0001249', 'HP:0004313', 'HP:0005403']
Immunoskeletal dysplasia with neurodevelopmental abnormalities (EXTL3 Deficiency)_EXTL3_AR	Immunoskeletal dysplasia with neurodevelopmental abnormalities (EXTL3 Deficiency)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 4 Immuno-osseous Dysplasias	AR	617425	EXTL3	EXTL3	2137	Platyspondyly, kyphosis, variable skeletal dysplasias, developmental delay	Reduced	Normal	Decreased to normal	nan	nan	[]	['hsa00534  Glycosaminoglycan biosynthesis - heparan sulfate / heparin', 'hsa01100  Metabolic pathways']	['HP:0002715', 'HP:0000926', 'HP:0000007', 'HP:0001263', 'HP:0002808', 'HP:0002652', 'HP:0004313', 'HP:0005403']
MYSM1 deficiency_MYSM1_AR	MYSM1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 4 Immuno-osseous Dysplasias	AR	612176	MYSM1	MYSM1	114803	Short stature, recurrent infections, congenital bone marrow failure, myelodysplasia, immunodeficiency affecting B-cells and granulocytes, skeletal anomalies, cataracts,  developmental delay.	T cell lymphopenia, reduced naÃ¯ve T cells	Immature B cells	nan	nan	nan	[]	[]	['HP:0004322', 'HP:0002863', 'HP:0002715', 'HP:0032320', 'HP:0005528', 'HP:0002719', 'HP:0000007', 'HP:0002721', 'HP:0000924', 'HP:0001263', 'HP:0005403', 'HP:0000518']
Cartilage hair hypoplasia (CHH)_RMRP_AR	Cartilage hair hypoplasia (CHH)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 4 Immuno-osseous Dysplasias	AR	Â 157660	RMRP	RMRP	6023	Short-limbed dwarfism with metaphyseal dysostosis, sparse hair, bone marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine	Varies from severely decreased (SCID) to normal, impaired lymphocyte proliferation	Normal	nan	Variable	nan	[]	['hsa03008  Ribosome biogenesis in eukaryotes']	['HP:0002715', 'HP:0002960', 'HP:0005528', 'HP:0002664', 'HP:0000007', 'HP:0003510', 'HP:0008873', 'HP:0002665', 'HP:0008070', 'HP:0005403', 'HP:0008669']
MOPD1 deficiency  (Roifman syndrome)_RNU4ATAC_AR	MOPD1 deficiency  (Roifman syndrome)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 4 Immuno-osseous Dysplasias	AR	601428	RNU4ATAC	RNU4ATAC	100151683	Recurrent bacterial infections, lymphadenopathy, Spondyloepiphyseal dysplasia, extreme intrauterine growth retardation, retinal dystrophy, facial dysmorphism, may present with microcephaly, short stature	Normal	Normal	Hypogammaglobulinemia, variably decreased specific antibodies	nan	nan	[]	[]	['HP:0004322', 'HP:0002718', 'HP:0002715', 'HP:0000556', 'HP:0001999', 'HP:0000007', 'HP:0001510', 'HP:0000252', 'HP:0002655', 'HP:0001511', 'HP:0004432', 'HP:0005403', 'HP:0002716']
Schimke Immuno-osseous Dysplasia_SMARCAL1_AR	Schimke Immuno-osseous Dysplasia	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 4 Immuno-osseous Dysplasias	AR	606622	SMARCAL1	SMARCAL1	50485	Short stature, spondiloepiphyseal dysplasia, intrauterine growth retardation, nephropathy, bacterial, viral, fungal infections, may present as SCID, bone marrow failure	Decreased	Normal	nan	Variable	nan	[]	[]	['HP:0004322', 'HP:0004430', 'HP:0002715', 'HP:0005528', 'HP:0000007', 'HP:0002721', 'HP:0001510', 'HP:0000112', 'HP:0005387', 'HP:0002655', 'HP:0001511', 'HP:0005403']
CARD11 DN LOF_CARD11_AD DN	CARD11 DN LOF	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AD DN	607210	CARD11	CARD11	84433	Severe atopy, recurrent infections	Normal numbers, low mitogens	Normal numbers	High IgE, poor specific antibody production	nan	nan	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway']	['HP:0000006', 'HP:0002715', 'HP:0001051', 'HP:0002719', 'HP:0003212', 'HP:0012475']
ERBIN deficiency_ERBB21P_AD	ERBIN deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AD	606944	ERBB21P	ERBIN	55914	Recurrent respiratory infections, susceptibility to S. aureus, eczema, hyperextensible joints, scoliosis, arterial dilatation in some	Increased Treg	Normal	Normal to increased IgE	Normal	nan	[]	['hsa04621  NOD-like receptor signaling pathway']	['HP:0000006', 'HP:0000964', 'HP:0002715', 'HP:0001051', 'HP:0011947', 'HP:0003212', 'HP:0002205', 'HP:0002650', 'HP:0001382']
IL6 receptor deficiency_IL6R_AR	IL6 receptor deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AR	147880	IL6R	IL6R	3570	Recurrent pyogenic infections, cold abscesses, high circulating IL-6 levels,	Normal	Normal	High IgE	Normal	nan	['Sarilumab: D10161<JP/US>', 'Satralizumab: D11079<JP/US>', 'Tocilizumab: D02596<JP/US>']	['hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04066  HIF-1 signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04640  Hematopoietic cell lineage', 'hsa04659  Th17 cell differentiation', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa05163  Human cytomegalovirus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer']	['HP:0002718', 'HP:0002715', 'HP:0001051', 'HP:0000007', 'HP:0025615', 'HP:0003212']
IL6 signal transducer (IL6ST) deficiency_IL6ST_AR	IL6 signal transducer (IL6ST) deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AR	618523	IL6ST	IL6ST	3572	Fatal Stuve-Weidemann-like syndrome; skeletal dysplasia, lung dysfunction, renal abnormalities, thrombocytopenia, dermatitis, eczema. Defective acute phase response. Complete unresponsiveness to IL-6 family cytokines	Most patients died early, no data	Most patients died early, no data	Most patients died early, no data	nan	nan	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04630  JAK-STAT signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis']	['HP:0000964', 'HP:0002715', 'HP:0001051', 'HP:0000007', 'HP:0002652', 'HP:0001873', 'HP:0033331', 'HP:0011123']
IL6 signal transducer (IL6ST) deficiency_IL6ST_AD DN	IL6 signal transducer (IL6ST) deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AD DN		IL6ST	IL6ST	3572	HIES â STAT3-like; dermatitis/eczema, eosinophilia, recurrent skin infections, pneumonia, bronchiectasis, pneumatoceles with severe secondary pulmonary aspergillosis, connective tissue defects (scoliosis, face, joints, fractures, palate, tooth retention). Phenocopies aspects of IL6R and IL11R deficiencies (due to unresponsiveness to these cytokines)	Normal T cell numbers, increased naÃ¯ve CD4 and CD8 T cell proportions. Decreased TCM CD4+ and CD8+ T cells, TEM CD8 T cells; MAIT, Tfh cells.  Increased Th2. Low to normal NK cell counts	Normal numbers of B cells, low memory B cells	Normal/low IgG, A, Normal IgM. Hyper IgE. Vaccine IgG normal	Normal	nan	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04630  JAK-STAT signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis']	['HP:0001880', 'HP:0000006', 'HP:0001581', 'HP:0002715', 'HP:0001051', 'HP:0100658', 'HP:0002720', 'HP:0002110', 'HP:0002090', 'HP:0003212', 'HP:0002650', 'HP:0004315']
PGM3 deficiency_PGM3_AR	PGM3 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AR	172100	PGM3	PGM3	5238	Severe atopy, autoimmunity, bacterial and viral infections, skeletal anomalies dysplasia: short stature, brachydactyly, dysmorphic facial features, and intellectual disability cognitive impairment, hypomyelination	CD8 and CD4 T cells may be decreased	Low B and memory B cells	Normal or elevated IgG and IgA, most high IgE,	nan	nan	[]	['hsa00520  Amino sugar and nucleotide sugar metabolism', 'hsa01100  Metabolic pathways', 'hsa01250  Biosynthesis of nucleotide sugars']	['HP:0004322', 'HP:0003237', 'HP:0002715', 'HP:0001051', 'HP:0002960', 'HP:0001999', 'HP:0001156', 'HP:0000007', 'HP:0000924', 'HP:0001249', 'HP:0003212', 'HP:0003261', 'HP:0100543']
Comel-Netherton syndrome_SPINK5_AR	Comel-Netherton syndrome	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AR	605010	SPINK5	SPINK5	11005	Congenital ichthyosis, bamboo hair, atopic diathesis, increased bacterial infections, failure to thrive	Normal	Low Switched and non-switched B cells	High IgE and IgA	Normal	nan	[]	[]	['HP:0001508', 'HP:0002715', 'HP:0001051', 'HP:0008064', 'HP:0000007', 'HP:0003212', 'HP:0007431', 'HP:0003261']
AD-HIES  Job syndrome_STAT3_AD LOF	AD-HIES  Job syndrome	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AD LOF	102582	STAT3	STAT3	6774	Distinctive facial features (broad nasal bridge), bacterial infections (boils and pulmonary abscesses, pneumatoceles) due to S. aureus, pulmonary aspergillus, Pneumocystis jirovecii, eczema, mucocutaneous candidiasis, hyperextensible joints, osteoporosis and bone fractures, scoliosis, retention of primary teeth,  coronary and cerebral aneurysm formation	Normal overall, Th-17 and T-follicular helper cells decreased	Normal,  reduced switched and non-switched memory B cells, BAFF expression increased	High IgE	Normal	nan	['Napabucasin: D10717']	['hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa04062  Chemokine signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04217  Necroptosis', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04630  JAK-STAT signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04931  Insulin resistance', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05205  Proteoglycans in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05212  Pancreatic cancer', 'hsa05221  Acute myeloid leukemia', 'hsa05223  Non-small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease', 'hsa05417  Lipid and atherosclerosis']	['HP:0000006', 'HP:0000964', 'HP:0002617', 'HP:0002728', 'HP:0002715', 'HP:0001051', 'HP:0020110', 'HP:0004944', 'HP:0025615', 'HP:0003212', 'HP:0000939', 'HP:0002650', 'HP:0000431', 'HP:0001382']
Loeys Dietz syndrome due to TGFBR1 deficiency_TGFBR1_AD	Loeys Dietz syndrome due to TGFBR1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AD	609192	TGFBR1	TGFBR1	7046	Recurrent respiratory infectons, eczema, food allergies, hyperextensible joints, scoliosis, retention of primary teeths, aortic anuerysms.	Normal	Normal	Increased IgE	Normal	nan	['Galunisertib: D10437']	['hsa04010  MAPK signaling pathway', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04068  FoxO signaling pathway', 'hsa04144  Endocytosis', 'hsa04218  Cellular senescence', 'hsa04350  TGF-beta signaling pathway', 'hsa04371  Apelin signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04390  Hippo signaling pathway', 'hsa04520  Adherens junction', 'hsa04659  Th17 cell differentiation', 'hsa04926  Relaxin signaling pathway', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05142  Chagas disease', 'hsa05161  Hepatitis B', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05210  Colorectal cancer', 'hsa05212  Pancreatic cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer', 'hsa05415  Diabetic cardiomyopathy']	['HP:0000006', 'HP:0012393', 'HP:0002617', 'HP:0000964', 'HP:0002715', 'HP:0001051', 'HP:0011947', 'HP:0004942', 'HP:0003212', 'HP:0002205', 'HP:0500093', 'HP:0002650', 'HP:0001382']
Loeys Dietz syndrome due to TGFBR2 deficiency_TGFBR2_AD	Loeys Dietz syndrome due to TGFBR2 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AD	610168	TGFBR2	TGFBR2	7048	Recurrent respiratory infectons, eczema, food allergies, hyperextensible joints, scoliosis, retention of primary teeths, aortic anuerysms.	Normal	Normal	Increased IgE	Normal	nan	['Bintrafusp alfa: D11893']	['hsa04010  MAPK signaling pathway', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04068  FoxO signaling pathway', 'hsa04144  Endocytosis', 'hsa04218  Cellular senescence', 'hsa04350  TGF-beta signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04390  Hippo signaling pathway', 'hsa04520  Adherens junction', 'hsa04659  Th17 cell differentiation', 'hsa04926  Relaxin signaling pathway', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05142  Chagas disease', 'hsa05161  Hepatitis B', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05210  Colorectal cancer', 'hsa05212  Pancreatic cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer', 'hsa05415  Diabetic cardiomyopathy']	['HP:0000006', 'HP:0012393', 'HP:0002617', 'HP:0000964', 'HP:0002715', 'HP:0001051', 'HP:0011947', 'HP:0004942', 'HP:0003212', 'HP:0002205', 'HP:0500093', 'HP:0002650', 'HP:0001382']
ZNF341 deficiency AR-HIES_ZNF341_AR	ZNF341 deficiency AR-HIES	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 5 Hyper IgE Syndromes (HIES)	AR	618282	ZNF341	ZNF341	84905	Bacterial infections, mild facial dysmorphism, pneumatoceles, hyperextensible joints, bone fractures, retention of primary teeth	Decreased Th17 cells	Decreased memory B cells	High IgE and IgG	Normal	nan	[]	[]	['HP:0003237', 'HP:0020110', 'HP:0002715', 'HP:0001051', 'HP:0001999', 'HP:0000007', 'HP:0003212', 'HP:0001382']
Methylene-tetrahydrofolate dehydrogenase 1 (MTHFD1) deficiency_MTHFD1_AR	Methylene-tetrahydrofolate dehydrogenase 1 (MTHFD1) deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 6 Defects of Vitamin B12 and Folate Metabolism	AR	172460	MTHFD1	MTHFD1	4522	Recurrent bacterial infection, Pneumocystis jirovecii, megaloblastic anemia, failure to thrive, neutropenia, seizures, intellectual disability, folate-responsive	Low thymic output, normal in vitro proliferation	Low	Low	Low	nan	[]	['hsa00670  One carbon pool by folate', 'hsa01100  Metabolic pathways', 'hsa01240  Biosynthesis of cofactors']	['HP:0002718', 'HP:0001508', 'HP:0002715', 'HP:0010976', 'HP:0012335', 'HP:0001903', 'HP:0000007', 'HP:0001889', 'HP:0001250', 'HP:0001875', 'HP:0001249', 'HP:0004313']
SLC46A1/PCFT deficiency causing hereditary folate malabsorbtion_SLC46A1_AR	SLC46A1/PCFT deficiency causing hereditary folate malabsorbtion	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 6 Defects of Vitamin B12 and Folate Metabolism	AR	229050	SLC46A1	SLC46A1	113235	Megaloblastic anemia, failure to thrive, if untreated for prolonged periods results in intellectual disability	Variable numbers and activation profile	Variable	Low	nan	nan	[]	['hsa01523  Antifolate resistance', 'hsa04977  Vitamin digestion and absorption', 'hsa04978  Mineral absorption']	['HP:0001508', 'HP:0002715', 'HP:0012335', 'HP:0001903', 'HP:0000007', 'HP:0001889', 'HP:0001249', 'HP:0004313']
Transcobalamin 2 deficiency_TCN2_AR	Transcobalamin 2 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 6 Defects of Vitamin B12 and Folate Metabolism	AR	613441	TCN2	TCN2	6948	Megaloblastic anemia, pancytopenia, if untreated for prolonged periods results in intellectual disability	Normal	Variable	Low	Variable	nan	[]	['hsa04977  Vitamin digestion and absorption']	['HP:0002715', 'HP:0012335', 'HP:0001903', 'HP:0000007', 'HP:0001889', 'HP:0001249', 'HP:0004313', 'HP:0001876']
EDA-ID due to IKBKB GOF mutation_IKBKB_AD GOF	EDA-ID due to IKBKB GOF mutation	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 7 Anhidrotic Ectodermodysplasia with Immunodeficiency (EDA-ID)	AD GOF	618204	IKBKB	IKBKB	3551	Recurrent bacterial, viral, fungal infections, variable ectodermal defects	Low	Normal count, poor function	Low	nan	nan	['Ertiprotafib: D04050']	['hsa01523  Antifolate resistance', 'hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04150  mTOR signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04910  Insulin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04930  Type II diabetes mellitus', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05212  Pancreatic cancer', 'hsa05215  Prostate cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0002715', 'HP:0004313', 'HP:0005403', 'HP:0000968']
EDA-ID due to NEMO /IKBKG deficiency (ectodermal dysplasia, immune deficiency)_IKBKG_XL	EDA-ID due to NEMO /IKBKG deficiency (ectodermal dysplasia, immune deficiency)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 7 Anhidrotic Ectodermodysplasia with Immunodeficiency (EDA-ID)	XL	300248	IKBKG	IKBKG	8517	Anhidrotic ectodermal dysplasia (in some), various infections (bacteria, mycobacteria, viruses and fungi), colitis, conical teeth, variable defects of skin, hair and teeth, monocyte dysfunction	Normal or decreased, TCR activation impaired	Normal, Low memory and isotype switched B cells	Decreased, some with elevated IgA, IgM, poor specific antibody responses, absent antibody to polysaccharide antigens	nan	Poor NK function	[]	['hsa01523  Antifolate resistance', 'hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05212  Pancreatic cancer', 'hsa05215  Prostate cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05340  Primary immunodeficiency', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0031404', 'HP:0002583', 'HP:0002715', 'HP:0003496', 'HP:0000698', 'HP:0410299', 'HP:0007476', 'HP:0004313', 'HP:0001417', 'HP:0003261', 'HP:0000968']
EDA-ID due to IKBA GOF_NFKBIA_AD GOF	EDA-ID due to IKBA GOF	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 7 Anhidrotic Ectodermodysplasia with Immunodeficiency (EDA-ID)	AD GOF	164008	NFKBIA	NFKBIA	4792	Anhidrotic ectodermal dysplasia,  various infections (bacteria, mycobacteria, viruses and fungi), colitis, variable defects of skin, hair and teeth, T cell and monocyte dysfunction	Normal total T cells, TCR activation impaired	Normal B cell numbers, impaired BCR activation, low memory and isotype switched B cells	Decreased IgG and IgA, elevated IgM, poor specific antibody responses, absent antibody to polysaccharide antigens	nan	nan	[]	['hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04210  Apoptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04926  Relaxin signaling pathway', 'hsa04931  Insulin resistance', 'hsa04936  Alcoholic liver disease', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05134  Legionellosis', 'hsa05135  Yersinia infection', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05215  Prostate cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05417  Lipid and atherosclerosis']	['HP:0031404', 'HP:0000006', 'HP:0002583', 'HP:0002715', 'HP:0002720', 'HP:0003496', 'HP:0004315', 'HP:0007476', 'HP:0410299', 'HP:0000968']
CRACR2A deficiency_CRACR2A_AR	CRACR2A deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 8 Calcium Channel Defects	AR		CRACR2A	CRACR2A	84766	Later onset chronic diarrhea, recurrent lower respiratory tract infections, including pneumonia. Poor T cell activation/proliferation in vitro	Mild CD4 T cell lymphopenia (low naÃ¯ve CD4 T). Normal NK cell numbers	Normal B cell numbers, low switched memory B cells	Panhypogamma (IgG, undetectable; IgM, IgA low).  intact B cell function in vitro	nan	nan	[]	[]	['HP:0002783', 'HP:0011947', 'HP:0002028', 'HP:0002014', 'HP:0002720', 'HP:0000007', 'HP:0002090', 'HP:0002850', 'HP:0004315']
ORAI-1 deficiency_ORAI1_AR	ORAI-1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 8 Calcium Channel Defects	AR	610277	ORAI1	ORAI1	84876	Autoimmunity, EDA, non-progressive myopathy	Normal, defective TCR mediated activation	Normal	Normal	nan	nan	[]	['hsa04020  Calcium signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04611  Platelet activation', 'hsa04924  Renin secretion', 'hsa04925  Aldosterone synthesis and secretion', 'hsa04927  Cortisol synthesis and secretion', 'hsa04934  Cushing syndrome', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0002960', 'HP:0000007', 'HP:0003198', 'HP:0007476', 'HP:0000968']
STIM1 deficiency_STIM1_AR	STIM1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 8 Calcium Channel Defects	AR	605921	STIM1	STIM1	6786	Autoimmunity, EDA, non-progressive myopathy	Normal, defective TCR mediated activation	Normal	Normal	nan	nan	[]	['hsa04020  Calcium signaling pathway', 'hsa04611  Platelet activation']	['HP:0002715', 'HP:0002960', 'HP:0000007', 'HP:0003198', 'HP:0007476', 'HP:0000968']
BCL11B deficiency_BCL11B_AD	BCL11B deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AD	617237	BCL11B	BCL11B	64919	Congenital abnormalities, neonatal teeth, dysmorphic facies, absent corpus callosum, neurocognitive deficits	Low	Normal	Normal	nan	nan	[]	['hsa05202  Transcriptional misregulation in cancer']	['HP:0000006', 'HP:0002715', 'HP:0001999', 'HP:0000695', 'HP:0001274', 'HP:0005403']
Hennekam-lymphangiectasia-lymphedema syndrome due to CCBE1 deficiency_CCBE1_AR	Hennekam-lymphangiectasia-lymphedema syndrome due to CCBE1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	612753	CCBE1	CCBE1	147372	Lymphangiectasia and lymphedema with facial abnormalities and other dysmorphic features	Low/variable	Low/variable	nan	nan	nan	[]	[]	['HP:0031842', 'HP:0002715', 'HP:0010976', 'HP:0000271', 'HP:0001004', 'HP:0000007']
CD28 deficiency_CD28_AR	CD28 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR		CD28	CD28	940	HPV susceptibility	Normal numbers of T and myeloid cells with decreased NK cells	Normal numbers of total B cells and subsets	Normal serum IgM, G, A; â¢ intact levels of pathogen-spec IgG	nan	nan	['Acazicolcept: D12300', 'Reltecimod (DG02994): D11281 D11348']	['hsa04514  Cell adhesion molecules', 'hsa04660  T cell receptor signaling pathway', 'hsa04672  Intestinal immune network for IgA production', 'hsa04940  Type I diabetes mellitus', 'hsa05162  Measles', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05320  Autoimmune thyroid disease', 'hsa05322  Systemic lupus erythematosus', 'hsa05323  Rheumatoid arthritis', 'hsa05330  Allograft rejection', 'hsa05332  Graft-versus-host disease', 'hsa05416  Viral myocarditis']	['HP:0000007']
DIAPH1 deficiency_DIAPH1_AR	DIAPH1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR		DIAPH1	DIAPH1	1729	"seizures, cortical blindness, microcephaly syndrome (SCBMS).
Recurrent bacterial, viral, fungal infections, B-lymphoma.  Decreased T cell activation/proliferation in vitro,  impaired adhesion/MTOC repositioning to immune synapse, defective cytoskeletal organization and mitochondrial dysfunction in SCBMS pathogenesis"	Decreased naive T cells, RTEs	hi naÃ¯ve/transitional, low memory	"Low IgM, normal IgG, variable IgA.
Near normal vaccine resp"	nan	nan	[]	['hsa04510  Focal adhesion', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05131  Shigellosis']	['HP:0000618', 'HP:0030374', 'HP:0003287', 'HP:0000007', 'HP:0001250', 'HP:0100704', 'HP:0002665', 'HP:0000252']
Vici syndrome due to EPG5 deficiency_EPG5_AR	Vici syndrome due to EPG5 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	Â 615068	EPG5	EPG5	57724	Agenesis of the corpus callosum, cataracts, cardiomyopathy, skin hypopigmentation,  intellectual disability, microcephaly, recurrent infections, chronic mucocutaneous candidiasis	Profound depletion of CD4+ cells	Defective	nan	nan	nan	[]	[]	['HP:0001010', 'HP:0002728', 'HP:0002715', 'HP:0010976', 'HP:0002719', 'HP:0000007', 'HP:0001249', 'HP:0001638', 'HP:0001274', 'HP:0000252', 'HP:0000518']
Hennekam-lymphangiectasia-lymphedema syndrome due to FAT4 deficiency_FAT4_AR	Hennekam-lymphangiectasia-lymphedema syndrome due to FAT4 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	Â·Â Â Â Â Â Â  612411	FAT4	FAT4	79633	Lymphangiectasia and lymphedema with facial abnormalities and other dysmorphic features	Low/variable	Low/variable	nan	nan	nan	[]	['hsa04392  Hippo signaling pathway - multiple species']	['HP:0031842', 'HP:0002715', 'HP:0010976', 'HP:0000271', 'HP:0001004', 'HP:0000007']
AIOLOS deficiency_IKZF3_AD	AIOLOS deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AD		IKZF3	IKZF3	22806	EBV susceptibility, recurrent sinopulmonary/respiratory infections, PJP, warts, M avium. B cell lymphoma (2/3), B-CLL	"Normal numbers T, NK cells. Increased naÃ¯ve CD4+ T cells, RTE. Decreased memory, Tfh; CD40L induction.
Increased %âs CD8 T cells; activated T cells"	"Abnormal B cell development
(decreased BM B precursors; 
hi CD21lo B; decreased memory B cells). Decreased response to CD40"	Severe hypogamma	nan	nan	[]	[]	['HP:0000006', 'HP:0002665', 'HP:0012191', 'HP:0200043']
Kabuki Syndrome 2 due to KDM6A deficiency_KDM6A_XL (females may be affected)	Kabuki Syndrome 2 due to KDM6A deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	XL (females may be affected)	300128	KDM6A	KDM6A	7403	Typical facial abnormalities, cleft or high arched palate, skeletal abnormalities, short stature, intellectual disability, congenital heart defects, recurrent infections (otitis media, pneumonia) in 50% of patients. Autoimmunity may be present	Normal	Normal	Low IgA and occasionally low IgG	Normal	nan	[]	['hsa05202  Transcriptional misregulation in cancer']	['HP:0004322', 'HP:0002715', 'HP:0002960', 'HP:0001627', 'HP:0000271', 'HP:0002719', 'HP:0002720', 'HP:0000924', 'HP:0001423', 'HP:0000388', 'HP:0001249', 'HP:0002090', 'HP:0000218', 'HP:0001417', 'HP:0004315']
Widemann-Steiner syndrome_KMT2A_AD	Widemann-Steiner syndrome	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AD	605130	KMT2A	KMT2A	4297	Respiratory infections, short stature, hypertelorism, hairy elbows, developmental delay, intellectual disability	Normal	Variably decreased switched memory B cells	Low	nan	nan	[]	['hsa00310  Lysine degradation', 'hsa01100  Metabolic pathways', 'hsa04934  Cushing syndrome', 'hsa05202  Transcriptional misregulation in cancer']	['HP:0004322', 'HP:0000006', 'HP:0002715', 'HP:0011947', 'HP:0000316', 'HP:0004313', 'HP:0001263', 'HP:0001249', 'HP:0004780']
Kabuki Syndrome 1 due to KMT2D deficiency_KMT2D (MLL2)_AD	Kabuki Syndrome 1 due to KMT2D deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AD	602113	KMT2D (MLL2)	KMT2D	8085	Typical facial abnormalities, cleft or high arched palate, skeletal abnormalities, short stature, intellectual disability, congenital heart defects, recurrent infections (otitis media, pneumonia) in 50% of patients. Autoimmunity may be present	Normal	Normal	Low IgA and occasionally low IgG	Normal	nan	[]	['hsa00310  Lysine degradation', 'hsa01100  Metabolic pathways', 'hsa04934  Cushing syndrome']	['HP:0004322', 'HP:0000006', 'HP:0002715', 'HP:0001627', 'HP:0002960', 'HP:0000271', 'HP:0002719', 'HP:0002720', 'HP:0000924', 'HP:0000388', 'HP:0001249', 'HP:0002090', 'HP:0000218', 'HP:0004315']
NFE2L2 GOF_NFE2L2_AD	NFE2L2 GOF	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AD	617744	NFE2L2	NFE2L2	4780	Recurrent respiratory and skin infections, growth retardation, , developmental delay; white matter cerebral lesions, increased level of homocysteine; increased expression of stress response genes	nan	Decreased switched memory B cells	Low	nan	nan	['Omaveloxolone: D10964']	['hsa04141  Protein processing in endoplasmic reticulum', 'hsa05012  Parkinson disease', 'hsa05200  Pathways in cancer', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05225  Hepatocellular carcinoma', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0002715', 'HP:0100658', 'HP:0001263', 'HP:0012758', 'HP:0001510', 'HP:0002060', 'HP:0004313']
Purine nucleoside phosphorylase (PNP) deficiency_PNP_AR	Purine nucleoside phosphorylase (PNP) deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	164050	PNP	PNP	4860	Autoimmune haemolytic anemia, neurological impairment	Progressive decrease	Normal	Normal to low	Variable	nan	['Forodesine (DG01392): D04245<JP> D06596', 'Peldesine: D05396', 'Ulodesine (DG01881): D10431 D10432']	['hsa00230  Purine metabolism', 'hsa00760  Nicotinate and nicotinamide metabolism', 'hsa01100  Metabolic pathways', 'hsa01232  Nucleotide metabolism']	['HP:0002715', 'HP:0002960', 'HP:0001903', 'HP:0000007', 'HP:0004313', 'HP:0012759', 'HP:0005403']
HOIL1 deficiency_RBCK1_AR	HOIL1 deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	610924	RBCK1	RBCK1	10616	Bacterial infections, autoinflammation, amylopectinosis	Normal numbers	Normal,  decreased memory B cells	nan	nan	nan	[]	['hsa04217  Necroptosis', 'hsa04621  NOD-like receptor signaling pathway', 'hsa05131  Shigellosis']	['HP:0000007', 'HP:0002718', 'HP:0002715', 'HP:0030374']
HOIP deficiency_RNF31_AR	HOIP deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	612487	RNF31	RNF31	55072	Bacterial infections, autoinflammation, amylopectinosis, lymphangiectasia	Normal numbers	Normal,  decreased memory B cells	nan	nan	nan	[]	['hsa04217  Necroptosis', 'hsa04621  NOD-like receptor signaling pathway', 'hsa05131  Shigellosis']	['HP:0002718', 'HP:0031842', 'HP:0002715', 'HP:0030374', 'HP:0000007']
Tricho-hepato-enteric syndrome due to SKIV2L mutations_SKIV2L_AR	Tricho-hepato-enteric syndrome due to SKIV2L mutations	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	" 614602 
"	SKIV2L	SKIV2L	6499	Respiratory infections,IUGR, facial dysmorphic features, wooly hair, early onset intractable diarrhea, liver cirrhosis, platelet abnormalities	Impaired function	Variably low switched memory B cells	Low	nan	nan	[]	['hsa03018  RNA degradation']	['HP:0002715', 'HP:0001999', 'HP:0011947', 'HP:0030374', 'HP:0002014', 'HP:0000007', 'HP:0001510', 'HP:0004313', 'HP:0002224', 'HP:0001511', 'HP:0002041', 'HP:0001394', 'HP:0001872']
Hepatic veno-occlusive disease with immunodeficiency (VODI)_SP110_AR	Hepatic veno-occlusive disease with immunodeficiency (VODI)	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	604457	SP110	SP110	3431	Hepatic veno-occlusive disease,  Susceptibility to Pneumocystis jirovecii pneumonia, CMV, candida, thrombocytopenia, hepatosplenomegaly, cerebrospinal leukodystrophy	Normal (decreased memory T cells)	Normal (decreased memory B cells)	Low	nan	nan	[]	[]	['HP:0002415', 'HP:0002715', 'HP:0030374', 'HP:0000007', 'HP:0004313', 'HP:0002090', 'HP:0020102', 'HP:0001873', 'HP:0001433']
STAT5b deficiency_STAT5B_AR	STAT5b deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	245590	STAT5B	STAT5B	6777	Growth-hormone insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, autoimmunity	Modestly decreased	Normal	Normal	nan	nan	[]	['hsa04012  ErbB signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04217  Necroptosis', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05223  Non-small cell lung cancer']	['HP:0004322', 'HP:0000964', 'HP:0006515', 'HP:0002715', 'HP:0002960', 'HP:0006527', 'HP:0000007', 'HP:0003510']
STAT5b deficiency_STAT5B_AD DN	STAT5b deficiency	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AD DN	604260	STAT5B	STAT5B	6777	Growth-failure, eczema	Normal	Normal	Increased igE	nan	nan	[]	['hsa04012  ErbB signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04217  Necroptosis', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05223  Non-small cell lung cancer']	['HP:0004322', 'HP:0000006', 'HP:0000964', 'HP:0002715', 'HP:0003212']
Tricho-hepato-enteric syndrome due to TTC37 mutations_TTC37_AR	Tricho-hepato-enteric syndrome due to TTC37 mutations	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	222470	TTC37	TTC37	9652	Respiratory infections,IUGR, facial dysmorphic features, wooly hair, early onset intractable diarrhea, liver cirrhosis, platelet abnormalities	Impaired function	Variably low switched memory B cells	Low	nan	nan	[]	['hsa03018  RNA degradation']	['HP:0002715', 'HP:0001999', 'HP:0011947', 'HP:0030374', 'HP:0002014', 'HP:0000007', 'HP:0001510', 'HP:0004313', 'HP:0002224', 'HP:0001511', 'HP:0002041', 'HP:0001394', 'HP:0001872']
Immunodeficiency with multiple intestinal atresias_TTC7A_AR	Immunodeficiency with multiple intestinal atresias	Table 2 Combined immunodeficiencies with associated or syndromic features	Subtable 9 Other Combined immunodeficiencies wwith syndromic features	AR	609332	TTC7A	TTC7A	57217	Bacterial (sepsis), fungal, viral infections, multiple intestinal atresias, often with intrauterine polyhydramnios and early demise, some with SCID phenotype	Variable, but sometimes absent low TRECs	Normal or low	Low	Normal	nan	[]	[]	['HP:0004430', 'HP:0002715', 'HP:0002721', 'HP:0000007', 'HP:0005387', 'HP:0011100', 'HP:0004313', 'HP:0001561', 'HP:0100806']
BMFS2 (Hebo deficiency)_ERCC6L2_AR	BMFS2 (Hebo deficiency)	Table 2 Combined immunodeficiencies with associated or syndromic features	nan	AR	615667	ERCC6L2	ERCC6L2	375748	Bone marrow failure, learning difficulties, microcephaly, facial dysmorphism	nan	nan	nan	nan	Hematopoietic stem cell	[]	[]	['HP:0001999', 'HP:0005528', 'HP:0000007', 'HP:0002721', 'HP:0000252']
BLNK deficiency_BLNK_AR	BLNK deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR	604515	BLNK	BLNK	29760	Severe bacterial infections, normal numbers of pro-B cells	Normal	Very low	Very low	nan	nan	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04662  B cell receptor signaling pathway', 'hsa05169  Epstein-Barr virus infection', 'hsa05340  Primary immunodeficiency']	['HP:0000007', 'HP:0002715', 'HP:0004432', 'HP:0005365']
BTK deficiency, X-linked agammaglobulinemia (XLA)_BTK_XL	BTK deficiency, X-linked agammaglobulinemia (XLA)	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	XL	300300	BTK	BTK	695	Severe bacterial infections, normal numbers of pro-B cells	Normal	Very low	Very low	Variable	nan	['Acalabrutinib (DG03089): D10893<JP/US> D11720', 'Atuzabrutinib: D12489', 'Branebrutinib: D11478', 'Edralbrutinib: D12383', 'Elsubrutinib: D12158', 'Evobrutinib: D12467', 'Fenebrutinib: D11457', 'Ibrutinib: D10223<JP/US>', 'Luxeptinib: D12052', 'Orelabrutinib: D12160', 'Pirtobrutinib: D12050', 'Remibrutinib: D12285', 'Rilzabrutinib: D11873', 'Spebrutinib (DG01863): D10730 D10731', 'Tirabrutinib hydrochloride: D11070<JP>', 'Tolebrutinib: D12213', 'Vecabrutinib (DG03023): D11428 D11502', 'Zanubrutinib: D11422<US>']	['hsa04064  NF-kappa B signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04611  Platelet activation', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa05169  Epstein-Barr virus infection', 'hsa05340  Primary immunodeficiency']	['HP:0001417', 'HP:0002715', 'HP:0004432', 'HP:0005365']
Iga deficiency_CD79A_AR	Iga deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR	112205	CD79A	CD79A	973	Severe bacterial infections, normal numbers of pro-B cells	Normal	Very low	Very low	nan	nan	[]	['hsa04662  B cell receptor signaling pathway', 'hsa05340  Primary immunodeficiency']	['HP:0000007', 'HP:0002715', 'HP:0004432', 'HP:0005365']
Igb deficiency_CD79B_AR	Igb deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR	147245	CD79B	CD79B	974	Severe bacterial infections, normal numbers of pro-B cells	Normal	Very low	Very low	nan	nan	['Polatuzumab vedotin: D10761<JP/US>']	['hsa04662  B cell receptor signaling pathway']	['HP:0000007', 'HP:0002715', 'HP:0004432', 'HP:0005365']
FNIP1 deficiency_FNIP1_AR	FNIP1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR		FNIP1	FNIP1	96459	"Early onset recurrent infections: sinopulmonary, bronchiectasis. Congenital heart defects (eg hypertrophic cardiomyopathy). Variable neutropenia (severe or intermittent),
Crohn disease (one patient, developmental delay.  increased AMPK activity"	Increased T cells	Low B cells	Very low	Variable neutropenia	nan	[]	['hsa04150  mTOR signaling pathway']	['HP:0005425', 'HP:0002715', 'HP:0001627', 'HP:0002719', 'HP:0000007', 'HP:0002110', 'HP:0001875', 'HP:0001263', 'HP:0001638', 'HP:0001639', 'HP:0004432', 'HP:0100280']
m heavy chain deficiency_IGHM_AR	m heavy chain deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR	147020	IGHM	IGHM	3507	Severe bacterial infections, normal numbers of pro-B cells	Normal	Very low	Very low	nan	nan			['HP:0000007', 'HP:0002715', 'HP:0004432', 'HP:0005365']
l5 deficiency_IGLL1_AR	l5 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR	146770	IGLL1	IGLL1	3543	Severe bacterial infections, normal numbers of pro-B cells	Normal	Very low	Very low	nan	nan	[]	['hsa05340  Primary immunodeficiency']	['HP:0000007', 'HP:0002715', 'HP:0004432', 'HP:0005365']
PIK3CD deficiency_PIK3CD_AR	PIK3CD deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR		PIK3CD	PIK3CD	5293	Severe bacterial infections; autoimmune complications (IBD)	nan	Very low	Very low	nan	nan	['Apitolisib: D10543', 'Bimiralisib: D11440', 'Buparlisib (DG01823): D10584 D10609', 'Copanlisib (DG01926): D10797 D10798<US> D10867', 'Dactolisib (DG01826): D10552 D10616', 'Dezapelisib: D10924', 'Duvelisib (DG03073): D10555 D11658<US>', 'Gedatolisib: D10635', 'Idelalisib: D10560<US>', 'Leniolisib (DG02927): D11158 D11159', 'Nemiralisib (DG02995): D11267 D11354', 'Omipalisib: D10718', 'Parsaclisib (DG03025): D11437 D11506', 'Pictilisib: D10189', 'Samotolisib: D11501', 'Taselisib: D11774', 'Umbralisib (DG02988): D11322 D11323<US>', 'Voxtalisib: D11727', 'Zandelisib: D12009']	['hsa00562  Inositol phosphate metabolism', 'hsa01100  Metabolic pathways', 'hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa01522  Endocrine resistance', 'hsa01524  Platinum drug resistance', 'hsa04012  ErbB signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04070  Phosphatidylinositol signaling system', 'hsa04071  Sphingolipid signaling pathway', 'hsa04072  Phospholipase D signaling pathway', 'hsa04140  Autophagy - animal', 'hsa04150  mTOR signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04152  AMPK signaling pathway', 'hsa04210  Apoptosis', 'hsa04211  Longevity regulating pathway', 'hsa04213  Longevity regulating pathway - multiple species', 'hsa04218  Cellular senescence', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04510  Focal adhesion', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04611  Platelet activation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04668  TNF signaling pathway', 'hsa04670  Leukocyte transendothelial migration', 'hsa04722  Neurotrophin signaling pathway', 'hsa04725  Cholinergic synapse', 'hsa04750  Inflammatory mediator regulation of TRP channels', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04910  Insulin signaling pathway', 'hsa04914  Progesterone-mediated oocyte maturation', 'hsa04915  Estrogen signaling pathway', 'hsa04917  Prolactin signaling pathway', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04923  Regulation of lipolysis in adipocytes', 'hsa04926  Relaxin signaling pathway', 'hsa04929  GnRH secretion', 'hsa04930  Type II diabetes mellitus', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa04960  Aldosterone-regulated sodium reabsorption', 'hsa04973  Carbohydrate digestion and absorption', 'hsa05010  Alzheimer disease', 'hsa05017  Spinocerebellar ataxia', 'hsa05020  Prion disease', 'hsa05100  Bacterial invasion of epithelial cells', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05146  Amoebiasis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05205  Proteoglycans in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05210  Colorectal cancer', 'hsa05211  Renal cell carcinoma', 'hsa05212  Pancreatic cancer', 'hsa05213  Endometrial cancer', 'hsa05214  Glioma', 'hsa05215  Prostate cancer', 'hsa05218  Melanoma', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05223  Non-small cell lung cancer', 'hsa05224  Breast cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer', 'hsa05230  Central carbon metabolism in cancer', 'hsa05231  Choline metabolism in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0002715', 'HP:0002960', 'HP:0005365', 'HP:0000007', 'HP:0002037', 'HP:0004432']
PIK3R1 deficiency_PIK3R1_AR	PIK3R1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR	171833	PIK3R1	PIK3R1	5295	Severe bacterial infections,  decreased or absent pro-B cells	nan	Very low	Very low	nan	nan	[]	['hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa01522  Endocrine resistance', 'hsa01524  Platinum drug resistance', 'hsa04012  ErbB signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04070  Phosphatidylinositol signaling system', 'hsa04071  Sphingolipid signaling pathway', 'hsa04072  Phospholipase D signaling pathway', 'hsa04140  Autophagy - animal', 'hsa04150  mTOR signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04152  AMPK signaling pathway', 'hsa04210  Apoptosis', 'hsa04211  Longevity regulating pathway', 'hsa04213  Longevity regulating pathway - multiple species', 'hsa04218  Cellular senescence', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04510  Focal adhesion', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04611  Platelet activation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04668  TNF signaling pathway', 'hsa04670  Leukocyte transendothelial migration', 'hsa04722  Neurotrophin signaling pathway', 'hsa04725  Cholinergic synapse', 'hsa04750  Inflammatory mediator regulation of TRP channels', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04910  Insulin signaling pathway', 'hsa04914  Progesterone-mediated oocyte maturation', 'hsa04915  Estrogen signaling pathway', 'hsa04917  Prolactin signaling pathway', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04923  Regulation of lipolysis in adipocytes', 'hsa04926  Relaxin signaling pathway', 'hsa04929  GnRH secretion', 'hsa04930  Type II diabetes mellitus', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa04960  Aldosterone-regulated sodium reabsorption', 'hsa04973  Carbohydrate digestion and absorption', 'hsa05010  Alzheimer disease', 'hsa05017  Spinocerebellar ataxia', 'hsa05020  Prion disease', 'hsa05100  Bacterial invasion of epithelial cells', 'hsa05131  Shigellosis', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05146  Amoebiasis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05205  Proteoglycans in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05210  Colorectal cancer', 'hsa05211  Renal cell carcinoma', 'hsa05212  Pancreatic cancer', 'hsa05213  Endometrial cancer', 'hsa05214  Glioma', 'hsa05215  Prostate cancer', 'hsa05218  Melanoma', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05223  Non-small cell lung cancer', 'hsa05224  Breast cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer', 'hsa05230  Central carbon metabolism in cancer', 'hsa05231  Choline metabolism in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000007', 'HP:0002715', 'HP:0004432', 'HP:0005365']
SLC39A7 (ZIP7) deficiency_SLC39A7_AR	SLC39A7 (ZIP7) deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR	601416	SLC39A7	SLC39A7	7922	Early onset infections, blistering dermatosis, failure to thrive, thrombocytopenia	nan	Very low	Very low	nan	nan	[]	['hsa05010  Alzheimer disease', 'hsa05012  Parkinson disease']	['HP:0001508', 'HP:0002715', 'HP:0005365', 'HP:0008066', 'HP:0000007', 'HP:0001873', 'HP:0004432']
Pu.1 deficiency_SPI1_AD	Pu.1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AD		SPI1	SPI1	6688	Sinopulmonary infections with encapsulated bacteria. Viral infections in some patients incl paralysis in 1 following live polio vaccine	Normal numbers of T and NK cells, increased % CD8s	Decreased B. B cell development arrested at pro to preâB stage	Undetectable	nan	Decreased DC	[]	['hsa04380  Osteoclast differentiation', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05221  Acute myeloid leukemia']	['HP:0000006', 'HP:0003470', 'HP:0010976', 'HP:0004432']
E47 transcription factor deficiency_TCF3_AD	E47 transcription factor deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AD	147141	TCF3	TCF3	6929	Recurrent bacterial infections	nan	Very low	Very low	nan	nan	[]	['hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05202  Transcriptional misregulation in cancer']	['HP:0000006', 'HP:0002718', 'HP:0002715', 'HP:0005365', 'HP:0004432']
E47 transcription factor deficiency_TCF3_AR	E47 transcription factor deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AR		TCF3	TCF3	6929	Severe, recurrent bacterial infections, failure to thrive	nan	Very low	Very low	nan	nan	[]	['hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05202  Transcriptional misregulation in cancer']	['HP:0002718', 'HP:0001508', 'HP:0002715', 'HP:0005365', 'HP:0000007', 'HP:0004432']
Hoffman syndrome/TOP2B deficiency_TOP2B_AD	Hoffman syndrome/TOP2B deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 1 Agammaglobulinemia	AD	126431	TOP2B	TOP2B	7155	Recurrent infections, facial dysmorphism, limb anomalies	nan	Very low	Very low	nan	nan	['Aclarubicin (DG00699): D01911<JP> D02756', 'Aldoxorubicin (DG01726): D10383 D10384', 'Amonafide (DG01268): D10090 D10091', 'Amrubicin (DG00703): D07100<JP> D08854', 'Amsacrine: D02321', 'Becatecarin: D03220', 'Berubicin hydrochloride: D08871', 'Crisnatol mesylate: D03602', 'Daunorubicin (DG00697): D01264<JP/US> D07776 D10787', 'Dexrazoxane (DG01162): D03730<JP/US> D07807<US>', 'Doxorubicin (DG00696): D01275<JP/US> D03899', 'Elsamitrucin: D03977', 'Epirubicin (DG00698): D02214<JP/US> D07901', 'Etoposide (DG00693): D00125<JP/US> D04107<US>', 'Fostriecin sodium: D04262', 'Idarubicin (DG00700): D01747<JP/US> D08062', 'Idronoxil: D04498', 'Ledoxantrone trihydrochloride: D04685', 'Losoxantrone hydrochloride: D04783', 'Menogaril: D04914', 'Mitindomide: D05054', 'Mitoxantrone (DG00701): D02166<JP/US> D08224', 'Pirarubicin (DG00702): D01885 D08386<JP>', 'Piroxantrone hydrochloride: D05510', 'Pixantrone (DG00704): D05522 D09654', 'Quarfloxin: D08981', 'Sobuzoxane: D01404<JP>', 'Teloxantrone hydrochloride: D06059', 'Teniposide: D02698', 'Tirapazamine: D06167', 'Topixantrone: D06190', 'Valrubicin: D02697<US>', 'Vosaroxin: D08024', 'Zorubicin: D06386']	['hsa01524  Platinum drug resistance']	['HP:0000006', 'HP:0002715', 'HP:0040064', 'HP:0001999', 'HP:0005365', 'HP:0002719', 'HP:0004432']
ARHGEF1 deficiency_ARHGEF1_AR	ARHGEF1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	618459	ARHGEF1	ARHGEF1	9138	Recurrent infections, bronchiectasis	nan	nan	Low	nan	nan	[]	['hsa04270  Vascular smooth muscle contraction', 'hsa04611  Platelet activation', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04928  Parathyroid hormone synthesis, secretion and action', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05135  Yersinia infection', 'hsa05163  Human cytomegalovirus infection', 'hsa05200  Pathways in cancer', 'hsa05205  Proteoglycans in cancer', 'hsa05417  Lipid and atherosclerosis']	['HP:0002715', 'HP:0002719', 'HP:0000007', 'HP:0002110', 'HP:0004313']
ATP6AP1 deficiency_ATP6AP1_XL	ATP6AP1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	XL	300197	ATP6AP1	ATP6AP1	537	Hepatopathy, leukopenia, low copper	nan	nan	Variable	nan	nan	[]	['hsa00190  Oxidative phosphorylation', 'hsa01100  Metabolic pathways', 'hsa04142  Lysosome', 'hsa04145  Phagosome', 'hsa05110  Vibrio cholerae infection', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05152  Tuberculosis', 'hsa05161  Hepatitis B', 'hsa05165  Human papillomavirus infection', 'hsa05323  Rheumatoid arthritis']	['HP:0002715', 'HP:0004313', 'HP:0001417', 'HP:0001410', 'HP:0001882']
CD19 deficiency_CD19_AR	CD19 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	107265	CD19	CD19	930	Recurrent infections, may have glomerulonephritis	nan	nan	Low	nan	nan	['Axicabtagene ciloleucel: D11144<US>', 'Blinatumomab: D09325<JP/US>', 'Brexucabtagene autoleucel: D11880<US>', 'Denintuzumab: D11231', 'Denintuzumab mafodotin: D11232', 'Duvortuxizumab: D11372', 'Inebilizumab: D11757<JP/US>', 'Lisocabtagene maraleucel: D11990<US>', 'Loncastuximab: D11333', 'Loncastuximab tesirine: D11338<US>', 'Obexelimab: D11496', 'Tafasitamab: D11601<US>', 'Tisagenlecleucel: D11386<US>']	['hsa04151  PI3K-Akt signaling pathway', 'hsa04640  Hematopoietic cell lineage', 'hsa04662  B cell receptor signaling pathway', 'hsa05169  Epstein-Barr virus infection', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0002719', 'HP:0000007', 'HP:0004313', 'HP:0000099']
CD20 deficiency_MS4A1_AR	CD20 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	112210	CD20	MS4A1	931	Recurrent infections	nan	nan	Low	nan	nan	['Epcoritamab: D12368', 'Glofitamab: D11833', 'Ibritumomab tiuxetan (90Y): D04489<JP/US>', 'Mosunetuzumab: D11463', 'Obinutuzumab: D09321<JP/US>', 'Ocaratuzumab: D10482', 'Ocrelizumab: D05218<US>', 'Odronextamab: D11534', 'Ofatumumab: D09314<JP/US>', 'Plamotamab: D11686', 'Rituximab: D02994<JP/US>', 'Tositumomab: D08621', 'Tositumomab/iodine (131I) tositumomab: D08622', 'Ublituximab: D11243', 'Veltuzumab: D09031']	['hsa04640  Hematopoietic cell lineage']	['HP:0002719', 'HP:0000007', 'HP:0002715', 'HP:0004313']
CD21 deficiency_CR2_AR	CD21 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	120650	CD21	CR2	1380	Recurrent infections	nan	nan	Low	nan	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04640  Hematopoietic cell lineage', 'hsa04662  B cell receptor signaling pathway', 'hsa05169  Epstein-Barr virus infection']	['HP:0002719', 'HP:0000007', 'HP:0002715', 'HP:0004313']
CD81 deficiency_CD81_AR	CD81 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	186845	CD81	CD81	975	Recurrent infections, may have glomerulonephritis	nan	nan	Low	nan	nan	[]	['hsa04662  B cell receptor signaling pathway', 'hsa05144  Malaria', 'hsa05160  Hepatitis C']	['HP:0002715', 'HP:0002719', 'HP:0000007', 'HP:0004313', 'HP:0000099']
IKAROS haplosufficiency_IKZF1_AD haploinsufficiency	IKAROS haplosufficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD haploinsufficiency	603023	IKZF1	IKZF1	10320	Recurrent sinopulmonary infections	Normal	Declining	Low	nan	nan	[]	[]	['HP:0000006', 'HP:0005425', 'HP:0002715', 'HP:0004313']
IRF2BP2 deficiency_IRF2BP2_AD	IRF2BP2 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD	615332	IRF2BP2	IRF2BP2	359948	Recurrent infections, possible autoimmunity and inflammatory disease	nan	nan	nan	nan	nan	[]	[]	['HP:0000006', 'HP:0002715', 'HP:0002960', 'HP:0002719', 'HP:0004313']
Mannosyl-oligosaccharide glucosidase deficiency (MOGS)_MOGS_AR	Mannosyl-oligosaccharide glucosidase deficiency (MOGS)	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	601336	MOGS (GCS1)	MOGS	7841	Bacterial and viral  infections,  severe neurologic disease, also known as congenital disorder of glycosylation type IIb (CDG-IIb) (GCS1)	Normal	Normal	Low	nan	nan	[]	['hsa00510  N-Glycan biosynthesis', 'hsa01100  Metabolic pathways', 'hsa04141  Protein processing in endoplasmic reticulum']	['HP:0005403', 'HP:0000007', 'HP:0002715', 'HP:0004313']
NFKB1 deficiency_NFKB1_AD	NFKB1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD	164011	NFKB1	NFKB1	4790	Recurrent sinopulmonary infections, COPD, EBV proliferation, autoimmune cytopenias, alopecia and autoimmune thyroiditis	nan	nan	nan	nan	nan	['Iguratimod: D01146<JP>']	['hsa01523  Antifolate resistance', 'hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04071  Sphingolipid signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04211  Longevity regulating pathway', 'hsa04218  Cellular senescence', 'hsa04380  Osteoclast differentiation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04917  Prolactin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04926  Relaxin signaling pathway', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05030  Cocaine addiction', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05134  Legionellosis', 'hsa05135  Yersinia infection', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05146  Amoebiasis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05206  MicroRNAs in cancer', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05212  Pancreatic cancer', 'hsa05215  Prostate cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0005425', 'HP:0006510', 'HP:0002715', 'HP:0002960', 'HP:0001596', 'HP:0100646', 'HP:0004313']
NFKB2 deficiency_NFKB2_AD	NFKB2 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD	615577	NFKB2	NFKB2	4791	Recurrent sinopulmonary infections, alopecia and endorinopathies	nan	nan	nan	nan	nan	[]	['hsa04010  MAPK signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa05134  Legionellosis', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05224  Breast cancer']	['HP:0000006', 'HP:0005425', 'HP:0002715', 'HP:0001596', 'HP:0004313']
PIK3CD mutation (GOF) APDS1_PIK3CD GOF_AD	PIK3CD mutation (GOF) APDS1	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD	602839	PIK3CD GOF	PIK3CD	5293	Severe bacterial infections, EBV Â± CMV viremia, autoimmunity, lymphadenopathy/splenomegaly,lymphoproliferation, lymphoma	nan	increased immature B cells, reduced memory B cells and increased transitional B cells	Normal/increased IgM, reduced IgG and IgA	nan	nan	['Apitolisib: D10543', 'Bimiralisib: D11440', 'Buparlisib (DG01823): D10584 D10609', 'Copanlisib (DG01926): D10797 D10798<US> D10867', 'Dactolisib (DG01826): D10552 D10616', 'Dezapelisib: D10924', 'Duvelisib (DG03073): D10555 D11658<US>', 'Gedatolisib: D10635', 'Idelalisib: D10560<US>', 'Leniolisib (DG02927): D11158 D11159', 'Nemiralisib (DG02995): D11267 D11354', 'Omipalisib: D10718', 'Parsaclisib (DG03025): D11437 D11506', 'Pictilisib: D10189', 'Samotolisib: D11501', 'Taselisib: D11774', 'Umbralisib (DG02988): D11322 D11323<US>', 'Voxtalisib: D11727', 'Zandelisib: D12009']	['hsa00562  Inositol phosphate metabolism', 'hsa01100  Metabolic pathways', 'hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa01522  Endocrine resistance', 'hsa01524  Platinum drug resistance', 'hsa04012  ErbB signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04070  Phosphatidylinositol signaling system', 'hsa04071  Sphingolipid signaling pathway', 'hsa04072  Phospholipase D signaling pathway', 'hsa04140  Autophagy - animal', 'hsa04150  mTOR signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04152  AMPK signaling pathway', 'hsa04210  Apoptosis', 'hsa04211  Longevity regulating pathway', 'hsa04213  Longevity regulating pathway - multiple species', 'hsa04218  Cellular senescence', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04510  Focal adhesion', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04611  Platelet activation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04668  TNF signaling pathway', 'hsa04670  Leukocyte transendothelial migration', 'hsa04722  Neurotrophin signaling pathway', 'hsa04725  Cholinergic synapse', 'hsa04750  Inflammatory mediator regulation of TRP channels', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04910  Insulin signaling pathway', 'hsa04914  Progesterone-mediated oocyte maturation', 'hsa04915  Estrogen signaling pathway', 'hsa04917  Prolactin signaling pathway', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04923  Regulation of lipolysis in adipocytes', 'hsa04926  Relaxin signaling pathway', 'hsa04929  GnRH secretion', 'hsa04930  Type II diabetes mellitus', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa04960  Aldosterone-regulated sodium reabsorption', 'hsa04973  Carbohydrate digestion and absorption', 'hsa05010  Alzheimer disease', 'hsa05017  Spinocerebellar ataxia', 'hsa05020  Prion disease', 'hsa05100  Bacterial invasion of epithelial cells', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05146  Amoebiasis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05205  Proteoglycans in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05210  Colorectal cancer', 'hsa05211  Renal cell carcinoma', 'hsa05212  Pancreatic cancer', 'hsa05213  Endometrial cancer', 'hsa05214  Glioma', 'hsa05215  Prostate cancer', 'hsa05218  Melanoma', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05223  Non-small cell lung cancer', 'hsa05224  Breast cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer', 'hsa05230  Central carbon metabolism in cancer', 'hsa05231  Choline metabolism in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0030381', 'HP:0002715', 'HP:0002960', 'HP:0030374', 'HP:0002720', 'HP:0003496', 'HP:0030377', 'HP:0002665', 'HP:0004313', 'HP:0020071']
PIK3CG deficiency_PIK3CG_AR	PIK3CG deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR		PIK3CG	PIK3CG	5294	Adenopathy, splenomegaly, HLH-like	Normal CD4 but low Treg, low CD8, poor proliferation	Normal but diminished memory	Low with preserved vaccine resposnes	nan	Eosinophilia	['Duvelisib (DG03073): D10555 D11658<US>', 'Eganelisib: D11896']	['hsa00562  Inositol phosphate metabolism', 'hsa01100  Metabolic pathways', 'hsa04022  cGMP-PKG signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04072  Phospholipase D signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04261  Adrenergic signaling in cardiomyocytes', 'hsa04371  Apelin signaling pathway', 'hsa04611  Platelet activation', 'hsa04725  Cholinergic synapse', 'hsa04921  Oxytocin signaling pathway', 'hsa05132  Salmonella infection', 'hsa05145  Toxoplasmosis', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection']	['HP:0002715', 'HP:0030374', 'HP:0000007', 'HP:0004313', 'HP:0001744']
PIK3R1 deficiency (LOF) APDS2_PIK3R1_AD	PIK3R1 deficiency (LOF) APDS2	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD	616005	PIK3R1	PIK3R1	5295	Severe bacterial infections, lymphadenopathy/splenomegaly,lymphoproliferation, lymphoma; developmental delay	nan	increased immature B cells, reduced memory B cells and increased transitional B cells	Normal/increased IgM, reduced IgG and IgA	nan	nan	[]	['hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa01522  Endocrine resistance', 'hsa01524  Platinum drug resistance', 'hsa04012  ErbB signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04070  Phosphatidylinositol signaling system', 'hsa04071  Sphingolipid signaling pathway', 'hsa04072  Phospholipase D signaling pathway', 'hsa04140  Autophagy - animal', 'hsa04150  mTOR signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04152  AMPK signaling pathway', 'hsa04210  Apoptosis', 'hsa04211  Longevity regulating pathway', 'hsa04213  Longevity regulating pathway - multiple species', 'hsa04218  Cellular senescence', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04510  Focal adhesion', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04611  Platelet activation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04668  TNF signaling pathway', 'hsa04670  Leukocyte transendothelial migration', 'hsa04722  Neurotrophin signaling pathway', 'hsa04725  Cholinergic synapse', 'hsa04750  Inflammatory mediator regulation of TRP channels', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04910  Insulin signaling pathway', 'hsa04914  Progesterone-mediated oocyte maturation', 'hsa04915  Estrogen signaling pathway', 'hsa04917  Prolactin signaling pathway', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04923  Regulation of lipolysis in adipocytes', 'hsa04926  Relaxin signaling pathway', 'hsa04929  GnRH secretion', 'hsa04930  Type II diabetes mellitus', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa04960  Aldosterone-regulated sodium reabsorption', 'hsa04973  Carbohydrate digestion and absorption', 'hsa05010  Alzheimer disease', 'hsa05017  Spinocerebellar ataxia', 'hsa05020  Prion disease', 'hsa05100  Bacterial invasion of epithelial cells', 'hsa05131  Shigellosis', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05146  Amoebiasis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05205  Proteoglycans in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05210  Colorectal cancer', 'hsa05211  Renal cell carcinoma', 'hsa05212  Pancreatic cancer', 'hsa05213  Endometrial cancer', 'hsa05214  Glioma', 'hsa05215  Prostate cancer', 'hsa05218  Melanoma', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05223  Non-small cell lung cancer', 'hsa05224  Breast cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer', 'hsa05230  Central carbon metabolism in cancer', 'hsa05231  Choline metabolism in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0030381', 'HP:0002715', 'HP:0030374', 'HP:0002720', 'HP:0003496', 'HP:0001263', 'HP:0030377', 'HP:0002665', 'HP:0004313']
POU2AF1 deficiency_POU2AF1_AR	POU2AF1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR		POU2AF1	POU2AF1	5450	Recurrent respiratory infections, possible chronic viral infection	Normal numbers T cells, decreased  cTfh cells	Normal B cell numbers, decreased  switched memory B cells, and  altered B cell phenotype	Agammaglobulinemia	nan	nan	[]	[]	['HP:0002205', 'HP:0000007', 'HP:0004432', 'HP:0011947']
PTEN Deficiency (LOF)_PTEN_AD	PTEN Deficiency (LOF)	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD	601728	PTEN	PTEN	5728	Recurrent infections, Lymphoproliferation, Autoimmunity; developmental delay	nan	nan	Normal to low	nan	nan	[]	['hsa00562  Inositol phosphate metabolism', 'hsa01100  Metabolic pathways', 'hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa04068  FoxO signaling pathway', 'hsa04070  Phosphatidylinositol signaling system', 'hsa04071  Sphingolipid signaling pathway', 'hsa04115  p53 signaling pathway', 'hsa04140  Autophagy - animal', 'hsa04150  mTOR signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04218  Cellular senescence', 'hsa04510  Focal adhesion', 'hsa04931  Insulin resistance', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05213  Endometrial cancer', 'hsa05214  Glioma', 'hsa05215  Prostate cancer', 'hsa05218  Melanoma', 'hsa05222  Small cell lung cancer', 'hsa05224  Breast cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05230  Central carbon metabolism in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05415  Diabetic cardiomyopathy']	['HP:0000006', 'HP:0002715', 'HP:0002960', 'HP:0002719', 'HP:0001263', 'HP:0004313']
RAC2 deficiency_RAC2_AR	RAC2 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	602049	RAC2	RAC2	5880	Recurrent sinopulmonary infections, selective IgA defiency; poststreptococcal glomerulonephritis; urticaria	nan	nan	Low	nan	nan	[]	['hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04071  Sphingolipid signaling pathway', 'hsa04310  Wnt signaling pathway', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04510  Focal adhesion', 'hsa04520  Adherens junction', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04670  Leukocyte transendothelial migration', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05135  Yersinia infection', 'hsa05163  Human cytomegalovirus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05210  Colorectal cancer', 'hsa05212  Pancreatic cancer', 'hsa05231  Choline metabolism in cancer', 'hsa05415  Diabetic cardiomyopathy', 'hsa05416  Viral myocarditis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0005425', 'HP:0002715', 'HP:0002720', 'HP:0000007', 'HP:0001025', 'HP:0004313', 'HP:0000099']
SEC61A1  deficiency_SEC61A1_AD	SEC61A1  deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD	609213	SEC61A1	SEC61A1	29927	Severe recurrent respiratory tract infections	nan	nan	Low	nan	nan	[]	['hsa03060  Protein export', 'hsa04141  Protein processing in endoplasmic reticulum', 'hsa04145  Phagosome', 'hsa05110  Vibrio cholerae infection']	['HP:0000006', 'HP:0011947', 'HP:0002715', 'HP:0004313']
SH3KBP1 (CIN85) deficiency_SH3KBP1_XL	SH3KBP1 (CIN85) deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	XL	300310	SH3KBP1	SH3KBP1	30011	Severe bacterial infections	nan	nan	Low	nan	nan	[]	['hsa04144  Endocytosis']	['HP:0001417', 'HP:0002715', 'HP:0004313']
TACI deficiency_TNFRSF13B_AD or AR	TACI deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD or AR	604907	TNFRSF13B	TNFRSF13B	23495	Variable clinical expression	nan	nan	Normal to low	nan	nan	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04672  Intestinal immune network for IgA production', 'hsa05340  Primary immunodeficiency']	['HP:0000006', 'HP:0000007', 'HP:0002715', 'HP:0004313']
BAFF receptor deficiency_TNFRSF13C_AR	BAFF receptor deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	606269	TNFRSF13C	TNFRSF13C	115650	Variable clinical expression	nan	nan	Low	nan	nan	['Ianalumab: D12151']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04064  NF-kappa B signaling pathway', 'hsa04672  Intestinal immune network for IgA production', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05340  Primary immunodeficiency']	['HP:0000007', 'HP:0002715', 'HP:0004313']
TWEAK deficiency_TNFSF12_AD	TWEAK deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AD	602695	TNFSF12	TNFSF12	8742	Pneumonia, bacterial infections, warts, thrombocytopenia.	nan	nan	Low IgM and A, lack of anti-pneumococcal  antibody	Low	nan	[]	['hsa04060  Cytokine-cytokine receptor interaction']	['HP:0000006', 'HP:0002715', 'HP:0002720', 'HP:0012476', 'HP:0002090', 'HP:0001875', 'HP:0001873', 'HP:0200043', 'HP:0002850', 'HP:0004313']
TRNT1 deficiency_TRNT1_AR	TRNT1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 2 CVID Phenotype	AR	612907	TRNT1	TRNT1	51095	congenital sideroblastic anemia, deafness, developmental delay	nan	Low	Low	nan	nan	[]	[]	['HP:0002715', 'HP:0010976', 'HP:0001903', 'HP:0000365', 'HP:0000007', 'HP:0001263', 'HP:0001924', 'HP:0004313']
AID deficiency_AICDA_AR	AID deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM	AR	605257	AICDA	AICDA	57379	Bacterial infections, enlarged lymph nodes and germinal centers	nan	nan	Low IgG and IgA with normal or high IgM	nan	nan	[]	['hsa04672  Intestinal immune network for IgA production', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0002720', 'HP:0000007', 'HP:0003496', 'HP:0004313', 'HP:0004315']
AID deficiency_AICDA_AD	AID deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM	AD	605257*	AICDA	AICDA	57379	Bacterial infections, enlarged lymph nodes and germinal centers	nan	Normal	Low IgG and IgA with normal or high IgM	nan	nan	[]	['hsa04672  Intestinal immune network for IgA production', 'hsa05340  Primary immunodeficiency']	['HP:0000006', 'HP:0002715', 'HP:0002720', 'HP:0003496', 'HP:0004313', 'HP:0004315']
CTNNBL1 deficiency_CTNNBL1_AR	CTNNBL1 deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM	AR		CTNNBL1	CTNNBL1	56259	Hyperplastic GC	Low, poor proliferation	Normal with low memory cells	Progressive hypogammaglobulinemia, impaired CSR, SHM	nan	nan	[]	['hsa03040  Spliceosome']	['HP:0000007', 'HP:0002715', 'HP:0004313']
INO80_INO80_AR	INO80	Table 3 Predominantly Antibody Deficiencies	Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM	AR	610169	INO80	INO80	54617	Severe bacterial infections	nan	nan	Low IgG and IgA with normal or high IgM	nan	nan	[]	[]	['HP:0002715', 'HP:0002720', 'HP:0000007', 'HP:0003496', 'HP:0004313', 'HP:0004315']
MSH6_MSH6_AR	MSH6	Table 3 Predominantly Antibody Deficiencies	Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM	AR	600678	MSH6	MSH6	2956	Family or personal history of cancer	nan	nan	Low IgG and IgA with normal or high IgM	nan	nan	[]	['hsa01524  Platinum drug resistance', 'hsa03430  Mismatch repair', 'hsa05200  Pathways in cancer', 'hsa05210  Colorectal cancer']	['HP:0002715', 'HP:0002664', 'HP:0002720', 'HP:0000007', 'HP:0003496', 'HP:0004313', 'HP:0004315']
TNFSF13 (APRIL) deficiency_TNFSF13_AR	TNFSF13 (APRIL) deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM	AR		TNFSF13	TNFSF13	8741	Mild infections	Normal	Normal B cell count with low memory B cells and plasmablasts	Low IgG	nan	nan	['Atacicept: D09704', 'Sibeprenlimab: D12374']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04672  Intestinal immune network for IgA production', 'hsa05323  Rheumatoid arthritis']	['HP:0000007', 'HP:0004315', 'HP:0002715', 'HP:0004313']
UNG deficiency_UNG_AR	UNG deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 3 Severe Reduction in Serum IgG and IgA with Normal/Elevated IgM and Normal Numbers of B cells, Hyper IgM	AR	191525	UNG	UNG	7374	Enlarged lymph nodes and germinal centers	nan	nan	Low IgG and IgA with normal or high IgM	nan	nan	[]	['hsa03410  Base excision repair', 'hsa05340  Primary immunodeficiency']	['HP:0002715', 'HP:0002720', 'HP:0000007', 'HP:0003496', 'HP:0004313', 'HP:0004315']
CARD11 GOF_CARD11_AD GOF	CARD11 GOF	Table 3 Predominantly Antibody Deficiencies	Subtable 4 Isotype, Light Chain, or Functional Deficiencies with Generally Normal Numbers of B Cells	AD GOF	607210	CARD11	CARD11	84433	Splenomegaly, lymphadenopathy, poor vaccine response	nan	High	nan	nan	nan	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway']	['HP:0000006', 'HP:0002715', 'HP:0004313', 'HP:0001744', 'HP:0002716']
Kappa chain deficiency_IGKC_AR	Kappa chain deficiency	Table 3 Predominantly Antibody Deficiencies	Subtable 4 Isotype, Light Chain, or Functional Deficiencies with Generally Normal Numbers of B Cells	AR	147200	IGKC	IGKC	3514	Asymptomatic	Normal	Normal	nan	nan	nan			['HP:0000007', 'HP:0010701', 'HP:0002715']
Ig heavy chain mutations and deletions_Mutation or chromosomal deletion at 14q32_AR	Ig heavy chain mutations and deletions	Table 3 Predominantly Antibody Deficiencies	Subtable 4 Isotype, Light Chain, or Functional Deficiencies with Generally Normal Numbers of B Cells	AR		Mutation or chromosomal deletion at 14q32	14q32	14q32	May be asymptomatic	Normal	Normal	Low	nan	nan			['HP:0000007', 'HP:0010701', 'HP:0002715', 'HP:0004313']
FAAP24 deficiency_FAAP24_AR	FAAP24 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 1 Familial Hemophagocytic Lymphohistiocytosis (FHL syndromes)	AR	610884	FAAP24	FAAP24	91442	EBV infection-driven lymphoproliferative disease	Increased activated T cells	Normal	nan	nan	nan	[]	['hsa03460  Fanconi anemia pathway']	['HP:0000007', 'HP:0002715', 'HP:0100828', 'HP:0012156']
Perforin deficiency (FHL2)_PRF1_AR	Perforin deficiency (FHL2)	Table 4 Diseases of Immune Dysregulation	Subtable 1 Familial Hemophagocytic Lymphohistiocytosis (FHL syndromes)	AR	170280	PRF1	PRF1	5551	Fever, HSM,  Hemophagocytic lymphohistiocytosis (HLH), cytopenias	Increased activated T cells	Normal	Normal	Neutropenia with active HLH	nan	[]	['hsa04210  Apoptosis', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04940  Type I diabetes mellitus', 'hsa05320  Autoimmune thyroid disease', 'hsa05330  Allograft rejection', 'hsa05332  Graft-versus-host disease', 'hsa05416  Viral myocarditis']	['HP:0002715', 'HP:0000007', 'HP:0100828', 'HP:0012156', 'HP:0001875', 'HP:0001945', 'HP:0001433']
RHOG deficiency_RHOG_AR	RHOG deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 1 Familial Hemophagocytic Lymphohistiocytosis (FHL syndromes)	AR		RHOG	RHOG	391	Clinical features of HLH (hemophagocytosis, hepatosplenomegaly, fever, cytopenias, low hemoglobin, hyper-triglyceridemia, elevated ferritin/sCD25	nan	nan	nan	nan	nan	[]	['hsa05100  Bacterial invasion of epithelial cells', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection']	['HP:0000007', 'HP:0012156', 'HP:0001945', 'HP:0002155', 'HP:0001433']
Lysinuric protein intolerance SLC7A7 deficiency_SLC7A7_AR	Lysinuric protein intolerance SLC7A7 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 1 Familial Hemophagocytic Lymphohistiocytosis (FHL syndromes)	AR	222700	SLC7A7	SLC7A7	9056	Lysinuric protein intolerance, bleeding tendency, alveolar proteinosis	Normal	Normal	nan	nan	Activated macrophages	[]	['hsa04974  Protein digestion and absorption']	['HP:0003297', 'HP:0002715', 'HP:0000007', 'HP:0012156', 'HP:0001892', 'HP:0006517']
Syntaxin 11 deficiency (FHL4)_STX11_AR	Syntaxin 11 deficiency (FHL4)	Table 4 Diseases of Immune Dysregulation	Subtable 1 Familial Hemophagocytic Lymphohistiocytosis (FHL syndromes)	AR	605014	STX11	STX11	8676	Fever, HSM, cHLH, cytopenias,	Increased activated T cells	Normal	Normal	Neutropenia with active HLH	nan	[]	['hsa04130  SNARE interactions in vesicular transport']	['HP:0002715', 'HP:0000007', 'HP:0100828', 'HP:0012156', 'HP:0001875', 'HP:0001945', 'HP:0001433']
STXBP2 / Munc18-2 deficiency (FHL5)_STXBP2_AR or AD	STXBP2 / Munc18-2 deficiency (FHL5)	Table 4 Diseases of Immune Dysregulation	Subtable 1 Familial Hemophagocytic Lymphohistiocytosis (FHL syndromes)	AR or AD	601717	STXBP2	STXBP2	6813	Fever, HSM, cHLH, cytopenias, enteropathy	Increased activated T cells	Normal	Normal	Neutropenia with active HLH	nan	[]	[]	['HP:0000006', 'HP:0002715', 'HP:0000007', 'HP:0100828', 'HP:0012156', 'HP:0001875', 'HP:0001945', 'HP:0001433', 'HP:0002242']
UNC13D / Munc13-4 deficiency (FHL3)_UNC13D_AR	UNC13D / Munc13-4 deficiency (FHL3)	Table 4 Diseases of Immune Dysregulation	Subtable 1 Familial Hemophagocytic Lymphohistiocytosis (FHL syndromes)	AR	608897	UNC13D	UNC13D	201294	Fever, HSM, HLH, cytopenias	Increased activated T cells	Normal	Normal	Neutropenia with active HLH	nan	[]	[]	['HP:0002715', 'HP:0000007', 'HP:0100828', 'HP:0012156', 'HP:0001875', 'HP:0001945', 'HP:0001433']
Hermansky-Pudlak syndrome, type 2_AP3B1_AR	Hermansky-Pudlak syndrome, type 2	Table 4 Diseases of Immune Dysregulation	Subtable 2 FHL Syndromes with Hypopigmentation	AR	603401	AP3B1	AP3B1	8546	Partial albinism, recurrent infections, pulmonary fibrosis, increased bleeding, HLH	Normal	Normal	nan	Low	nan	[]	['hsa04142  Lysosome']	['HP:0001022', 'HP:0002715', 'HP:0002719', 'HP:0002206', 'HP:0000007', 'HP:0012156', 'HP:0001875', 'HP:0007443']
Hermansky-Pudlak syndrome, type 10_AP3D1_AR	Hermansky-Pudlak syndrome, type 10	Table 4 Diseases of Immune Dysregulation	Subtable 2 FHL Syndromes with Hypopigmentation	AR	617050	AP3D1	AP3D1	8943	Oculocutaneous albinism, recurrent infections, seizures, hearing loss and neurodevelopmental delay	Normal	Normal	nan	Low	nan	[]	['hsa04142  Lysosome']	['HP:0001022', 'HP:0002715', 'HP:0000365', 'HP:0002719', 'HP:0000007', 'HP:0001250', 'HP:0012156', 'HP:0012758', 'HP:0001875']
Chediak-Higashi syndrome_LYST_AR	Chediak-Higashi syndrome	Table 4 Diseases of Immune Dysregulation	Subtable 2 FHL Syndromes with Hypopigmentation	AR	606897	LYST	LYST	1130	Partial albinism, recurrent infections, fever, HSM, HLH, giant lysosomes, neutropenia, cytopenias, bleeding tendency, progressive neurological dysfunction	Increased activated T cells	Normal	nan	Low	nan	[]	[]	['HP:0001022', 'HP:0002715', 'HP:0002719', 'HP:0000007', 'HP:0100828', 'HP:0012156', 'HP:0001875', 'HP:0001945', 'HP:0007443', 'HP:0001892', 'HP:0001433']
Griscelli syndrome, type 2_RAB27A_AR	Griscelli syndrome, type 2	Table 4 Diseases of Immune Dysregulation	Subtable 2 FHL Syndromes with Hypopigmentation	AR	603868	RAB27A	RAB27A	5873	Partial albinism, fever, HSM, HLH, cytopenias	Normal	Normal	nan	nan	nan	[]	[]	['HP:0001022', 'HP:0002715', 'HP:0000007', 'HP:0012156', 'HP:0001945', 'HP:0007443', 'HP:0001433']
BACH2 deficiency_BACH2_AD	BACH2 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AD	605394	BACH2	BACH2	60468	Lymphocytic colitis, sinopulmonary infections	Progressive T cell lymphopenia	Impaired memory B cell development	Low	Normal	nan	[]	[]	['HP:0000006', 'HP:0002583', 'HP:0002715', 'HP:0002960', 'HP:0004313']
CTLA4 deficiency (ALPSV)_CTLA4_AD	CTLA4 deficiency (ALPSV)	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AD	123890	CTLA4	CTLA4	1493	Autoimmune cytopenias, enteropathy, interstitial lung disease, extra-lymphoid lymphocytic infiltration recurrent infections	Decreased	Decreased	Variable	Normal	nan	['Bavunalimab: D12317', 'Botensilimab: D12448', 'Cadonilimab: D12190', 'Ipilimumab: D04603<JP/US>', 'Quavonlimab: D12233', 'Tremelimumab: D06657<US>', 'Volrustomig: D12347', 'Vudalimab: D12186', 'Zalifrelimab: D11823']	['hsa04514  Cell adhesion molecules', 'hsa04660  T cell receptor signaling pathway', 'hsa05320  Autoimmune thyroid disease', 'hsa05323  Rheumatoid arthritis']	['HP:0000006', 'HP:0002088', 'HP:0002715', 'HP:0002960', 'HP:0010976', 'HP:0002719', 'HP:0006530', 'HP:0005403', 'HP:0002242']
DEF6 deficiency_DEF6_AR	DEF6 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AR	610094	DEF6	DEF6	50619	Enteropathy, hepatosplenomegaly, cardiomyopathy, recurrent infections	Mild decrease	Low to normal	Normal	Normal	Impaired Treg function	[]	[]	['HP:0002715', 'HP:0002960', 'HP:0002719', 'HP:0000007', 'HP:0001638', 'HP:0001433', 'HP:0002242']
FERMT1 deficiency (Kindler syndrome)_FERMT1_AR	FERMT1 deficiency (Kindler syndrome)	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AR	173650	FERMT1	FERMT1	55612	Dermatosis characterized by congenital blistering, skin atrophy, photosensitivity, skin fragility, and scaling	Normal	Normal	nan	nan	Skin	[]	[]	['HP:0004334', 'HP:0002715', 'HP:0002960', 'HP:0008066', 'HP:0000992', 'HP:0000007', 'HP:0001030']
IPEX, immune dysregulation, polyendocrinopathy, enteropathy X-linked_FOXP3_XL	IPEX, immune dysregulation, polyendocrinopathy, enteropathy X-linked	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	XL	300292	FOXP3	FOXP3	50943	Autoimmune enteropathy, early onset diabetes, hyroiditis hemolytic anemia, thrombocytopenia, eczema	Normal	Normal	High IgE and IgA	nan	nan	[]	['hsa04659  Th17 cell differentiation', 'hsa05321  Inflammatory bowel disease']	['HP:0000964', 'HP:0002715', 'HP:0002960', 'HP:0100646', 'HP:0001903', 'HP:0003212', 'HP:0001873', 'HP:0003261', 'HP:0001417', 'HP:0002242', 'HP:0001878']
CD25 deficiency_IL2RA_AR	CD25 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AR	147730	IL2RA	IL2RA	3559	Lymphoproliferation, autoimmunity, impaired T cell proliferation	Normal to decreased	Normal	nan	nan	nan	['Aldesleukin: D00748<US>', 'Antithymocyte immunoglobulin (rabbit): D09190<JP/US>', 'Basiliximab: D03058<JP/US>', 'Camidanlumab: D11324', 'Camidanlumab tesirine: D11325', 'Celmoleukin: D02743', 'Daclizumab: D03639', 'Denileukin diftitox: D03682<JP>', 'Melredableukin alfa: D12386', 'Nemvaleukin alfa: D12371', 'Rezpegaldesleukin: D12328', 'Teceleukin: D02749<JP>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04144  Endocytosis', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04640  Hematopoietic cell lineage', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer']	['HP:0000007', 'HP:0002715', 'HP:0002960']
CD122 deficiency_IL2RB_AR	CD122 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AR	618495	IL2RB	IL2RB	3560	"Lymphoproliferation, lymphadenopathy, hepatosplenomegaly, autoimmune hemolytic anemia, dermatitis, enteropathy,
recurrent viral (EBV, CMV) infections"	Increased  memory CD8 T cells, decreased Tregs	Increased memory B cells	High	nan	Poor NK function	['Aldesleukin: D00748<US>', 'Bempegaldesleukin: D11669', 'Celmoleukin: D02743', 'Rezpegaldesleukin: D12328', 'Teceleukin: D02749<JP>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04144  Endocytosis', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05202  Transcriptional misregulation in cancer']	['HP:0010702', 'HP:0002715', 'HP:0002960', 'HP:0001890', 'HP:0001903', 'HP:0000007', 'HP:0002716', 'HP:0001433', 'HP:0011123', 'HP:0030375', 'HP:0002242', 'HP:0001878']
LRBA deficiency_LRBA_AR	LRBA deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AR	606453	LRBA	LRBA	987	Recurrent infections, inflammatory bowel disease, autoimmunity, EBV infections	Normal or decreased CD4 numbers, T cell dysregulation	Low or normal numbers of B cells	Variable	Normal	nan	[]	[]	['HP:0002715', 'HP:0002960', 'HP:0010976', 'HP:0002719', 'HP:0000007', 'HP:0002037']
IKZF1 GOF_IKZF1_AD GOF	IKZF1 GOF	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AD GOF		IKZF1	IKZF1	10320	Organ specific autoimmunity, atopy, adenopathy.  Some infections.	Low	Low	High	nan	Eosinophilia	[]	[]	['HP:0000006', 'HP:0010702', 'HP:0010976', 'HP:0002715', 'HP:0002960', 'HP:0005403']
STAT3 GOF mutation_STAT3_AD GOF	STAT3 GOF mutation	Table 4 Diseases of Immune Dysregulation	Subtable 3 Regulatory T Cell Defects	AD GOF	102582	STAT3	STAT3	6774	Lymphoproliferation, solid organ autoimmunity, recurrent infections	Decreased	Decreased	Normal	Normal	nan	['Napabucasin: D10717']	['hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa04062  Chemokine signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04217  Necroptosis', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04630  JAK-STAT signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04931  Insulin resistance', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05205  Proteoglycans in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05212  Pancreatic cancer', 'hsa05221  Acute myeloid leukemia', 'hsa05223  Non-small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease', 'hsa05417  Lipid and atherosclerosis']	['HP:0000006', 'HP:0002715', 'HP:0002960', 'HP:0010976', 'HP:0002719', 'HP:0005403']
APECED (APS-1),  autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy_AIRE_AR	APECED (APS-1),  autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy	Table 4 Diseases of Immune Dysregulation	Subtable 4 Autoimmunity with or without Lymphoproliferation	AR	607358	AIRE	AIRE	326	Autoimmunity: hypoparathyroidism hypothyroidism, adrenal insufficiency, diabetes, gonadal dysfunction and other endocrine abnormalities, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia areata enteropathy, pernicious anemia	Normal	Normal	Normal	Normal	nan	[]	['hsa04120  Ubiquitin mediated proteolysis', 'hsa05340  Primary immunodeficiency']	['HP:0000829', 'HP:0000821', 'HP:0002728', 'HP:0002715', 'HP:0002960', 'HP:0001596', 'HP:0000846', 'HP:0001903', 'HP:0000007', 'HP:0002232', 'HP:0011771', 'HP:0006297', 'HP:0002242']
APECED (APS-1),  autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy_AIRE_AD	APECED (APS-1),  autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy	Table 4 Diseases of Immune Dysregulation	Subtable 4 Autoimmunity with or without Lymphoproliferation	AD	607358	AIRE	AIRE	326	Autoimmunity: hypoparathyroidism hypothyroidism, adrenal insufficiency, diabetes, gonadal dysfunction and other endocrine abnormalities, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia areata enteropathy, pernicious anemia	Normal	Normal	Normal	Normal	nan	[]	['hsa04120  Ubiquitin mediated proteolysis', 'hsa05340  Primary immunodeficiency']	['HP:0000006', 'HP:0000821', 'HP:0000829', 'HP:0002728', 'HP:0002715', 'HP:0002960', 'HP:0001596', 'HP:0000846', 'HP:0001903', 'HP:0002232', 'HP:0011771', 'HP:0006297', 'HP:0002242']
ITCH deficiency_ITCH_AR	ITCH deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 4 Autoimmunity with or without Lymphoproliferation	AR	606409	ITCH	ITCH	83737	Early-onset chronic lung disease (interstitial pneumonitis), autoimmunity (thyroiditis, type I diabetes, chronic diarrhea/enteropathy, and hepatitis), failure to thrive, developmental delay, dysmorphic facial features	Not assessed	Not assessed	Normal	Normal	nan	[]	['hsa04120  Ubiquitin mediated proteolysis', 'hsa04144  Endocytosis', 'hsa04668  TNF signaling pathway', 'hsa04932  Non-alcoholic fatty liver disease']	['HP:0006528', 'HP:0006515', 'HP:0002715', 'HP:0002960', 'HP:0002088', 'HP:0001508', 'HP:0100646', 'HP:0001999', 'HP:0100651', 'HP:0000007', 'HP:0001263', 'HP:0006530', 'HP:0012115']
JAK1 GOF_JAK1_AD GOF	JAK1 GOF	Table 4 Diseases of Immune Dysregulation	Subtable 4 Autoimmunity with or without Lymphoproliferation	AD GOF	147795	JAK1	JAK1	3716	HSM, eosinophilic enteritis, thyroid disease, poor growth, viral infections	Not assessed	Not assessed	nan	nan	Eosinophilia	['Abrocitinib: D11400<JP/US>', 'Baricitinib: D10308<JP/US>', 'Brepocitinib (DG03044): D11537 D11538', 'Delgocitinib: D11046<JP>', 'Deuruxolitinib (DG03114): D11866 D11867', 'Filgotinib (DG01991): D10871 D10872 D11106<JP>', 'Gusacitinib (DG03080): D11676 D11677', 'Itacitinib (DG02833): D10944 D10945', 'Ivarmacitinib (DG03175): D12211 D12212', 'Momelotinib (DG01366): D10315 D10358 D10889', 'Nezulcitinib: D12118', 'Oclacitinib (DG02005): D10141 D10142', 'Peficitinib (DG01853): D10653 D10721<JP>', 'Ruxolitinib (DG00719): D09959 D09960<JP/US>', 'Solcitinib: D10728', 'Tofacitinib (DG00742): D09783<JP/US> D09970', 'Tuspetinib: D12476', 'Upadacitinib (DG02829): D10994<US> D10995 D11048<JP>']	['hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05140  Leishmaniasis', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05212  Pancreatic cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer']	['HP:0001880', 'HP:0000006', 'HP:0002715', 'HP:0002960', 'HP:0001510', 'HP:0032064', 'HP:0001433', 'HP:0000820']
PD1 deficiency_PDCD1_AR	PD1 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 4 Autoimmunity with or without Lymphoproliferation	AR		PDCD1	PDCD1	5133	Tuberculosis, autoimmunity (T1D, hypothyroidism and JIA),  fatal pulmonary autoimmunity, hepatosplenomegaly	mild lymphopenia but mostly intact. Increased CD4-CD8- DN T cells, Decreased  VÎ´2+ Î³Î´ T, MAIT and CD56hi NK cells	Normal	high serum IgG, IgA; normal IgM, IgE. Anti-insulin autoantibody	nan	nan	['Balstilimab: D11820', 'Budigalimab: D11643', 'Cadonilimab: D12190', 'Cemiplimab: D11108<US>', 'Cetrelimab: D11488', 'Dostarlimab: D11366<US>', 'Izuralimab: D12195', 'Nivolumab: D10316<JP/US>', 'Pacmilimab: D11948', 'Pembrolizumab: D10574<JP/US>', 'Penpulimab: D12198', 'Peresolimab: D12231', 'Pidilizumab: D10390', 'Retifanlimab: D11827', 'Rosnilimab: D12223', 'Sintilimab: D12119', 'Spartalizumab: D11605', 'Tislelizumab: D11487', 'Toripalimab: D12202', 'Volrustomig: D12347', 'Vudalimab: D12186', 'Zeluvalimab: D12332', 'Zimberelimab: D12063']	['hsa04514  Cell adhesion molecules', 'hsa04660  T cell receptor signaling pathway', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer']	['HP:0003237', 'HP:0000821', 'HP:0034062', 'HP:0002960', 'HP:0000007', 'HP:0003261', 'HP:0001433']
Prolidase deficiency_PEPD_AR	Prolidase deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 4 Autoimmunity with or without Lymphoproliferation	AR	613230	PEPD	PEPD	5184	Autoantibodies common, chronic skin ulcers, eczema, infections	Normal	Normal	nan	nan	nan	[]	[]	['HP:0000964', 'HP:0002715', 'HP:0002960', 'HP:0000007', 'HP:0200042']
SOCS1 deficiency_SOCS1_AD halploinsufficiency	SOCS1 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 4 Autoimmunity with or without Lymphoproliferation	AD halploinsufficiency		SOCS1	SOCS1	8651	Multisystem autoimmunity, SLE features, psoriasis, MIS-C with COVID, type I IFN signature	Low CD4/CD8	Normal B cell numbers but low memory	Low immunogobulins	nan	nan	[]	['hsa04120  Ubiquitin mediated proteolysis', 'hsa04380  Osteoclast differentiation', 'hsa04630  JAK-STAT signaling pathway', 'hsa04910  Insulin signaling pathway', 'hsa04917  Prolactin signaling pathway', 'hsa04930  Type II diabetes mellitus', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05145  Toxoplasmosis', 'hsa05206  MicroRNAs in cancer']	['HP:0000006', 'HP:0002715', 'HP:0002960', 'HP:0030374', 'HP:0003765', 'HP:0004313']
Tripeptidyl-Peptidase II Deficiency_TPP2_AR	Tripeptidyl-Peptidase II Deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 4 Autoimmunity with or without Lymphoproliferation	AR	190470	TPP2	TPP2	7174	Variable lymphoproliferation, severe autoimmune cytopenias,  recurrent infections	Decreased	Decreased	High	nan	nan	[]	[]	['HP:0010702', 'HP:0002715', 'HP:0002960', 'HP:0010976', 'HP:0002719', 'HP:0000007', 'HP:0005403']
ELF deficiency_ELF4_XL	ELF deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 5 Immune Dysregulation with Colitis	XL		ELF4	ELF4	2000	"Early onset mucosal autoinflammation/ IBD, fevers and ulcers.  Responded to IL-1, TNF or IL-12p40 blockade.
Hyper inflammatory macrophages"	Normal	Normal	Normal levels of serum IgM, G, A  but reduced responses to live viral vaccines	nan	nan	[]	[]	['HP:0001417', 'HP:0002037', 'HP:0001945', 'HP:0032140']
IL-10 deficiency_IL10_AR	IL-10 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 5 Immune Dysregulation with Colitis	AR	124092	IL10	IL10	3586	Inflammatory bowel disease (IBD) Folliculitis, recurrent respiratory diseases, arthritis,	Normal	Normal	Normal	Normal	nan	['Pirfenidone: D01583<JP/US>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04068  FoxO signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04660  T cell receptor signaling pathway', 'hsa04672  Intestinal immune network for IgA production', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05143  African trypanosomiasis', 'hsa05144  Malaria', 'hsa05145  Toxoplasmosis', 'hsa05146  Amoebiasis', 'hsa05150  Staphylococcus aureus infection', 'hsa05152  Tuberculosis', 'hsa05310  Asthma', 'hsa05320  Autoimmune thyroid disease', 'hsa05321  Inflammatory bowel disease', 'hsa05322  Systemic lupus erythematosus', 'hsa05330  Allograft rejection']	['HP:0025084', 'HP:0002715', 'HP:0000007', 'HP:0004386', 'HP:0002037', 'HP:0001369']
IL-10Ra deficiency_IL10RA_AR	IL-10Ra deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 5 Immune Dysregulation with Colitis	AR	146933	IL10RA	IL10RA	3587	IBD, Folliculitis, recurrent respiratory diseases, arthritis, lymphoma	Normal	Normal	Normal	Normal	nan	['Ilodecakin: D04505', 'Pegilodecakin: D11200']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04630  JAK-STAT signaling pathway', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05163  Human cytomegalovirus infection']	['HP:0025084', 'HP:0002715', 'HP:0000007', 'HP:0004386', 'HP:0002665', 'HP:0002037', 'HP:0001369']
IL-10Rb deficiency_IL10RB_AR	IL-10Rb deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 5 Immune Dysregulation with Colitis	AR	123889	IL10RB	IL10RB	3588	IBD, folliculitis, recurrent respiratory diseases, arthritis, lymphoma	Normal	Normal	Normal	Normal	nan	['Ilodecakin: D04505', 'Pegilodecakin: D11200']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04630  JAK-STAT signaling pathway', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05163  Human cytomegalovirus infection']	['HP:0025084', 'HP:0002715', 'HP:0000007', 'HP:0004386', 'HP:0002665', 'HP:0002037', 'HP:0001369']
NFAT5 haploinsufficiency_NFAT5_AD	NFAT5 haploinsufficiency	Table 4 Diseases of Immune Dysregulation	Subtable 5 Immune Dysregulation with Colitis	AD	604708	NFAT5	NFAT5	10725	IBD, recurrent sinopulmonary infections	Normal	Normal	Normal	Normal	nan	[]	[]	['HP:0000006', 'HP:0005425', 'HP:0002715', 'HP:0004386', 'HP:0002037']
RIPK1 deficiency_RIPK1_AR	RIPK1 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 5 Immune Dysregulation with Colitis	AR	618108	RIPK1	RIPK1	8737	Reccurrent infections, early-onset IBD, progressive polyarthritis	Low	Normal to low	Normal	Normal	nan	['Eclitasertib: D12352']	['hsa04064  NF-kappa B signaling pathway', 'hsa04210  Apoptosis', 'hsa04217  Necroptosis', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04668  TNF signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05160  Hepatitis C', 'hsa05163  Human cytomegalovirus infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection']	['HP:0002715', 'HP:0002719', 'HP:0000007', 'HP:0004386', 'HP:0002037', 'HP:0005403']
TGFB1 deficiency_TGFB1_AR	TGFB1 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 5 Immune Dysregulation with Colitis	AR	618213	TGFB1	TGFB1	7040	IBD, immunodeficiency, recurrent viral infections, microcephaly, and encephalopathy	Normal	Normal	Normal	Normal	nan	['Fresolimumab: D09620']	['hsa04010  MAPK signaling pathway', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04068  FoxO signaling pathway', 'hsa04110  Cell cycle', 'hsa04218  Cellular senescence', 'hsa04350  TGF-beta signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04390  Hippo signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa04672  Intestinal immune network for IgA production', 'hsa04926  Relaxin signaling pathway', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05144  Malaria', 'hsa05145  Toxoplasmosis', 'hsa05146  Amoebiasis', 'hsa05152  Tuberculosis', 'hsa05161  Hepatitis B', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05205  Proteoglycans in cancer', 'hsa05210  Colorectal cancer', 'hsa05211  Renal cell carcinoma', 'hsa05212  Pancreatic cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer', 'hsa05321  Inflammatory bowel disease', 'hsa05323  Rheumatoid arthritis', 'hsa05410  Hypertrophic cardiomyopathy', 'hsa05414  Dilated cardiomyopathy', 'hsa05415  Diabetic cardiomyopathy']	['HP:0002715', 'HP:0004429', 'HP:0002721', 'HP:0000007', 'HP:0004386', 'HP:0002037', 'HP:0001298', 'HP:0000252']
ALPS-Caspase10_CASP10_AD	ALPS-Caspase10	Table 4 Diseases of Immune Dysregulation	Subtable 6 Autoimmune Lymphoproliferative Syndrome (ALPS, Canale Smith syndrome)	AD	601762	CASP10	CASP10	843	Adenopathies, splenomegaly, autoimmunity	Increased DN T cells	Normal	Normal	Normal	nan	[]	['hsa04210  Apoptosis', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa05152  Tuberculosis', 'hsa05161  Hepatitis B']	['HP:0000006', 'HP:0002715', 'HP:0002960', 'HP:0100828', 'HP:0001744']
ALPS-Caspase 8_CASP8_AR	ALPS-Caspase 8	Table 4 Diseases of Immune Dysregulation	Subtable 6 Autoimmune Lymphoproliferative Syndrome (ALPS, Canale Smith syndrome)	AR	601763	CASP8	CASP8	841	Adenopathies, splenomegaly, bacterial and viral infections	Slightly increased DN T cells	Normal	Low	Normal	nan	[]	['hsa01524  Platinum drug resistance', 'hsa04115  p53 signaling pathway', 'hsa04210  Apoptosis', 'hsa04215  Apoptosis - multiple species', 'hsa04217  Necroptosis', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05016  Huntington disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05132  Salmonella infection', 'hsa05134  Legionellosis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05416  Viral myocarditis', 'hsa05417  Lipid and atherosclerosis']	['HP:0002715', 'HP:0002960', 'HP:0000007', 'HP:0004313', 'HP:0001744']
FADD deficiency_FADD_AR	FADD deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 6 Autoimmune Lymphoproliferative Syndrome (ALPS, Canale Smith syndrome)	AR	602457	FADD	FADD	8772	Functional hyposplenism, bacterial and viral infections, recurrent episodes of encephalopathy and liver dysfunction	Increased DN T cells	Normal	nan	nan	nan	[]	['hsa01524  Platinum drug resistance', 'hsa04210  Apoptosis', 'hsa04215  Apoptosis - multiple species', 'hsa04217  Necroptosis', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05132  Salmonella infection', 'hsa05142  Chagas disease', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer']	['HP:0002715', 'HP:0002960', 'HP:0000007', 'HP:0100828', 'HP:0001298', 'HP:0001971', 'HP:0001410']
ALPS-FAS_FAS_AD	ALPS-FAS	Table 4 Diseases of Immune Dysregulation	Subtable 6 Autoimmune Lymphoproliferative Syndrome (ALPS, Canale Smith syndrome)	AD	134637	TNFRSF6	FAS	355	Splenomegaly, adenopathies, autoimmune cytopenias, increased lymphoma risk, IgG and A normal or increased, elevated serum FasL and IL-10, vitamin B12	Increased CD4-CD8-TCR a/bï double negative (DN) T cells	Normal, low memory B cells	Normal	Normal	nan	[]	['hsa01524  Platinum drug resistance', 'hsa04010  MAPK signaling pathway', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04115  p53 signaling pathway', 'hsa04210  Apoptosis', 'hsa04217  Necroptosis', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04668  TNF signaling pathway', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04936  Alcoholic liver disease', 'hsa04940  Type I diabetes mellitus', 'hsa05010  Alzheimer disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05142  Chagas disease', 'hsa05143  African trypanosomiasis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05205  Proteoglycans in cancer', 'hsa05320  Autoimmune thyroid disease', 'hsa05330  Allograft rejection', 'hsa05332  Graft-versus-host disease', 'hsa05417  Lipid and atherosclerosis']	['HP:0000006', 'HP:0002715', 'HP:0002960', 'HP:0030374', 'HP:0100828', 'HP:0002665', 'HP:0001744']
ALPS-FAS_FAS_AR	ALPS-FAS	Table 4 Diseases of Immune Dysregulation	Subtable 6 Autoimmune Lymphoproliferative Syndrome (ALPS, Canale Smith syndrome)	AR	134637	TNFRSF6	FAS	355	Splenomegaly, adenopathies, autoimmune cytopenias, increased lymphoma risk, IgG and A normal or increased, elevated serum FasL and IL-10, vitamin B12	Increased CD4-CD8-TCR a/bï double negative (DN) T cells	Normal, low memory B cells	Normal	Normal	nan	[]	['hsa01524  Platinum drug resistance', 'hsa04010  MAPK signaling pathway', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04115  p53 signaling pathway', 'hsa04210  Apoptosis', 'hsa04217  Necroptosis', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04668  TNF signaling pathway', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04936  Alcoholic liver disease', 'hsa04940  Type I diabetes mellitus', 'hsa05010  Alzheimer disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05142  Chagas disease', 'hsa05143  African trypanosomiasis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05205  Proteoglycans in cancer', 'hsa05320  Autoimmune thyroid disease', 'hsa05330  Allograft rejection', 'hsa05332  Graft-versus-host disease', 'hsa05417  Lipid and atherosclerosis']	['HP:0002715', 'HP:0002960', 'HP:0030374', 'HP:0000007', 'HP:0100828', 'HP:0002665', 'HP:0001744']
ALPS-FASLG_FASLG_AR	ALPS-FASLG	Table 4 Diseases of Immune Dysregulation	Subtable 6 Autoimmune Lymphoproliferative Syndrome (ALPS, Canale Smith syndrome)	AR	134638	TNFSF6	FASLG	356	Splenomegaly, adenopathies, autoimmune cytopenias, SLE, soluble FasL is not elevated	Increased DN T cells	Normal	Normal	Normal	nan	[]	['hsa01524  Platinum drug resistance', 'hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04068  FoxO signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04217  Necroptosis', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04722  Neurotrophin signaling pathway', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04936  Alcoholic liver disease', 'hsa04940  Type I diabetes mellitus', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05142  Chagas disease', 'hsa05143  African trypanosomiasis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05205  Proteoglycans in cancer', 'hsa05320  Autoimmune thyroid disease', 'hsa05330  Allograft rejection', 'hsa05332  Graft-versus-host disease', 'hsa05417  Lipid and atherosclerosis']	['HP:0002715', 'HP:0002960', 'HP:0000007', 'HP:0100828', 'HP:0001744']
RLTPR (CARMIL2) deficiency_CARMIL2_AR	RLTPR (CARMIL2) deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	AR	610859	CARMIL2	CARMIL2	146206	Recurrent bacterial, fungal and mycobacterial infections, viral warts, molluscum and EBV lymphoproliferative and other malignancy, atopy	Nl number, low Treg, high CD4, poor function	Nl number	nan	nan	nan	[]	[]	['HP:0020072', 'HP:0000007', 'HP:0200043', 'HP:0002715']
CD27 deficiency_CD27_AR	CD27 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	AR	615122	CD27	CD27	939	Features triggered by EBV infection, HLH, aplastic anemia, lymphoma	Normal	No memory B cells	nan	Normal	Low iNKT	['Boserolimab: D12256']	['hsa04060  Cytokine-cytokine receptor interaction']	['HP:0002715', 'HP:0020072', 'HP:0001903', 'HP:0000007', 'HP:0001915', 'HP:0002665']
CD70 deficiency_CD70_AR	CD70 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	AR	602840	CD70	CD70	970	EBV susceptibility, Hodgkin lymphoma	Nl number, low Treg, poor activation and function	Nl number, poor antibody and memory responses	nan	Normal	nan	['Vorsetuzumab: D10342', 'Vorsetuzumab mafodotin: D10341']	['hsa04060  Cytokine-cytokine receptor interaction']	['HP:0002715', 'HP:0020072', 'HP:0000007', 'HP:0002665', 'HP:0012189']
CTPS1 deficiency_CTPS1_AR	CTPS1 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	AR	615897	CTPS1	CTPS1	1503	Recurrent/chronic bacterial and viral infections (EBV, VZV), EBV lymphoproliferation, B-cell non-Hodgkin lymphoma	Nl to low, poor proliferation to antigen	Nl/low	nan	Normal	nan	[]	['hsa00240  Pyrimidine metabolism', 'hsa01100  Metabolic pathways', 'hsa01232  Nucleotide metabolism', 'hsa01240  Biosynthesis of cofactors']	['HP:0002715', 'HP:0020072', 'HP:0000007', 'HP:0002665', 'HP:0012539']
MAGT1 deficiency (XMEN)_MAGT1_XL	MAGT1 deficiency (XMEN)	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	XL	300853	MAGT1	MAGT1	84061	EBV infection, lymphoma, viral infections, respiratory and GI infections	Low CD4 Low recent thymic emigrant cels, poor proliferation to CD3	Normal	nan	nan	nan	[]	[]	['HP:0004798', 'HP:0002715', 'HP:0020072', 'HP:0002665', 'HP:0001417']
PRKCD deficiency_PRKCD_AR	PRKCD deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	AR	176977	PRKCD	PRKCD	5580	Recurrent infections, EBV chronic infection, lymphoproliferation, SLE-like autoimmunity (nephrotic and antiphospholipid syndromes), low IgG	Normal	Low memory B cells, high CD5 B cells	nan	nan	nan	['Delcasertib (DG02094): D10456 D10457', 'Safingol: D05784', 'Safingol hydrochloride: D05785', 'Sotrastaurin (DG01406): D09671 D09718']	['hsa04062  Chemokine signaling pathway', 'hsa04140  Autophagy - animal', 'hsa04270  Vascular smooth muscle contraction', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04722  Neurotrophin signaling pathway', 'hsa04750  Inflammatory mediator regulation of TRP channels', 'hsa04912  GnRH signaling pathway', 'hsa04915  Estrogen signaling pathway', 'hsa04930  Type II diabetes mellitus', 'hsa04931  Insulin resistance', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05020  Prion disease', 'hsa05131  Shigellosis', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05415  Diabetic cardiomyopathy']	['HP:0002715', 'HP:0002960', 'HP:0020072', 'HP:0030374', 'HP:0002719', 'HP:0000007', 'HP:0031035']
RASGRP1 deficiency_RASGRP1_AR	RASGRP1 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	AR	603962	RASGRP1	RASGRP1	10125	Recurrent pneumonia, herpesvirus infections, EBV associated lymphoma	Poor activation, proliferation, motility	Poor activation, proliferation, motility	nan	Normal	nan	[]	['hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04611  Platelet activation', 'hsa04660  T cell receptor signaling pathway', 'hsa05200  Pathways in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer']	['HP:0002715', 'HP:0020072', 'HP:0000007', 'HP:0002090', 'HP:0006532', 'HP:0002665']
SH2D1A (SAP) deficiency (XLP1)_SH2D1A_XL	SH2D1A (SAP) deficiency (XLP1)	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	XL	300490	SH2D1A	SH2D1A	4068	EBV, HLH, Lymphoproliferation, Aplastic anaemia	Normal or Increased activated T cells	Reduced Memory B cells	Variable	Normal	Low iNKT	[]	['hsa04650  Natural killer cell mediated cytotoxicity']	['HP:0002715', 'HP:0020072', 'HP:0001903', 'HP:0001915', 'HP:0001417']
TET2 deficiency_TET2_AR	TET2 deficiency	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	AR		TET2	TET2	54790	ALPS-like, viral ifnection, EBV+ lymphoma, FTT, developmenal delay, EBV viremia	High DN T cells, low TH1, Th17 and TFH	Normal numbers of B cells with low memory	Variable	nan	Poor fas-mediated apoptosis	[]	[]	['HP:0001508', 'HP:0002715', 'HP:0020072', 'HP:0000007', 'HP:0001263', 'HP:0002665', 'HP:0020071']
CD137 deficiency (41BB)_TNFRSF9_AR	CD137 deficiency (41BB)	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	AR	602250	TNFRSF9	TNFRSF9	3604	EBV lymphoproliferation, B-cell lymphoma	Normal	Normal	Low	Normal	nan	['Urelumab: D09984']	['hsa04060  Cytokine-cytokine receptor interaction']	['HP:0002715', 'HP:0020072', 'HP:0000007', 'HP:0002665', 'HP:0004313']
XIAP deficiency (XLP2)_XIAP_XL	XIAP deficiency (XLP2)	Table 4 Diseases of Immune Dysregulation	Subtable 7 Susceptibility to EBV and Lymphoproliferative Conditions	XL	300079	XIAP	XIAP	331	EBV infection, Splenomegaly, lymphoproliferation, HLH, Colitis, IBD, hepatitis, Low iNKT cells, hypogammaglobulinemia	Normal or Increased activated T cells; low/normal iNK T cells	Normal or reduced Memory B cells	Variable	Normal	nan	[]	['hsa01524  Platinum drug resistance', 'hsa04064  NF-kappa B signaling pathway', 'hsa04120  Ubiquitin mediated proteolysis', 'hsa04210  Apoptosis', 'hsa04215  Apoptosis - multiple species', 'hsa04217  Necroptosis', 'hsa04510  Focal adhesion', 'hsa04621  NOD-like receptor signaling pathway', 'hsa05145  Toxoplasmosis', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05222  Small cell lung cancer']	['HP:0002583', 'HP:0002715', 'HP:0020072', 'HP:0030374', 'HP:0002037', 'HP:0004313', 'HP:0001417', 'HP:0001744', 'HP:0012115']
Specific granule deficiency_CEBPE_AR	Specific granule deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	189965	CEBPE	CEBPE	1053	Neutrophils with bilobed nuclei	nan	nan	nan	Low	nan	[]	['hsa05202  Transcriptional misregulation in cancer', 'hsa05221  Acute myeloid leukemia']	['HP:0000007', 'HP:0410252', 'HP:0002715', 'HP:0001875']
3-Methylglutaconic aciduria_CLPB_AR	3-Methylglutaconic aciduria	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	616254	CLPB	CLPB	81570	Neurocognitive developmental aberrations, microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR	nan	nan	nan	Low	nan	[]	['hsa04213  Longevity regulating pathway - multiple species']	['HP:0002715', 'HP:0001252', 'HP:0001251', 'HP:0000007', 'HP:0001250', 'HP:0001943', 'HP:0001510', 'HP:0001875', 'HP:0000252', 'HP:0001511', 'HP:0410252', 'HP:0000518']
G-CSF receptor deficiency_CSF3R_AR	G-CSF receptor deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	138971	CSF3R	CSF3R	1441	nan	nan	nan	nan	Low	nan	['Balugrastim: D10310', 'Efbemalenograstim alfa: D11986', 'Eflapegrastim: D11188<US>', 'Filgrastim: D03235<JP/US>', 'Lenograstim: D03247<JP>', 'Leridistim: D04695', 'Lipegfilgrastim: D10242', 'Milodistim: D05036', 'Nartograstim: D03245', 'Pegfilgrastim: D06889<JP/US>', 'Pegnartograstim: D05389', 'Pegteograstim: D11026']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04640  Hematopoietic cell lineage', 'hsa05200  Pathways in cancer']	['HP:0000007', 'HP:0410252', 'HP:0002715', 'HP:0001875']
CXCR2 deficiency_CXCR2_AR	CXCR2 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR		CXCR2	CXCR2	3579	Myelokathexis (3/6 pts), recurrent gingivitis, oral ulcers, hypergammaglobulinemia	Normal numbers of CD4+ T cells, variable CD8+ T cells, NK cells normal	Normal	High serum IgG, IgA, IgM	Severe neutropenia	nan	['Danirixin: D10387', 'Elubrixin (DG01371): D10332 D10420', 'Navarixin: D10075', 'Reparixin: D08984']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04062  Chemokine signaling pathway', 'hsa04072  Phospholipase D signaling pathway', 'hsa04144  Endocytosis', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05163  Human cytomegalovirus infection']	['HP:0003237', 'HP:0010702', 'HP:0031160', 'HP:0000155', 'HP:0000007', 'HP:0003496', 'HP:0034284', 'HP:0000230', 'HP:0003261']
Schwachman Diamond syndrome due to DNAJC21 deficiency_DNAJC21_AR	Schwachman Diamond syndrome due to DNAJC21 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	617048	DNAJC21	DNAJC21	134218	Metaphyseal changes, short stature, developmental delay, pancreatic dysfunction, bone marrow failure	nan	nan	nan	Low	nan	[]	[]	['HP:0004322', 'HP:0002715', 'HP:0005528', 'HP:0000007', 'HP:0001263', 'HP:0001875', 'HP:0410252']
Schwachman Diamond syndrome due to EFL1 deficiency_EFL1_AR	Schwachman Diamond syndrome due to EFL1 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	617941	EFL1	EFL1	79631	Metaphyseal changes, short stature, developmental delay, pancreatic dysfunction, bone marrow failure	nan	nan	nan	Low	nan	[]	['hsa03008  Ribosome biogenesis in eukaryotes']	['HP:0004322', 'HP:0002715', 'HP:0005528', 'HP:0000007', 'HP:0001263', 'HP:0001875', 'HP:0410252']
Elastase deficiency (SCN1)_ELANE_AD	Elastase deficiency (SCN1)	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AD	130130	ELANE	ELANE	1991	Susceptibility to MDS/leukemia, Severe congenital neutropenia or cyclic neutropenia	nan	nan	nan	Low	nan	['Depelestat: D03686', 'Sivelestat (DG01401): D01918<JP> D03788', 'Ulinastatin: D05183<JP>']	['hsa04613  Neutrophil extracellular trap formation', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05322  Systemic lupus erythematosus']	['HP:0000006', 'HP:0002715', 'HP:0001875', 'HP:0040289', 'HP:0410252']
G6PC3 deficiency (SCN4)_G6PC3_AR	G6PC3 deficiency (SCN4)	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	611045	G6PC3	G6PC3	92579	Structural heart defects, urogenital abnormalities, inner ear deafness, and venous angiectasias of trunks and limbs	nan	nan	nan	Low	nan	[]	['hsa00010  Glycolysis / Gluconeogenesis', 'hsa00052  Galactose metabolism', 'hsa00500  Starch and sucrose metabolism', 'hsa01100  Metabolic pathways', 'hsa04068  FoxO signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04152  AMPK signaling pathway', 'hsa04910  Insulin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04922  Glucagon signaling pathway', 'hsa04931  Insulin resistance', 'hsa04973  Carbohydrate digestion and absorption']	['HP:0002715', 'HP:0001627', 'HP:0000365', 'HP:0000119', 'HP:0000007', 'HP:0001875', 'HP:0410252', 'HP:0009900']
Glycogen storage disease type 1b_SLC37A4_AR	Glycogen storage disease type 1b	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	602671	G6PT1	SLC37A4	2542	Fasting hypoglycemia, lactic acidosis, hyperlipidemia, hepatomegaly	nan	nan	nan	Low	Monocytes	[]	['hsa04973  Carbohydrate digestion and absorption']	['HP:0003077', 'HP:0002715', 'HP:0002240', 'HP:0000007', 'HP:0001943', 'HP:0001875', 'HP:0003128', 'HP:0003162', 'HP:0410252', 'HP:0001941']
GFI 1 deficiency (SCN2)_GFI1_AD	GFI 1 deficiency (SCN2)	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AD	600871	GFI1	GFI1	2672	B/T lymphopenia	nan	nan	nan	Low	nan	[]	[]	['HP:0001888', 'HP:0000006', 'HP:0002715', 'HP:0001875', 'HP:0410252']
HAX1 deficiency (Kostmann Disease) (SCN3)_HAX1_AR	HAX1 deficiency (Kostmann Disease) (SCN3)	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	605998	HAX1	HAX1	10456	Cognitive and neurological defects in patients with defects in both HAX1 isoforms, susceptibility to MDS/leukemia	nan	nan	nan	Low	nan	[]	[]	['HP:0000007', 'HP:0410252', 'HP:0002715', 'HP:0001875']
HYOU1 deficiency_HYOU1_AR	HYOU1 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	601746	HYOU1	HYOU1	10525	Hypoglycemia, inflammatory complications	nan	nan	nan	Low	nan	[]	['hsa04141  Protein processing in endoplasmic reticulum']	['HP:0002715', 'HP:0000007', 'HP:0001875', 'HP:0001943', 'HP:0410252']
JAGN1 deficiency_JAGN1_AR	JAGN1 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	616012	JAGN1	JAGN1	84522	Myeloid maturation arrest, osteopenia	nan	nan	nan	Low	nan	[]	[]	['HP:0000938', 'HP:0002715', 'HP:0000007', 'HP:0001875', 'HP:0410253', 'HP:0410252']
P14/LAMTOR2 deficiency_LAMTOR2_AR	P14/LAMTOR2 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	610389	LAMTOR2	LAMTOR2	28956	Neutropenia, Hypogammaglobulinemia Â¯CD8 cytotoxicity, partial albinism, growth failure	nan	nan	nan	Low	Monocytes	[]	['hsa04150  mTOR signaling pathway']	['HP:0001022', 'HP:0002715', 'HP:0000007', 'HP:0001510', 'HP:0001875', 'HP:0007443', 'HP:0004313', 'HP:0410252']
Shwachman-Diamond Syndrome due to SBSD deficiency_SBDS_AR	Shwachman-Diamond Syndrome due to SBSD deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	607444	SBDS	SBDS	51119	Pancytopenia, exocrine pancreatic insufficiency, chondrodysplasia	nan	nan	nan	Low	nan	[]	['hsa03008  Ribosome biogenesis in eukaryotes']	['HP:0002715', 'HP:0001738', 'HP:0000007', 'HP:0001875', 'HP:0001876', 'HP:0410252']
SMARCD2 deficiency_SMARCD2_AR	SMARCD2 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	601736	SMARCD2	SMARCD2	6603	Neutropenia, developmental aberrations, skeletal abnormalities, hematopoietic stem cells, myelodysplasia	nan	nan	nan	Low	nan	[]	['hsa04714  Thermogenesis', 'hsa05225  Hepatocellular carcinoma']	['HP:0002863', 'HP:0002715', 'HP:0000007', 'HP:0000924', 'HP:0001875', 'HP:0410252']
SRP54 deficiency_SRP54_AD	SRP54 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AD		SRP54	SRP54	6729	Schwachman Diamond features	nan	nan	nan	Low	nan	[]	['hsa03060  Protein export']	['HP:0000006', 'HP:0410252', 'HP:0002715', 'HP:0001875']
Barth Syndrome, (3-Methylglutaconic aciduria type II)_TAFAZZIN_XL	Barth Syndrome, (3-Methylglutaconic aciduria type II)	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	XL	300394	TAZ	TAFAZZIN	6901	Cardiomyopathy, myopathy, growth retardation	nan	nan	nan	Low	nan	[]	['hsa00564  Glycerophospholipid metabolism']	['HP:0002715', 'HP:0001510', 'HP:0001875', 'HP:0001638', 'HP:0003198', 'HP:0001417', 'HP:0410252']
Clericuzio syndrome (Poikiloderma with neutropenia)_USB1_AR	Clericuzio syndrome (Poikiloderma with neutropenia)	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	613276	USB1	USB1	79650	Retinopathy, developmental delay, facial dysmorphisms, poikiloderma	nan	nan	nan	Low	nan	[]	[]	['HP:0002715', 'HP:0000007', 'HP:0001263', 'HP:0001875', 'HP:0001029', 'HP:0410252', 'HP:0000488']
Cohen syndrome_VPS13B_AR	Cohen syndrome	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	607817	VPS13B	VPS13B	157680	Dysmorphism, mental retardation, obesity, deafness, neutropenia	nan	nan	nan	Low	nan	[]	[]	['HP:0002715', 'HP:0000365', 'HP:0001513', 'HP:0000007', 'HP:0001875', 'HP:0001249', 'HP:0410252']
VPS45 deficiency (SCN5)_VPS45_AR	VPS45 deficiency (SCN5)	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	AR	610035	VPS45	VPS45	11311	Extramedullary hematopoiesis, bone marrow fibrosis, nephromegaly	nan	nan	nan	Low	nan	[]	['hsa04144  Endocytosis']	['HP:0001978', 'HP:0002715', 'HP:0000105', 'HP:0000007', 'HP:0001875', 'HP:0410252']
X-linked neutropenia/ myelodysplasia WAS GOF_WAS_XL GOF	X-linked neutropenia/ myelodysplasia WAS GOF	Table 5 Congenital defects of phagocyte number or function	Subtable 1 Congenital Neutropenias	XL GOF	300392	WAS	WAS	7454	Neutropenia, myeloid maturation arrest, monocytopenia, variable lymphoid anomalies	nan	nan	nan	Low	nan	[]	['hsa04062  Chemokine signaling pathway', 'hsa04520  Adherens junction', 'hsa04530  Tight junction', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa05135  Yersinia infection', 'hsa05231  Choline metabolism in cancer']	['HP:0002715', 'HP:0012312', 'HP:0001875', 'HP:0410253', 'HP:0001417', 'HP:0410252']
b actin deficiency_ACTB_AD	b actin deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AD	102630	ACTB	ACTB	60	Mental retardation, short stature	nan	nan	nan	nan	nan	[]	['hsa04015  Rap1 signaling pathway', 'hsa04145  Phagosome', 'hsa04210  Apoptosis', 'hsa04390  Hippo signaling pathway', 'hsa04510  Focal adhesion', 'hsa04520  Adherens junction', 'hsa04530  Tight junction', 'hsa04611  Platelet activation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04670  Leukocyte transendothelial migration', 'hsa04714  Thermogenesis', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04921  Oxytocin signaling pathway', 'hsa04971  Gastric acid secretion', 'hsa05014  Amyotrophic lateral sclerosis', 'hsa05100  Bacterial invasion of epithelial cells', 'hsa05110  Vibrio cholerae infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05164  Influenza A', 'hsa05205  Proteoglycans in cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05410  Hypertrophic cardiomyopathy', 'hsa05412  Arrhythmogenic right ventricular cardiomyopathy', 'hsa05414  Dilated cardiomyopathy', 'hsa05416  Viral myocarditis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0004322', 'HP:0000006', 'HP:0002715', 'HP:0001249']
CEBPE defects_CEBPE_AR GOF	CEBPE defects	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR GOF		CEBPE	CEBPE	1053	Recurrent abdominal pain, aseptic fevers, inflammation, abscesses, type I IFN signature	nan	nan	nan	nan	Mild bleeding diathesis	[]	['hsa05202  Transcriptional misregulation in cancer', 'hsa05221  Acute myeloid leukemia']	['HP:0002715', 'HP:0000007', 'HP:0025615', 'HP:0012531', 'HP:0010280', 'HP:0001945', 'HP:0002027']
Cystic fibrosis_CFTR_AR	Cystic fibrosis	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR	602421	CFTR	CFTR	1080	Respiratory infections, pancreatic insufficiency, elevated sweat chloride	nan	nan	nan	Normal	Macrophage dysfunction	['Bamocaftor (DG03043): D11535 D11536', 'Crofelemer: D03605<US>', 'Deutivacaftor: D11423', 'Elexacaftor: D11507', 'Galicaftor: D11724', 'Icenticaftor: D12454', 'Ivacaftor: D09916<US>', 'Ivacaftor and lumacaftor: D10685<US>', 'Ivacaftor and tezacaftor: D11042<US>', 'Ivacaftor, tezacaftor and elexacaftor: D11700<US>', 'Lumacaftor: D10134', 'Navocaftor: D12140', 'Nesolicaftor: D11682', 'Olacaftor: D11402', 'Posenacaftor: D11683', 'Tezacaftor: D11041']	['hsa02010  ABC transporters', 'hsa04024  cAMP signaling pathway', 'hsa04152  AMPK signaling pathway', 'hsa04530  Tight junction', 'hsa04971  Gastric acid secretion', 'hsa04972  Pancreatic secretion', 'hsa04976  Bile secretion', 'hsa05110  Vibrio cholerae infection']	['HP:0002783', 'HP:0002715', 'HP:0012236', 'HP:0001738', 'HP:0011947', 'HP:0000007', 'HP:0000975']
Papillon-LefÃ¨vre Syndrome_CTSC_AR	Papillon-LefÃ¨vre Syndrome	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR	602365	CTSC	CTSC	1075	Periodontitis, palmoplantar hyperkeratosis in some patients	nan	nan	nan	Normal	nan	['Brensocatib: D12120']	['hsa04142  Lysosome', 'hsa04210  Apoptosis']	['HP:0000704', 'HP:0002715', 'HP:0000962', 'HP:0000007', 'HP:0000972']
Leukocyte adhesion deficiency type 3 (LAD3)_FERMT3_AR	Leukocyte adhesion deficiency type 3 (LAD3)	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR	607901	FERMT3	FERMT3	83706	LAD type 1 plus bleeding tendency	nan	nan	nan	High	nan	[]	['hsa04611  Platelet activation']	['HP:0410258', 'HP:0011897', 'HP:0002715', 'HP:0000007', 'HP:0001892']
Localized juvenile periodontitis_FPR1_AR	Localized juvenile periodontitis	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR	136537	FPR1	FPR1	2357	Periodontitis only	nan	nan	nan	Normal	nan	[]	['hsa04015  Rap1 signaling pathway', 'hsa04080  Neuroactive ligand-receptor interaction', 'hsa04613  Neutrophil extracellular trap formation', 'hsa05150  Staphylococcus aureus infection']	['HP:0000007', 'HP:0000704', 'HP:0002715']
Leukocyte adhesion deficiency type 1 (LAD1)_ITGB2_AR	Leukocyte adhesion deficiency type 1 (LAD1)	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR	600065	ITGB2	ITGB2	3689	Delayed cord separation, skin ulcers, periodontitis, leukocytosis	nan	nan	nan	High	nan	['Erlizumab: D04045', 'Fuzapladib sodium hydrate: D11919', 'Rovelizumab: D08993']	['hsa04015  Rap1 signaling pathway', 'hsa04145  Phagosome', 'hsa04390  Hippo signaling pathway', 'hsa04514  Cell adhesion molecules', 'hsa04610  Complement and coagulation cascades', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04670  Leukocyte transendothelial migration', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05133  Pertussis', 'hsa05134  Legionellosis', 'hsa05140  Leishmaniasis', 'hsa05144  Malaria', 'hsa05146  Amoebiasis', 'hsa05150  Staphylococcus aureus infection', 'hsa05152  Tuberculosis', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05323  Rheumatoid arthritis', 'hsa05416  Viral myocarditis']	['HP:0410258', 'HP:0011897', 'HP:0000704', 'HP:0002715', 'HP:0001974', 'HP:0000007', 'HP:0200042']
Neutropenia with combined immune deficiency due to MKL1 deficiency_MRTFA_AR	Neutropenia with combined immune deficiency due to MKL1 deficiency	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR	606078	MKL1	MRTFA	57591	Mild thrombocytopenia	nan	nan	nan	Low	nan	[]	[]	['HP:0002715', 'HP:0000007', 'HP:0001875', 'HP:0001873', 'HP:0410252']
Rac 2 deficiency (LOF)_RAC2_AD LOF	Rac 2 deficiency (LOF)	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AD LOF	602049	RAC2	RAC2	5880	Poor wound healing, leukocytosis	nan	nan	nan	High	nan	[]	['hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04071  Sphingolipid signaling pathway', 'hsa04310  Wnt signaling pathway', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04510  Focal adhesion', 'hsa04520  Adherens junction', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04670  Leukocyte transendothelial migration', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05135  Yersinia infection', 'hsa05163  Human cytomegalovirus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05210  Colorectal cancer', 'hsa05212  Pancreatic cancer', 'hsa05231  Choline metabolism in cancer', 'hsa05415  Diabetic cardiomyopathy', 'hsa05416  Viral myocarditis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0410258', 'HP:0000006', 'HP:0011897', 'HP:0001058', 'HP:0002715', 'HP:0001974']
Leukocyte adhesion deficiency type 2   (LAD2)_SLC35C1_AR	Leukocyte adhesion deficiency type 2   (LAD2)	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR	605881	SLC35C1	SLC35C1	55343	Mild LAD type 1 features with hh-blood group, growth retardation, developmental delay	nan	nan	nan	High	nan	[]	[]	['HP:0410258', 'HP:0011897', 'HP:0002715', 'HP:0000007', 'HP:0001510', 'HP:0001263']
WDR1 deficiency (Lazy leukocyte)_WDR1_AR	WDR1 deficiency (Lazy leukocyte)	Table 5 Congenital defects of phagocyte number or function	Subtable 2 Defects of Motility	AR	604734	WDR1	WDR1	9948	Mild neutropenia, poor wound healing, severe stomatitis, neutrophil nuclei herniate	nan	nan	nan	Low	nan	[]	[]	['HP:0011897', 'HP:0001058', 'HP:0002715', 'HP:0000007', 'HP:0001875', 'HP:0010280']
Autosomal recessive CGD p22phox_CYBA_AR	Autosomal recessive CGD p22phox	Table 5 Congenital defects of phagocyte number or function	Subtable 3 Defects of Respiratory Burst	AR	608508	CYBA	CYBA	1535	Infections, autoinflammatory phenotype	nan	nan	Normal	Normal	Neutrophil dysfunction	[]	['hsa04145  Phagosome', 'hsa04380  Osteoclast differentiation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04670  Leukocyte transendothelial migration', 'hsa05020  Prion disease', 'hsa05140  Leishmaniasis', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000007', 'HP:0002718', 'HP:0002715']
X-linked chronic granulomatous disease (CGD), gp91phox_CYBB_XL	X-linked chronic granulomatous disease (CGD), gp91phox	Table 5 Congenital defects of phagocyte number or function	Subtable 3 Defects of Respiratory Burst	XL	300481	CYBB	CYBB	1536	Infections, autoinflammatory phenotype, IBD, McLeod phenotype in patients with deletions extending into the contiguous Kell locus	nan	nan	Normal	Normal	Neutrophil dysfunction	[]	['hsa04066  HIF-1 signaling pathway', 'hsa04145  Phagosome', 'hsa04216  Ferroptosis', 'hsa04217  Necroptosis', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04670  Leukocyte transendothelial migration', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05010  Alzheimer disease', 'hsa05020  Prion disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05140  Leishmaniasis', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis']	['HP:0001417', 'HP:0002037', 'HP:0002718', 'HP:0002715']
Autosomal recessive CGD p47phox_NCF1_AR	Autosomal recessive CGD p47phox	Table 5 Congenital defects of phagocyte number or function	Subtable 3 Defects of Respiratory Burst	AR	608512	NCF1	NCF1	653361	Infections, autoinflammatory phenotype	nan	nan	Normal	Normal	Neutrophil dysfunction	[]	['hsa04062  Chemokine signaling pathway', 'hsa04145  Phagosome', 'hsa04380  Osteoclast differentiation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04670  Leukocyte transendothelial migration', 'hsa05020  Prion disease', 'hsa05140  Leishmaniasis', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000007', 'HP:0002718', 'HP:0002715']
Autosomal recessive CGD p67phox_NCF2_AR	Autosomal recessive CGD p67phox	Table 5 Congenital defects of phagocyte number or function	Subtable 3 Defects of Respiratory Burst	AR	608515	NCF2	NCF2	4688	Infections, autoinflammatory phenotype	nan	nan	Normal	Normal	Neutrophil dysfunction	[]	['hsa04145  Phagosome', 'hsa04380  Osteoclast differentiation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04670  Leukocyte transendothelial migration', 'hsa05020  Prion disease', 'hsa05140  Leishmaniasis', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000007', 'HP:0002718', 'HP:0002715']
Autosomal recessive CGD p40phox_NCF4_AR	Autosomal recessive CGD p40phox	Table 5 Congenital defects of phagocyte number or function	Subtable 3 Defects of Respiratory Burst	AR	601488	NCF4	NCF4	4689	Infections, autoinflammatory phenotype	nan	nan	Normal	Normal	Neutrophil dysfunction	[]	['hsa04145  Phagosome', 'hsa04380  Osteoclast differentiation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04670  Leukocyte transendothelial migration', 'hsa05020  Prion disease', 'hsa05140  Leishmaniasis', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis']	['HP:0000007', 'HP:0002718', 'HP:0002715']
Autosomal recessive CGD EROS_CYBC1_AR	Autosomal recessive CGD EROS	Table 5 Congenital defects of phagocyte number or function	Subtable 3 Defects of Respiratory Burst	AR	618334	CYBC1	CYBC1	79415	nan	nan	nan	Normal	Normal	Neutrophil dysfunction	[]	[]	['HP:0000007', 'HP:0002718', 'HP:0002715']
G6PD deficiency Class I_G6PD_XL	G6PD deficiency Class I	Table 5 Congenital defects of phagocyte number or function	Subtable 3 Defects of Respiratory Burst	XL	305900	G6PD	G6PD	2539	Infections	nan	nan	Normal	Normal	Neutrophil dysfunction	[]	['hsa00030  Pentose phosphate pathway', 'hsa00480  Glutathione metabolism', 'hsa01100  Metabolic pathways', 'hsa01200  Carbon metabolism', 'hsa05230  Central carbon metabolism in cancer', 'hsa05415  Diabetic cardiomyopathy']	['HP:0001417', 'HP:0002718', 'HP:0002715']
Congenital pulmonary alveolar proteinosis due to CSF2RA mutations_CSF2RA_XL	Congenital pulmonary alveolar proteinosis due to CSF2RA mutations	Table 5 Congenital defects of phagocyte number or function	Subtable 4 Other Non-Lymphoid Defects	XL	300770	CSF2RA	CSF2RA	1438	Alveolar proteinosis	Normal	Normal	Normal	Normal	Alveolar macrophages	['Mavrilimumab: D09930', 'Molgramostim: D05066', 'Regramostim: D05712', 'Sargramostim: D05803<US>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04630  JAK-STAT signaling pathway', 'hsa04640  Hematopoietic cell lineage', 'hsa05200  Pathways in cancer']	['HP:0001417', 'HP:0006517']
Congenital pulmonary alveolar proteinosis due to CSF2RB mutations_CSF2RB_AR	Congenital pulmonary alveolar proteinosis due to CSF2RB mutations	Table 5 Congenital defects of phagocyte number or function	Subtable 4 Other Non-Lymphoid Defects	AR	614370	CSF2RB	CSF2RB	1439	Alveolar proteinosis	Normal	Normal	Normal	Normal	Alveolar macrophages	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04210  Apoptosis', 'hsa04630  JAK-STAT signaling pathway', 'hsa05200  Pathways in cancer']	['HP:0006517', 'HP:0000007']
GATA2 deficiency (MonoMac syndrome)_GATA2_AD	GATA2 deficiency (MonoMac syndrome)	Table 5 Congenital defects of phagocyte number or function	Subtable 4 Other Non-Lymphoid Defects	AD	137295	GATA2	GATA2	2624	Susceptibility to mycobacteria, HPV, histoplasmosis, alveolar proteinosis, MDS/AML/CMMoL, lymphedema	nan	Declining	Normal	Normal	Low monocytes, DC, NK	[]	[]	['HP:0000006', 'HP:0002715', 'HP:0001004', 'HP:0012312', 'HP:0032256', 'HP:0006517']
Macrophage gp91 phox deficiency_CYBB_XL	Macrophage gp91 phox deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	XL	300481	CYBB	CYBB	1536	Isolated susceptibility to mycobacteria	Normal	Normal	Normal	Normal	Macrophage dysfunction	[]	['hsa04066  HIF-1 signaling pathway', 'hsa04145  Phagosome', 'hsa04216  Ferroptosis', 'hsa04217  Necroptosis', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04670  Leukocyte transendothelial migration', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05010  Alzheimer disease', 'hsa05020  Prion disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05140  Leishmaniasis', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis']	['HP:0001417', 'HP:0011274', 'HP:0002715']
IFNG deficiency_IFNG_AR	IFNG deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR		IFNG	IFNG	3458	Susceptibility to mycobacteria	Normal	Normal	Normal	nan	nan	['Emapalumab: D11120<US>', 'Fontolizumab: D04242']	['hsa03050  Proteasome', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04066  HIF-1 signaling pathway', 'hsa04217  Necroptosis', 'hsa04350  TGF-beta signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04612  Antigen processing and presentation', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04940  Type I diabetes mellitus', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05143  African trypanosomiasis', 'hsa05144  Malaria', 'hsa05145  Toxoplasmosis', 'hsa05146  Amoebiasis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05164  Influenza A', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease', 'hsa05322  Systemic lupus erythematosus', 'hsa05323  Rheumatoid arthritis', 'hsa05330  Allograft rejection', 'hsa05332  Graft-versus-host disease', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000007', 'HP:0011274', 'HP:0002715']
IFN-g receptor 1 deficiency_IFNGR1_AR	IFN-g receptor 1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	107470	IFNGR1	IFNGR1	3459	Susceptibility to mycobacteria and Salmonella	Normal	Normal	Normal	Normal	nan	['Interferon gamma (DG00737): D00747<US> D03357<JP> D08805']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04066  HIF-1 signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05164  Influenza A', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0000007', 'HP:0011274', 'HP:0002715']
IFN-g receptor 1 deficiency_IFNGR1_AD	IFN-g receptor 1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AD	107470	IFNGR1	IFNGR1	3459	Susceptibility to mycobacteria and Salmonella	Normal	Normal	Normal	Normal	nan	['Interferon gamma (DG00737): D00747<US> D03357<JP> D08805']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04066  HIF-1 signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05164  Influenza A', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0000006', 'HP:0011274', 'HP:0002715']
IFN-g receptor 2 deficiency_IFNGR2_AR	IFN-g receptor 2 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	147569	IFNGR2	IFNGR2	3460	Susceptibility to mycobacteria and Salmonella	Normal	Normal	Normal	Normal	nan	['Interferon gamma (DG00737): D00747<US> D03357<JP> D08805']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04066  HIF-1 signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05164  Influenza A', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0000007', 'HP:0011274', 'HP:0002715']
IL-12p40 (IL-12 and IL-23) deficiency_IL12B_AR	IL-12p40 (IL-12 and IL-23) deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	161561	IL12B	IL12B	3593	Susceptibility to mycobacteria and Salmonella	Normal	Normal	Normal	Normal	nan	['Apilimod mesylate: D06556', 'Briakinumab: D09588', 'Lisofylline: D04748', 'Ustekinumab: D09214<JP/US>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04936  Alcoholic liver disease', 'hsa04940  Type I diabetes mellitus', 'hsa05133  Pertussis', 'hsa05134  Legionellosis', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05143  African trypanosomiasis', 'hsa05145  Toxoplasmosis', 'hsa05146  Amoebiasis', 'hsa05152  Tuberculosis', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05205  Proteoglycans in cancer', 'hsa05321  Inflammatory bowel disease', 'hsa05330  Allograft rejection', 'hsa05417  Lipid and atherosclerosis']	['HP:0000007', 'HP:0011274', 'HP:0002715']
IL-12 and IL-23 receptor b1 chain deficiency_IL12RB1_AR	IL-12 and IL-23 receptor b1 chain deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	601604	IL12RB1	IL12RB1	3594	Susceptibility to mycobacteria and Salmonella	Normal	Normal	Normal	Normal	nan	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05200  Pathways in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0000007', 'HP:0011274', 'HP:0002715']
IL-12Rb2 deficiency_IL12RB2_AR	IL-12Rb2 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR		IL12RB2	IL12RB2	3595	Susceptibility to mycobacteria and Salmonella	Normal	Normal	Normal	Normal	nan	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa05200  Pathways in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0000007', 'HP:0011274', 'HP:0002715']
IL-23R deficiency_IL23R_AR	IL-23R deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR		IL23R	IL23R	149233	Susceptibility to mycobacteria and Salmonella	Normal	Normal	Normal	Normal	nan	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04630  JAK-STAT signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa05200  Pathways in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0000007', 'HP:0011274', 'HP:0002715']
IRF8 deficiency (AD)_IRF8_AD	IRF8 deficiency (AD)	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AD	601565	IRF8	IRF8	3394	Susceptibility to mycobacteria	Normal	Normal	Normal	Normal	CD1c+ MDC	[]	['hsa05133  Pertussis']	['HP:0000006', 'HP:0011274', 'HP:0002715']
IRF8 deficiency (AR)_IRF8_AR	IRF8 deficiency (AR)	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	601565	IRF8	IRF8	3394	Susceptibility to mycobacteria and multiple other infectious agents	Normal	Normal	Normal	Normal	CD1c+ MDC	[]	['hsa05133  Pertussis']	['HP:0000007', 'HP:0011274', 'HP:0002715']
ISG15 deficiency_ISG15_AR	ISG15 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	147571	ISG15	ISG15	9636	Susceptibility to mycobacteria, brain calcifications	nan	nan	nan	nan	Ubiquitously expressed	[]	['hsa04622  RIG-I-like receptor signaling pathway', 'hsa05165  Human papillomavirus infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000007', 'HP:0011274', 'HP:0002715', 'HP:0002514']
JAK1 (LOF)_JAK1_AR	JAK1 (LOF)	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	147795	JAK1	JAK1	3716	Susceptibility to mycobacteria and viruses, urothelial carcinoma	nan	nan	nan	nan	nan	['Abrocitinib: D11400<JP/US>', 'Baricitinib: D10308<JP/US>', 'Brepocitinib (DG03044): D11537 D11538', 'Delgocitinib: D11046<JP>', 'Deuruxolitinib (DG03114): D11866 D11867', 'Filgotinib (DG01991): D10871 D10872 D11106<JP>', 'Gusacitinib (DG03080): D11676 D11677', 'Itacitinib (DG02833): D10944 D10945', 'Ivarmacitinib (DG03175): D12211 D12212', 'Momelotinib (DG01366): D10315 D10358 D10889', 'Nezulcitinib: D12118', 'Oclacitinib (DG02005): D10141 D10142', 'Peficitinib (DG01853): D10653 D10721<JP>', 'Ruxolitinib (DG00719): D09959 D09960<JP/US>', 'Solcitinib: D10728', 'Tofacitinib (DG00742): D09783<JP/US> D09970', 'Tuspetinib: D12476', 'Upadacitinib (DG02829): D10994<US> D10995 D11048<JP>']	['hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04550  Signaling pathways regulating pluripotency of stem cells', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05140  Leishmaniasis', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05212  Pancreatic cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer']	['HP:0000007', 'HP:0011274', 'HP:0002715', 'HP:0030731']
RORgt deficiency_RORC_AR	RORgt deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	602943	RORC	RORC	6097	Susceptibility to mycobacteria and candida	nan	nan	nan	nan	nan	['Cedirogant: D12274']	['hsa04659  Th17 cell differentiation', 'hsa04710  Circadian rhythm', 'hsa05321  Inflammatory bowel disease']	['HP:0000007', 'HP:0011274', 'HP:0002715']
SPPL2a deficiency_SPPL2A_AR	SPPL2a deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR		SPPL2A	SPPL2A	84888	Susceptibility to mycobacteria, Salmonella,	Poor Th1	nan	nan	nan	CDC	[]	[]	['HP:0000007', 'HP:0011274', 'HP:0002715']
STAT1 deficiency (AD LOF)_STAT1_AD	STAT1 deficiency (AD LOF)	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AD	600555	STAT1	STAT1	6772	Susceptibility to mycobacteria, Salmonella,	Normal	Normal	Normal	Normal	nan	[]	['hsa04062  Chemokine signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05140  Leishmaniasis', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05212  Pancreatic cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0000006', 'HP:0011274', 'HP:0002715']
TBX21 deficiency_TBX21_AR	TBX21 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR		TBX21	TBX21	30009	Susceptibility to mycobacteria	Low MAIT, CXCR3 Th1 T cells	Normal	Normal	nan	nan	[]	['hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05321  Inflammatory bowel disease']	['HP:0000007', 'HP:0011274', 'HP:0002715']
Tyk2 deficiency_TYK2_AR	Tyk2 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR	176941	TYK2	TYK2	7297	Susceptibility to intracellular bacteria (mycobacteria, Salmonella), viruses, +/- elevated IgE	nan	nan	nan	nan	Normal, but multiple cytokine signaling defect	['Brepocitinib (DG03044): D11537 D11538', 'Delgocitinib: D11046<JP>', 'Deucravacitinib: D11817<JP/US>', 'Filgotinib (DG01991): D11106<JP>', 'Nezulcitinib: D12118', 'Ropsacitinib: D12056', 'Tofacitinib (DG00742): D09783<JP/US> D09970']	['hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000007', 'HP:0011274', 'HP:0002715']
P1104A TYK2 homozygosity_TYK2_AR	P1104A TYK2 homozygosity	Table 6 Defects in intrinsic and innate immunity	Subtable 1 Mendelian Susceptibility to mycobacterial disease (MSMD)	AR		TYK2	TYK2	7297	Susceptibility to mycobacteria	nan	nan	nan	nan	nan	['Brepocitinib (DG03044): D11537 D11538', 'Delgocitinib: D11046<JP>', 'Deucravacitinib: D11817<JP/US>', 'Filgotinib (DG01991): D11106<JP>', 'Nezulcitinib: D12118', 'Ropsacitinib: D12056', 'Tofacitinib (DG00742): D09783<JP/US> D09970']	['hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000007', 'HP:0011274', 'HP:0002715']
CIB1 deficiency_CIB1_AR	CIB1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 2 Epidermodysplasia verruciformis (HPV)	AR	618267	CIB1	CIB1	10519	HPV (group B1) infections and cancer of the skin (typical EV)	nan	nan	nan	nan	Keratinocytes	[]	[]	['HP:0020114', 'HP:0002715', 'HP:0008069', 'HP:0002664', 'HP:0000007']
WHIM (Warts, Hypogammaglobulinemia, infections, Myelokathexis)  syndrome_CXCR4_AD GOF	WHIM (Warts, Hypogammaglobulinemia, infections, Myelokathexis)  syndrome	Table 6 Defects in intrinsic and innate immunity	Subtable 2 Epidermodysplasia verruciformis (HPV)	AD GOF	162643	CXCR4	CXCR4	7852	Warts (HPV) infection, neutropenia, low B cell number, hypogammaglobulinemia	Variable	Variable	Variable	Variable	Granulocytes + Lymphocytes	['Balixafortide: D12128', 'Mavorixafor: D11510', 'Motixafortide (DG03214): D12281 D12282', 'Plerixafor: D08971<JP/US>']	['hsa03250  Viral life cycle - HIV-1', 'hsa03260  Virion - Human immunodeficiency virus', 'hsa04020  Calcium signaling pathway', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04062  Chemokine signaling pathway', 'hsa04144  Endocytosis', 'hsa04360  Axon guidance', 'hsa04670  Leukocyte transendothelial migration', 'hsa04672  Intestinal immune network for IgA production', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05163  Human cytomegalovirus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05200  Pathways in cancer']	['HP:0000006', 'HP:0020114', 'HP:0002715', 'HP:0001875', 'HP:0200043', 'HP:0004313']
EVER1 deficiency_TMC6_AR	EVER1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 2 Epidermodysplasia verruciformis (HPV)	AR	605828	TMC6	TMC6	11322	Human papillomavirus (HPV) (group B1) infections and cancer of the skin (typical EV)	nan	nan	nan	nan	Keratinocytes and leukocytes	[]	[]	['HP:0020114', 'HP:0002715', 'HP:0008069', 'HP:0002664', 'HP:0000007']
EVER2 deficiency_TMC8_AR	EVER2 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 2 Epidermodysplasia verruciformis (HPV)	AR	605829	TMC8	TMC8	147138	HPV (group B1) infections and cancer of the skin (typical EV)	nan	nan	nan	nan	Keratinocytes and leukocytes	[]	[]	['HP:0020114', 'HP:0002715', 'HP:0008069', 'HP:0002664', 'HP:0000007']
CD16 deficiency_FCGR3A_AR	CD16 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR	146740	FCGR3A	FCGR3A	2214	severe herpes viral infections, particularly VZV, Epstein Barr virus (EBV), and (HPV)	Normal	Normal	Normal	Normal	NK cell dysfunction	[]	['hsa04145  Phagosome', 'hsa04380  Osteoclast differentiation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa05140  Leishmaniasis', 'hsa05150  Staphylococcus aureus infection', 'hsa05152  Tuberculosis', 'hsa05322  Systemic lupus erythematosus']	['HP:0031691', 'HP:0000007', 'HP:0002715']
MDA5 deficiency (LOF)_IFIH1_AR	MDA5 deficiency (LOF)	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR	606951	IFIH1	IFIH1	64135	Rhinovirus and other RNA viruses	Normal	Normal	Normal	Normal	Somatic and hematopoietic	[]	['hsa04622  RIG-I-like receptor signaling pathway', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0031691', 'HP:0000007', 'HP:0002715']
IFNAR1 deficiency_IFNAR1_AR	IFNAR1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR		IFNAR1	IFNAR1	3454	Severe disease caused by Yellow Fever vaccine and Measles vaccine, severe COVID-19	Normal	Normal	Normal	Normal	nan	['Albinterferon alfa-2b: D08844', 'Anifrolumab: D11082<JP/US>', 'Interferon alfa natural: D03305<JP>', 'Interferon alfa-2a: D00745', 'Interferon alfa-2b: D02745<US>', 'Interferon alfa-n1: D04552', 'Interferon alfacon-1: D02744', 'Interferon alpha', '(abbr) INFalpha (DG01750): D04553<US>', 'Interferon beta natural: D03304<JP>', 'Interferon beta-1a: D04554<JP/US>', 'Interferon beta-1b: D00746<JP/US>', 'Peginterferon alfa-2a: D02747<JP/US>', 'Peginterferon alfa-2b: D02748', 'Peginterferon beta-1a: D10483<US>', 'Ropeginterferon alfa-2b: D11027<US>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer']	['HP:0031691', 'HP:0000007', 'HP:0001945', 'HP:0002715']
IFNAR2 deficiency_IFNAR2_AR	IFNAR2 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR	602376	IFNAR2	IFNAR2	3455	Severe viral infections (disseminated vaccine-strain measles, HHV6), severe COVID-19	Normal	Normal	Normal	Normal	Broadly expressed	['Albinterferon alfa-2b: D08844', 'Anifrolumab: D11082<JP/US>', 'Interferon alfa natural: D03305<JP>', 'Interferon alfa-2a: D00745', 'Interferon alfa-2b: D02745<US>', 'Interferon alfa-n1: D04552', 'Interferon alfacon-1: D02744', 'Interferon alpha', '(abbr) INFalpha (DG01750): D04553<US>', 'Interferon beta natural: D03304<JP>', 'Interferon beta-1a: D04554<JP/US>', 'Interferon beta-1b: D00746<JP/US>', 'Peginterferon alfa-2a: D02747<JP/US>', 'Peginterferon alfa-2b: D02748', 'Peginterferon beta-1a: D10483<US>', 'Ropeginterferon alfa-2b: D11027<US>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa05160  Hepatitis C', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer']	['HP:0031691', 'HP:0031696', 'HP:0000007', 'HP:0002715']
IRF7 deficiency_IRF7_AR	IRF7 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR	605047	IRF7	IRF7	3665	Severe influenza and COVID-19	nan	nan	nan	nan	Leukocytes, plasmacytoid dendritic cells, Non-hematopoietic cells	[]	['hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05203  Viral carcinogenesis', 'hsa05417  Lipid and atherosclerosis']	['HP:0031691', 'HP:0000007', 'HP:0002715']
IRF9 deficiency_IRF9_AR	IRF9 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR		IRF9	IRF9	10379	Severe influenza disease	nan	nan	nan	nan	nan	[]	['hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa05160  Hepatitis C', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05203  Viral carcinogenesis']	['HP:0031691', 'HP:0000007', 'HP:0002715']
NOS2 deficiency_NOS2_AR	NOS2 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR		NOS2	NOS2	4843	nan	Low CD4 T cells	Low	nan	Normal	nan	['Cindunistat (DG01391): D10386 D10419', 'Pimagedine hydrochloride: D05479', 'Tilarginine acetate: D09018']	['hsa00220  Arginine biosynthesis', 'hsa00330  Arginine and proline metabolism', 'hsa01100  Metabolic pathways', 'hsa04020  Calcium signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04146  Peroxisome', 'hsa04371  Apelin signaling pathway', 'hsa04926  Relaxin signaling pathway', 'hsa05010  Alzheimer disease', 'hsa05014  Amyotrophic lateral sclerosis', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05133  Pertussis', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05146  Amoebiasis', 'hsa05152  Tuberculosis', 'hsa05200  Pathways in cancer', 'hsa05222  Small cell lung cancer']	['HP:0010976', 'HP:0002715', 'HP:0032218', 'HP:0000007', 'HP:0031691']
RNA polymerase III deficiency due to POLR3A defects_POLR3A_AD	RNA polymerase III deficiency due to POLR3A defects	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AD		POLR3A	POLR3A	11128	Severe VZV	Normal	Normal	Normal	Normal	nan	[]	['hsa03020  RNA polymerase', 'hsa04623  Cytosolic DNA-sensing pathway']	['HP:0031691', 'HP:0000006', 'HP:0002715']
RNA polymerase III deficiency due to POLR3C defects_POLR3C_AD	RNA polymerase III deficiency due to POLR3C defects	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AD		POLR3C	POLR3C	10623	Severe VZV	Normal	Normal	Normal	Normal	nan	[]	['hsa03020  RNA polymerase', 'hsa04623  Cytosolic DNA-sensing pathway']	['HP:0031691', 'HP:0000006', 'HP:0002715']
RNA polymerase III deficiency due to POLR3F defects_POLR3F_AD	RNA polymerase III deficiency due to POLR3F defects	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AD		POLR3F	POLR3F	10621	Severe VZV	Normal	Normal	Normal	Normal	nan	[]	['hsa03020  RNA polymerase', 'hsa04623  Cytosolic DNA-sensing pathway']	['HP:0031691', 'HP:0000006', 'HP:0002715']
STAT1 deficiency (AR LOF)_STAT1_AR	STAT1 deficiency (AR LOF)	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR	600555	STAT1	STAT1	6772	Severe viral infections, mycobacterial infection	nan	nan	nan	nan	T and NK cells and monocytes	[]	['hsa04062  Chemokine signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05140  Leishmaniasis', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05212  Pancreatic cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0031691', 'HP:0000007', 'HP:0002715']
STAT2 deficiency_STAT2_AR	STAT2 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR	600556	STAT2	STAT2	6773	Severe viral infections (disseminated vaccine-strain measles)	nan	nan	nan	nan	T and NK cells	[]	['hsa04062  Chemokine signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer']	['HP:0031691', 'HP:0031696', 'HP:0000007', 'HP:0002715']
TLR7 deficiency_TLR7_XL	TLR7 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	XL		TLR7	TLR7	51284	COVID-19 susceptibility	nan	nan	nan	nan	nan	['Bropirimine: D01666', 'Enpatoran: D12261', 'Guretolimod: D12453', 'Imiquimod: D02500<JP/US>', 'Isatoribine: D04619', 'Loxoribine: D04787', 'Vesatolimod: D11003']	['hsa04613  Neutrophil extracellular trap formation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0031691', 'HP:0002715', 'HP:0001417']
ZNFX1 deficiency_ZNFX1_AR	ZNFX1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 3 Predisposition to Severe Viral Infection	AR		ZNFX1	ZNFX1	57169	severe infections by RNA/DNA viruses, early-onset, systemic, severe, acute inflammation with major dysfunctions of liver, brain, kidneys, lungs. Virally triggered inflammatory episodes (HLH, intermittent monocytosis, thrombocytopenia, hepatosplenomegaly, lymphadenopathy. Mycobacterial disease (BCGosis, disseminated TB).  High mortality. Increased ISG in response to poly I/C	Normal lymphocyte numbers, intact T cell function	Low	Normal	nan	nan	[]	[]	['HP:0012311', 'HP:0020087', 'HP:0032169', 'HP:0010976', 'HP:0000007', 'HP:0001873', 'HP:0001433', 'HP:0001410', 'HP:0002716']
ATG4A_ATG4A_AD	ATG4A	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AD		ATG4A	ATG4A	115201	Mollaret's meningitis HSV2	nan	Normal	Normal	Normal	nan	[]	['hsa04136  Autophagy - other', 'hsa04140  Autophagy - animal']	['HP:0000006', 'HP:0001287', 'HP:0012302', 'HP:0002715']
DBR1 deficiency_DBR1_AR	DBR1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AR		DBR1	DBR1	51163	HSE of the brainstem. Other viral infections of the brainstem.	Normal	Normal	Normal	Normal	CNS resident cells and fibroblasts	[]	[]	['HP:0000007', 'HP:0012302', 'HP:0002715']
IRF3 deficiency_IRF3_AD	IRF3 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AD	616532	IRF3	IRF3	3661	Herpes simplex virus 1 encephalitis	Normal	Normal	Normal	Normal	CNS resident cells and fibroblasts	[]	['hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04936  Alcoholic liver disease', 'hsa05131  Shigellosis', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05203  Viral carcinogenesis', 'hsa05417  Lipid and atherosclerosis']	['HP:0000006', 'HP:0012302', 'HP:0002715']
MAP1LC3B2_MAP1LC3B2_AD	MAP1LC3B2	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AD		MAP1LC3B2	MAP1LC3B2	643246	Mollaret's meningitis HSV2	nan	Normal	Normal	Normal	nan	[]	['hsa04137  Mitophagy - animal', 'hsa04140  Autophagy - animal', 'hsa04216  Ferroptosis', 'hsa04371  Apelin signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa05014  Amyotrophic lateral sclerosis', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05131  Shigellosis', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection']	['HP:0000006', 'HP:0001287', 'HP:0012302', 'HP:0002715']
SNORA31 deficiency_SNORA31_AD	SNORA31 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AD		SNORA31	SNORA31	677814	Forebrain HSE	nan	Normal	Normal	Normal	nan	[]	[]	['HP:0000006', 'HP:0012302', 'HP:0002715']
TBK1 deficiency_TBK1_AD	TBK1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AD	604834	TBK1	TBK1	29110	Herpes simplex virus 1 encephalitis	Normal	Normal	Normal	Normal	CNS resident cells and fibroblasts	[]	['hsa04014  Ras signaling pathway', 'hsa04137  Mitophagy - animal', 'hsa04140  Autophagy - animal', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05014  Amyotrophic lateral sclerosis', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05131  Shigellosis', 'hsa05135  Yersinia infection', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05417  Lipid and atherosclerosis']	['HP:0000006', 'HP:0012302', 'HP:0002715']
TRIF deficiency_TICAM1_AD	TRIF deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AD	607601	TICAM1	TICAM1	148022	Herpes simplex virus 1 encephalitis	Normal	Normal	Normal	Normal	CNS resident cells and fibroblasts	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04217  Necroptosis', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05417  Lipid and atherosclerosis']	['HP:0000006', 'HP:0012302', 'HP:0002715']
TLR3 deficiency_TLR3_AD	TLR3 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AD	603029	TLR3	TLR3	7098	Herpes simplex virus 1 encephalitis (incomplete clinical penetrance for all etiologies listed here)	Normal	Normal	Normal	Normal	Central nervous system (CNS) resident cells and fibroblasts	['Rintatolimod: D09661']	['hsa04217  Necroptosis', 'hsa04620  Toll-like receptor signaling pathway', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000006', 'HP:0012302', 'HP:0002715']
TLR3 deficiency_TLR3_AR	TLR3 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AR	603029	TLR3	TLR3	7098	Herpes simplex virus 1 encephalitis (incomplete clinical penetrance for all etiologies listed here)	Normal	Normal	Normal	Normal	Central nervous system (CNS) resident cells and fibroblasts	['Rintatolimod: D09661']	['hsa04217  Necroptosis', 'hsa04620  Toll-like receptor signaling pathway', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000007', 'HP:0012302', 'HP:0002715']
TRAF3 deficiency_TRAF3_AD	TRAF3 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AD	601896	TRAF3	TRAF3	7187	Herpes simplex virus 1 encephalitis	Normal	Normal	Normal	Normal	CNS resident cells and fibroblasts	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05222  Small cell lung cancer', 'hsa05417  Lipid and atherosclerosis']	['HP:0000006', 'HP:0012302', 'HP:0002715']
UNC93B1 deficiency_UNC93B1_AR	UNC93B1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 4 Herpes Simplex Encephalitis (HSE)	AR	608204	UNC93B1	UNC93B1	81622	Herpes simplex virus 1 encephalitis, severe COVID-19	Normal	Normal	Normal	Normal	CNS resident cells and fibroblasts	[]	[]	['HP:0000007', 'HP:0012302', 'HP:0002715']
CARD9 deficiency_CARD9_AR	CARD9 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 5 Predisposition to invasive fungal infections	AR	607212	CARD9	CARD9	64170	Invasive candidiasis infection, deep dermatophytoses, other invasive fungal infections	Normal	Normal	Normal	Normal	Mononuclear phagocytes	[]	['hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa05152  Tuberculosis', 'hsa05168  Herpes simplex virus 1 infection']	['HP:0032515', 'HP:0002715', 'HP:0020101', 'HP:0000007', 'HP:0002841']
IL-17F deficiency_IL17F_AD	IL-17F deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 6 Predisposition to Mucocutaneous Candidiasis	AD	606496	IL17F	IL17F	112744	CMC, folliculitis	Normal	Normal	Normal	Normal	T cells	['Afasevikumab: D10902', 'Bimekizumab: D11550<JP>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04657  IL-17 signaling pathway', 'hsa04659  Th17 cell differentiation', 'hsa05321  Inflammatory bowel disease']	['HP:0025084', 'HP:0000006', 'HP:0002728', 'HP:0005401', 'HP:0002715']
IL-17RA deficiency_IL17RA_AR	IL-17RA deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 6 Predisposition to Mucocutaneous Candidiasis	AR	605461	IL17RA	IL17RA	23765	CMC, folliculitis	Normal	Normal	Normal	Normal	Epithelial cells, fibroblasts, mononuclear phagocytes	['Brodalumab: D10061<JP/US>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04657  IL-17 signaling pathway', 'hsa04936  Alcoholic liver disease']	['HP:0025084', 'HP:0002728', 'HP:0005401', 'HP:0002715', 'HP:0000007']
IL-17RC deficiency_IL17RC_AR	IL-17RC deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 6 Predisposition to Mucocutaneous Candidiasis	AR	610925	IL17RC	IL17RC	84818	CMC	Normal	Normal	Normal	Normal	Epithelial cells, fibroblasts, mononuclear phagocytes	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04657  IL-17 signaling pathway', 'hsa04936  Alcoholic liver disease']	['HP:0000007', 'HP:0005401', 'HP:0002715', 'HP:0002728']
MAPK8 deficiency_MAPK8_AD LOF	MAPK8 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 6 Predisposition to Mucocutaneous Candidiasis	AD LOF		MAPK8	MAPK8	5599	CMC and Ehlers Danlos	Low Th17	Normal	Normal	Normal	nan	['Tanzisertib: D10168']	['hsa01522  Endocrine resistance', 'hsa04010  MAPK signaling pathway', 'hsa04012  ErbB signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04024  cAMP signaling pathway', 'hsa04068  FoxO signaling pathway', 'hsa04071  Sphingolipid signaling pathway', 'hsa04137  Mitophagy - animal', 'hsa04140  Autophagy - animal', 'hsa04141  Protein processing in endoplasmic reticulum', 'hsa04210  Apoptosis', 'hsa04215  Apoptosis - multiple species', 'hsa04217  Necroptosis', 'hsa04310  Wnt signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04510  Focal adhesion', 'hsa04530  Tight junction', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04723  Retrograde endocannabinoid signaling', 'hsa04728  Dopaminergic synapse', 'hsa04750  Inflammatory mediator regulation of TRP channels', 'hsa04910  Insulin signaling pathway', 'hsa04912  GnRH signaling pathway', 'hsa04914  Progesterone-mediated oocyte maturation', 'hsa04917  Prolactin signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04926  Relaxin signaling pathway', 'hsa04930  Type II diabetes mellitus', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05012  Parkinson disease', 'hsa05016  Huntington disease', 'hsa05017  Spinocerebellar ataxia', 'hsa05020  Prion disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05210  Colorectal cancer', 'hsa05212  Pancreatic cancer', 'hsa05231  Choline metabolism in cancer', 'hsa05415  Diabetic cardiomyopathy', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0002728', 'HP:0005401', 'HP:0002715']
STAT1 GOF_STAT1_AD GOF	STAT1 GOF	Table 6 Defects in intrinsic and innate immunity	Subtable 6 Predisposition to Mucocutaneous Candidiasis	AD GOF	600555	STAT1	STAT1	6772	CMC, various fungal, bacterial and viral (HSV) infections, auto-immunity (thyroiditis, diabetes, cytopenias), enteropathy	Variable	Variable	Variable	Normal	T cells, B cells, monocytes	[]	['hsa04062  Chemokine signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05140  Leishmaniasis', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05212  Pancreatic cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05321  Inflammatory bowel disease']	['HP:0000006', 'HP:0002728', 'HP:0005401', 'HP:0002715', 'HP:0002960', 'HP:0100646', 'HP:0002242']
ACT1 deficiency_TRAF3IP2_AR	ACT1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 6 Predisposition to Mucocutaneous Candidiasis	AR	607043	TRAF3IP2	TRAF3IP2	10758	CMC, blepharitis, folliculitis and macroglossia	Normal	Normal	Normal	Normal	T cells, fibroblasts	[]	['hsa04218  Cellular senescence', 'hsa04657  IL-17 signaling pathway']	['HP:0025084', 'HP:0002728', 'HP:0005401', 'HP:0002715', 'HP:0000007', 'HP:0000498', 'HP:0000158']
IRAK1 deficiency_IRAK1_XL	IRAK1 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 7 TLR Signaling Pathway Deficiency with Bacterial Susceptibility	XL	Not yet attributed	IRAK1	IRAK1	3654	Bacterial infections, X-linked MECP2 deficiency-related syndrome due to a large de novo Xq28 chromosomal deletion encompassing both MECP2 and IRAK1	Normal	Normal	Normal	Normal	Lymphocytes + Granulocytes+ Monocytes	[]	['hsa04010  MAPK signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05417  Lipid and atherosclerosis']	['HP:0001417', 'HP:0002718', 'HP:0002715']
IRAK4 deficiency_IRAK4_AR	IRAK4 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 7 TLR Signaling Pathway Deficiency with Bacterial Susceptibility	AR	606883	IRAK4	IRAK4	51135	Bacterial infections (pyogens)	Normal	Normal	Normal	Normal	Lymphocytes + Granulocytes+ Monocytes	['Emavusertib (DG03236): D12411 D12412', 'Zimlovisertib: D12167']	['hsa04010  MAPK signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05417  Lipid and atherosclerosis']	['HP:0000007', 'HP:0002718', 'HP:0002715']
MyD88 deficiency_MYD88_AR	MyD88 deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 7 TLR Signaling Pathway Deficiency with Bacterial Susceptibility	AR	602170	MYD88	MYD88	4615	Bacterial infections (pyogens)	Normal	Normal	Normal	Normal	Lymphocytes + Granulocytes+ Monocytes	[]	['hsa04010  MAPK signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05134  Legionellosis', 'hsa05135  Yersinia infection', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05143  African trypanosomiasis', 'hsa05144  Malaria', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05417  Lipid and atherosclerosis']	['HP:0000007', 'HP:0002718', 'HP:0002715']
TIRAP deficiency_TIRAP_AR	TIRAP deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 7 TLR Signaling Pathway Deficiency with Bacterial Susceptibility	AR	614382	TIRAP	TIRAP	114609	Staphylococcal disease during childhood	Normal	Normal	Normal	Normal	Lymphocytes + Granulocytes+ Monocytes	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05152  Tuberculosis', 'hsa05161  Hepatitis B', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05417  Lipid and atherosclerosis']	['HP:0000007', 'HP:0002718', 'HP:0002715']
TLR8 disease_TLR8_XL GOF	TLR8 disease	Table 6 Defects in intrinsic and innate immunity	Subtable 7 TLR Signaling Pathway Deficiency with Bacterial Susceptibility	XL GOF		TLR8	TLR8	51311	Infections, lymphoproliferation, hepatosplenomegaly, lymphadenopathy.  Infectious susceptibility, BM failure. Severe chronic AIHA (post-infections), progressive autoinflammatory disease. Proinï¬ammatory phenotype with activated T cells, elevated serum cytokines associated with impaired B-cell maturation	Normal	Altered maturation	Normal to increased	Neutropenia	Low pDC	['Enpatoran: D12261', 'Motolimod: D10716', 'Selgantolimod: D11871']	['hsa04613  Neutrophil extracellular trap formation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0010702', 'HP:0002960', 'HP:0001890', 'HP:0001903', 'HP:0001433', 'HP:0001417', 'HP:0002716', 'HP:0001878']
Trypanosomiasis susceptibility_APOL1_AD	Trypanosomiasis susceptibility	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AD	603743	APOL1	APOL1	8542	Trypanosomiasis	Normal	Normal	Normal	Normal	nan	[]	['hsa05143  African trypanosomiasis']	['HP:0000006', 'HP:0002715']
CLCN7 deficiency associated osteopetrosis_CLCN7_AR	CLCN7 deficiency associated osteopetrosis	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	602727	CLCN7	CLCN7	1186	Osteopetrosis with hypocalcemia, neurologic features	nan	nan	nan	nan	Osteoclasts	[]	[]	['HP:0002901', 'HP:0011002', 'HP:0000007', 'HP:0002715']
Isolated congenital asplenia (ICA) due to HMOX deficiency_HMOX_AR	Isolated congenital asplenia (ICA) due to HMOX deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	141250	HMOX	HMOX1	3162	Hemolysis, nephritis, inflammation	Normal	Normal	Normal	Normal	No spleen, Macrophages	['Stannsoporfin: D05922']	['hsa00860  Porphyrin metabolism', 'hsa01100  Metabolic pathways', 'hsa04066  HIF-1 signaling pathway', 'hsa04216  Ferroptosis', 'hsa04978  Mineral absorption', 'hsa05200  Pathways in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05225  Hepatocellular carcinoma', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0001746', 'HP:0000007', 'HP:0000123', 'HP:0002715']
Acute liver failure due to NBAS deficiency_NBAS_AR	Acute liver failure due to NBAS deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	608025	NBAS	NBAS	51594	Fever induces liver failure	Normal	Normal	Normal	Normal	Somatic and hematopoietic	[]	[]	['HP:0002715', 'HP:0000007', 'HP:0006554', 'HP:0001945', 'HP:0001399']
NCSTN deficiency hidradenitis suppurativa_NCSTN_AD	NCSTN deficiency hidradenitis suppurativa	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AD	605254	NCSTN	NCSTN	23385	Hidradenitis suppurativa with acne	Normal	Normal	Normal	Normal	Epidermis	['Avagacestat: D09869', 'Begacestat: D08869', 'Crenigacestat: D11151', 'Nirogacestat (DG03016): D10960 D11453', 'Osugacestat: D12235', 'Semagacestat: D09377', 'Tarenflurbil: D09010']	['hsa04330  Notch signaling pathway', 'hsa05010  Alzheimer disease']	['HP:0040154', 'HP:0000006', 'HP:0002715', 'HP:0001061']
OSTM1 deficiency associated osteopetrosis_OSTM1_AR	OSTM1 deficiency associated osteopetrosis	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	Â Â  607649	OSTM1	OSTM1	28962	Osteopetrosis with hypocalcemia, neurologic features	nan	nan	nan	nan	Osteoclasts	[]	[]	['HP:0002901', 'HP:0011002', 'HP:0000007', 'HP:0002715']
PLEKHM1 deficiency associated osteopetrosis_PLEKHM1_AR	PLEKHM1 deficiency associated osteopetrosis	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	Â  611466	PLEKHM1	PLEKHM1	9842	Osteopetrosis	nan	nan	nan	nan	Osteoclasts	[]	['hsa05132  Salmonella infection']	['HP:0011002', 'HP:0000007', 'HP:0002715']
PSEN deficiency hidradenitis suppurativa_PSEN_AD	PSEN deficiency hidradenitis suppurativa	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AD	104311	PSEN	PSEN1	5663	Hidradenitis suppurative with cutaneous hyperpigmentation	Normal	Normal	Normal	Normal	Epidermis	['Avagacestat: D09869', 'Begacestat: D08869', 'Crenigacestat: D11151', 'Nirogacestat (DG03016): D10960 D11453', 'Osugacestat: D12235', 'Semagacestat: D09377', 'Tarenflurbil: D09010']	['hsa04310  Wnt signaling pathway', 'hsa04330  Notch signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa05010  Alzheimer disease', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05165  Human papillomavirus infection']	['HP:0040154', 'HP:0000006', 'HP:0000953', 'HP:0002715']
PSENEN deficiency hidradenitis suppurativa_PSENEN_AD	PSENEN deficiency hidradenitis suppurativa	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AD	607632	PSENEN	PSENEN	55851	Hidradenitis suppurativa	Normal	Normal	Normal	Normal	Epidermis	['Avagacestat: D09869', 'Begacestat: D08869', 'Crenigacestat: D11151', 'Nirogacestat (DG03016): D10960 D11453', 'Osugacestat: D12235', 'Semagacestat: D09377', 'Tarenflurbil: D09010']	['hsa04330  Notch signaling pathway', 'hsa05010  Alzheimer disease']	['HP:0040154', 'HP:0000006', 'HP:0002715']
Acute necrotizing encephalopathy_RANBP2_AD	Acute necrotizing encephalopathy	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AD	601181	RANBP2	RANBP2	5903	Fever induces acute encephalopathy	Normal	Normal	Normal	Normal	Ubiquitous expression	[]	['hsa03013  Nucleocytoplasmic transport', 'hsa03250  Viral life cycle - HIV-1', 'hsa05014  Amyotrophic lateral sclerosis']	['HP:0000006', 'HP:0002715', 'HP:0006965', 'HP:0001298', 'HP:0001945', 'HP:0006846']
Isolated congenital asplenia (ICA) due to RPSA deficiency_RPSA_AD	Isolated congenital asplenia (ICA) due to RPSA deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AD	271400	RPSA	RPSA	3921	Bacteremia (encapsulated bacteria)	Normal	Normal	Normal	Normal	No spleen	[]	['hsa03010  Ribosome', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000006', 'HP:0001746', 'HP:0002715', 'HP:0031864']
SNX10 deficiency associated osteopetrosis_SNX10_AR	SNX10 deficiency associated osteopetrosis	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	Â  614780	SNX10	SNX10	29887	Osteopetrosis with visual impairment	nan	nan	nan	nan	Osteoclasts	[]	[]	['HP:0011002', 'HP:0000007', 'HP:0002715', 'HP:0000505']
TCIRG1 deficiency associated osteopetrosis_TCIRG1_AR	TCIRG1 deficiency associated osteopetrosis	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	604592	TCIRG1	TCIRG1	10312	Osteopetrosis with hypocalcemia	nan	nan	nan	nan	Osteoclasts	[]	['hsa00190  Oxidative phosphorylation', 'hsa01100  Metabolic pathways', 'hsa04142  Lysosome', 'hsa04145  Phagosome', 'hsa04721  Synaptic vesicle cycle', 'hsa04966  Collecting duct acid secretion', 'hsa05110  Vibrio cholerae infection', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05152  Tuberculosis', 'hsa05165  Human papillomavirus infection', 'hsa05323  Rheumatoid arthritis']	['HP:0002901', 'HP:0011002', 'HP:0000007', 'HP:0002715']
TNFRSF11A deficiency associated osteopetrosis_TNFRSF11A_AR	TNFRSF11A deficiency associated osteopetrosis	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	Â  603499	TNFRSF11A	TNFRSF11A	8792	Osteopetrosis	nan	nan	nan	nan	Osteoclasts	[]	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04064  NF-kappa B signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa05323  Rheumatoid arthritis']	['HP:0011002', 'HP:0000007', 'HP:0002715']
TNFSF11 deficiency associated osteopetrosis_TNFSF11_AR	TNFSF11 deficiency associated osteopetrosis	Table 6 Defects in intrinsic and innate immunity	Subtable 8 Other Inborn Errors of Immunity Related to Non-Hematopoietic Tissues	AR	602642	TNFSF11	TNFSF11	8600	Osteopetrosis with severe growth retardation	nan	nan	nan	nan	Stromal	['Denosumab: D03684<JP/US>']	['hsa04060  Cytokine-cytokine receptor interaction', 'hsa04064  NF-kappa B signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04917  Prolactin signaling pathway', 'hsa04928  Parathyroid hormone synthesis, secretion and action', 'hsa05207  Chemical carcinogenesis - receptor activation', 'hsa05224  Breast cancer', 'hsa05323  Rheumatoid arthritis']	['HP:0011002', 'HP:0000007', 'HP:0002715', 'HP:0001510']
IL-18BP deficiency_IL18BP_AR	IL-18BP deficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 9  Other inborn errors of immunity related to leukocytes	AR		IL18BP	IL18BP	10068	Fulminant viral hepatitis	nan	nan	nan	nan	nan	[]	[]	['HP:0006562', 'HP:0000007', 'HP:0012115', 'HP:0002715']
IRF4 haplo-insufficiency_IRF4_AD	IRF4 haplo-insufficiency	Table 6 Defects in intrinsic and innate immunity	Subtable 9  Other inborn errors of immunity related to leukocytes	AD		IRF4	IRF4	3662	Whippleâs disease	nan	nan	nan	nan	nan	[]	['hsa04659  Th17 cell differentiation']	['HP:0000006', 'HP:0002715']
Spondyloenchondro-dysplasia with immune dysregulation (SPENCD)_ACP5_AR	Spondyloenchondro-dysplasia with immune dysregulation (SPENCD)	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	171640	ACP5	ACP5	54	Short stature, SP, ICC, SLE, thrombocytopenia and autoimmune hemolytic anemia, possibly recurrent bacterial and viral infections	nan	nan	nan	nan	nan	[]	['hsa00740  Riboflavin metabolism', 'hsa01100  Metabolic pathways', 'hsa04142  Lysosome', 'hsa04380  Osteoclast differentiation', 'hsa05323  Rheumatoid arthritis']	['HP:0004322', 'HP:0002960', 'HP:0001257', 'HP:0001903', 'HP:0000007', 'HP:0002721', 'HP:0001973', 'HP:0001873', 'HP:0001878', 'HP:0002313', 'HP:0002385', 'HP:0002514', 'HP:0001890']
ADA2 deficiency_ADA2_AR	ADA2 deficiency	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	607575	ADA2	ADA2	51816	Polyarteritis nodosa, childhood-onset, early-onset recurrent ischemic stroke and fever	nan	nan	nan	nan	nan	[]	['hsa00230  Purine metabolism', 'hsa01100  Metabolic pathways', 'hsa01232  Nucleotide metabolism']	['HP:0002715', 'HP:0000007', 'HP:0002140', 'HP:0001945', 'HP:0001297', 'HP:0002633']
ADAR1 deficiency, AGS6_ADAR_AR	ADAR1 deficiency, AGS6	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	146920	ADAR1	ADAR	103	Classical AGS, BSN, SP	Normal	Normal	Normal	Normal	nan	[]	['hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0001257', 'HP:0000007', 'HP:0002721', 'HP:0002313', 'HP:0002385', 'HP:0002514']
ATAD3A deficiency_ATAD3A_AD (1 AR)	ATAD3A deficiency	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AD (1 AR)		ATAD3A	ATAD3A	55210	Predominantly neuro defects (development delay, spasticity), elevated ISG expression, increased serum type 1 IFNs	nan	nan	nan	nan	nan	[]	[]	['HP:0000006', 'HP:0000007', 'HP:0001263', 'HP:0001257']
C2orf69 deficiency_C2orf69_AR	C2orf69 deficiency	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR		C2orf69	C2orf69	205327	"Brain abnormalities (hypomyelination, microcephaly), liver dysfunction,
severe and recurrent autoinflammation, leukoencephalopathy with recurrent seizures. Often fatal"	nan	nan	nan	nan	nan	[]	[]	['HP:0002352', 'HP:0000007', 'HP:0001250', 'HP:0000252', 'HP:0012443', 'HP:0001410']
CDC42 defects_CDC42_AD	CDC42 defects	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AD		CDC42	CDC42	998	Neonatal onset pancytopenia, fever, rash, HSM, HLH, myelofibrosis, developemntal delay, FTT.  Recognized mutation-phenotype associations	Variable T cell counts	Variable	Variable	nan	Low NK function	[]	['hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04015  Rap1 signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04144  Endocytosis', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04510  Focal adhesion', 'hsa04520  Adherens junction', 'hsa04530  Tight junction', 'hsa04660  T cell receptor signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04670  Leukocyte transendothelial migration', 'hsa04722  Neurotrophin signaling pathway', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04912  GnRH signaling pathway', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05100  Bacterial invasion of epithelial cells', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05165  Human papillomavirus infection', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05205  Proteoglycans in cancer', 'hsa05211  Renal cell carcinoma', 'hsa05212  Pancreatic cancer', 'hsa05417  Lipid and atherosclerosis']	['HP:0000006', 'HP:0001508', 'HP:0011974', 'HP:0002721', 'HP:0001263', 'HP:0001945', 'HP:0000988', 'HP:0001433', 'HP:0001876', 'HP:0002514']
DNASE1L3 deficiency_DNASE1L3_AR	DNASE1L3 deficiency	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	602244	DNASE1L3	DNASE1L3	1776	Systemic lupus erythematosus, lupus nephritis, hypocomplementemic urticarial vasculitis	nan	nan	nan	nan	nan	[]	[]	['HP:0002725', 'HP:0000007', 'HP:0002721', 'HP:0033726', 'HP:0002633', 'HP:0000123', 'HP:0002514']
DNASE2 deficiency_DNASE2_AR	DNASE2 deficiency	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	126350	DNASE2	DNASE2	1777	Glomerulonephritis, arthropathy, vasculitis	nan	nan	nan	nan	nan	[]	['hsa04142  Lysosome', 'hsa04623  Cytosolic DNA-sensing pathway']	['HP:0003040', 'HP:0000007', 'HP:0002721', 'HP:0002633', 'HP:0000099', 'HP:0002514']
Aicardi-Goutieres syndrome 7 (AGS7)_IFIH1_AD GOF	Aicardi-Goutieres syndrome 7 (AGS7)	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AD GOF	606951	IFIH1	IFIH1	64135	Classical AGS, SLE, SP, SMS	Normal	Normal	Normal	Normal	nan	[]	['hsa04622  RIG-I-like receptor signaling pathway', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000006', 'HP:0001257', 'HP:0002721', 'HP:0002313', 'HP:0002385', 'HP:0002514']
LSM11 deficiency_LSM11_AR	LSM11 deficiency	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR		LSM11	LSM11	134353	Classical AGS, SLE, FCL	nan	nan	nan	nan	nan	[]	[]	['HP:0000007', 'HP:0009710', 'HP:0002514', 'HP:0002721']
OAS1 GOF_OAS1_AD GOF	OAS1 GOF	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AD GOF	164350	OAS1	OAS1	4938	Pulmonary alveolar proteinosis, skin rash	nan	nan	nan	nan	nan	[]	['hsa04621  NOD-like receptor signaling pathway', 'hsa05160  Hepatitis C', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000006', 'HP:0002721', 'HP:0000988', 'HP:0006517', 'HP:0002514']
RNASEH2A deficiency, AGS4_RNASEH2A_AR	RNASEH2A deficiency, AGS4	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	606034	RNASEH2A	RNASEH2A	10535	Classical AGS	Normal	Normal	Normal	Normal	nan	[]	['hsa03030  DNA replication']	['HP:0000007', 'HP:0002514', 'HP:0002721']
RNASEH2B deficiency, AGS2_RNASEH2B_AR	RNASEH2B deficiency, AGS2	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	610326	RNASEH2B	RNASEH2B	79621	Classical AGS, SP	Normal	Normal	Normal	Normal	nan	[]	['hsa03030  DNA replication']	['HP:0001257', 'HP:0000007', 'HP:0002721', 'HP:0002313', 'HP:0002385', 'HP:0002514']
RNASEH2C deficiency, AGS3_RNASEH2C_AR	RNASEH2C deficiency, AGS3	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	610330	RNASEH2C	RNASEH2C	84153	Classical AGS	Normal	Normal	Normal	Normal	nan	[]	['hsa03030  DNA replication']	['HP:0000007', 'HP:0002514', 'HP:0002721']
RNU7-1 deficiency_RNU7-1_AR	RNU7-1 deficiency	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR		RNU7-1	RNU7-1	100147744	Classical AGS, SLE, FCL	nan	nan	nan	nan	nan	[]	[]	['HP:0000007', 'HP:0009710', 'HP:0002514', 'HP:0002721']
SAMHD1 deficiency, AGS5_SAMHD1_AR	SAMHD1 deficiency, AGS5	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	606754	SAMHD1	SAMHD1	25939	Classical AGS, FCL	Normal	Normal	Normal	Normal	nan	[]	['hsa03250  Viral life cycle - HIV-1', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa05170  Human immunodeficiency virus 1 infection']	['HP:0000007', 'HP:0009710', 'HP:0002514', 'HP:0002721']
STAT2 R148 LOF/regulation (prevents binding to USP18)_STAT2_AR	STAT2 R148 LOF/regulation (prevents binding to USP18)	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR		STAT2	STAT2	6773	Severe fatal early onset autoinflammation (skin ulceration, fever, seizures, intracranial calcification, multiorgan dysfunction, abnormal neurodevelopment; phenocopy of USP18 deficiency). High serum IFN-Î±, IL6, TNF. IFN-opathy gene signature (impaired regulation of late cellular responses to type 1 IFN),	Variable	nan	Low to normal	nan	Variable NK counts	[]	['hsa04062  Chemokine signaling pathway', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04630  JAK-STAT signaling pathway', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer']	['HP:0001257', 'HP:0000007', 'HP:0001250', 'HP:0002721', 'HP:0001945', 'HP:0004313', 'HP:0012759', 'HP:0002313', 'HP:0002385', 'HP:0002514']
STING-like disease_STING1_AR GOF	STING-like disease	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR GOF		TMEM173	STING1	340061	Failure to thrive; early onset rash, fever, dyspnea, interstitial lung disease/pneumonitis, polyarthritis, autoAbs, clubbing. Increased inflammatory markers, IFN gene signature. Phenocopy of SAVI due to AD GOF TMEM173 variants.  2 patients succumbed; 4 successfully treated with JAK inhibitors	nan	nan	Increased	nan	nan	[]	['hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa05131  Shigellosis', 'hsa05163  Human cytomegalovirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0010702', 'HP:0001508', 'HP:0000007', 'HP:0002094', 'HP:0001945', 'HP:0000988', 'HP:0001217']
STING--associated vasculopathy, infantile-onset_STING1_AD GOF	STING--associated vasculopathy, infantile-onset	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AD GOF	612374	TMEM173	STING1	340061	Skin vasculopathy, inflammatory lung disease, systemic autoinflammation and ICC, FCL	nan	nan	nan	nan	nan	[]	['hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa05131  Shigellosis', 'hsa05163  Human cytomegalovirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000006', 'HP:0002088', 'HP:0002715', 'HP:0033428', 'HP:0009710', 'HP:0002633', 'HP:0002514']
TREX1 deficiency, Aicardi-Goutieres syndrome 1 (AGS1)_TREX1_AR	TREX1 deficiency, Aicardi-Goutieres syndrome 1 (AGS1)	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	606609	TREX1	TREX1	11277	Classical AGS, SLE, FCL	Normal	Normal	Normal	Normal	nan	[]	['hsa04623  Cytosolic DNA-sensing pathway']	['HP:0000007', 'HP:0009710', 'HP:0002514', 'HP:0002721']
TREX1 deficiency, Aicardi-Goutieres syndrome 1 (AGS1)_TREX1_AD	TREX1 deficiency, Aicardi-Goutieres syndrome 1 (AGS1)	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AD	606609	TREX1	TREX1	11277	Classical AGS, SLE, FCL	Normal	Normal	Normal	Normal	nan	[]	['hsa04623  Cytosolic DNA-sensing pathway']	['HP:0000006', 'HP:0009710', 'HP:0002514', 'HP:0002721']
USP18 deficiency_USP18_AR	USP18 deficiency	Table 7 Autoinflammatory Disorders	Subtable 1 Type 1 Interferonopathies	AR	607057	USP18	USP18	11274	TORCH like syndrome	nan	nan	nan	nan	nan	[]	[]	['HP:0000007', 'HP:0002514', 'HP:0002721']
Familial Mediterranean fever_MEFV_AR	Familial Mediterranean fever	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AR	249100	MEFV	MEFV	4210	Recurrent fever, serositis and inflammation responsive to colchicine. Predisoposes to vasculitis and inflammatory bowel disease.	Normal	Normal	Normal	Normal	Mature granulocytes, cytokine-activated monocytes.	[]	['hsa04621  NOD-like receptor signaling pathway', 'hsa05135  Yersinia infection']	['HP:0001954', 'HP:0000007', 'HP:0002721', 'HP:0045073', 'HP:0002037', 'HP:0001945', 'HP:0002633']
Familial Mediterranean fever_MEFV_AD	Familial Mediterranean fever	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AD	249100	MEFV	MEFV	4210	Recurrent fever, serositis and inflammation responsive to colchicine. Predisoposes to vasculitis and inflammatory bowel disease. Usually M694del variant.	Normal	Normal	Normal	Normal	Mature granulocytes, cytokine-activated monocytes.	[]	['hsa04621  NOD-like receptor signaling pathway', 'hsa05135  Yersinia infection']	['HP:0001954', 'HP:0000006', 'HP:0002721', 'HP:0045073', 'HP:0002037', 'HP:0001945', 'HP:0002633']
Mevalonate kinase deficiency (Hyper IgD syndrome)_MVK_AR	Mevalonate kinase deficiency (Hyper IgD syndrome)	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AR	260920	MVK	MVK	4598	Periodic fever and leukocytosis with high IgD levels	Normal	Normal	Normal	Normal	Somatic and hemaotpoietic	[]	['hsa00900  Terpenoid backbone biosynthesis', 'hsa01100  Metabolic pathways', 'hsa04146  Peroxisome']	['HP:0001954', 'HP:0001974', 'HP:0000007', 'HP:0002721', 'HP:0032323', 'HP:0001945']
NLRC4 (GOF)-MAS (macrophage activating syndrome) or familial cold autoinflammatory syndrome 4_NLRC4_AD GOF	NLRC4 (GOF)-MAS (macrophage activating syndrome) or familial cold autoinflammatory syndrome 4	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AD GOF	616115	NLRC4	NLRC4	58484	Severe enterocolitis and macrophage activation syndrome	Normal	Normal	Normal	Normal	PMNs monocytes macrophages	[]	['hsa04621  NOD-like receptor signaling pathway', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05134  Legionellosis', 'hsa05135  Yersinia infection']	['HP:0001954', 'HP:0000006', 'HP:0004387', 'HP:0002721']
NLRP1 deficiency_NLRP1_AR	NLRP1 deficiency	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AR	606579	NLRP1	NLRP1	22861	Dyskeratosis, autoimmunity and arthritis	Normal	Normal	Normal	Normal	leukocytes	[]	['hsa04621  NOD-like receptor signaling pathway']	['HP:0001954', 'HP:0002960', 'HP:0000007', 'HP:0002721', 'HP:0001369']
NLRP1 GOF_NLRP1_AD GOF	NLRP1 GOF	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AD GOF	615225	NLRP1	NLRP1	22861	Palmoplantar carcinoma, corneal scarring	Normal	Normal	Normal	Normal	Keratinocytes	[]	['hsa04621  NOD-like receptor signaling pathway']	['HP:0001954', 'HP:0000006', 'HP:0000559', 'HP:0030731', 'HP:0100699', 'HP:0002721']
Familial cold autoinflammatory syndrome 2_NLRP12_AD GOF	Familial cold autoinflammatory syndrome 2	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AD GOF	611762	NLRP12	NLRP12	91662	Non-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure.	Normal	Normal	Normal	Normal	PMNs, monocytes	[]	['hsa04621  NOD-like receptor signaling pathway']	['HP:0001954', 'HP:0000006', 'HP:0001974', 'HP:0002721', 'HP:0001025', 'HP:0001945', 'HP:0001369', 'HP:0011137', 'HP:0025143']
Familial cold autoinflammatory syndrome 1_NLRP3_AD GOF	Familial cold autoinflammatory syndrome 1	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AD GOF	120100	NLRP3	NLRP3	114548	Non-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure.	Normal	Normal	Normal	Normal	PMNs, monocytes	['Selnoflast (DG03239): D12422 D12423']	['hsa04217  Necroptosis', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05164  Influenza A', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05417  Lipid and atherosclerosis']	['HP:0001954', 'HP:0000006', 'HP:0001974', 'HP:0002721', 'HP:0001025', 'HP:0001945', 'HP:0001369', 'HP:0011137', 'HP:0025143']
Neonatal onset multisystem inflammatory disease (NOMID) or chronic infantile  neurologic cutaneous and articular syndrome (CINCA)_NLRP3_AD GOF	Neonatal onset multisystem inflammatory disease (NOMID) or chronic infantile  neurologic cutaneous and articular syndrome (CINCA)	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AD GOF	607115	NLRP3	NLRP3	114548	Neonatal onset rash, chronic meningitis, and arthropathy with fever and inflammation.	Normal	Normal	Normal	Normal	PMNs, chondrocytes	['Selnoflast (DG03239): D12422 D12423']	['hsa04217  Necroptosis', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05164  Influenza A', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05417  Lipid and atherosclerosis']	['HP:0001954', 'HP:0000006', 'HP:0003040', 'HP:0002721', 'HP:0001945', 'HP:0001287', 'HP:0000988']
Muckle-Wells syndrome_NLRP3_AD GOF	Muckle-Wells syndrome	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AD GOF	191900	NLRP3	NLRP3	114548	Urticaria, SNHL, amyloidosis.	Normal	Normal	Normal	Normal	PMNs Monocytes	['Selnoflast (DG03239): D12422 D12423']	['hsa04217  Necroptosis', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05133  Pertussis', 'hsa05135  Yersinia infection', 'hsa05164  Influenza A', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05417  Lipid and atherosclerosis']	['HP:0001954', 'HP:0000006', 'HP:0000407', 'HP:0000365', 'HP:0002721', 'HP:0001025', 'HP:0011034']
RIPK1 deficiency_RIPK1_AD	RIPK1 deficiency	Table 7 Autoinflammatory Disorders	Subtable 2 Defects Affecting the Inflammasome	AD		RIPK1	RIPK1	8737	Autoinflamamtion with fver, HSM, ulcers, arthralgia, GI inflammation.  Responds to tocilizumab	nan	nan	nan	nan	nan	['Eclitasertib: D12352']	['hsa04064  NF-kappa B signaling pathway', 'hsa04210  Apoptosis', 'hsa04217  Necroptosis', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04668  TNF signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05160  Hepatitis C', 'hsa05163  Human cytomegalovirus infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection']	['HP:0001954', 'HP:0000006', 'HP:0002721', 'HP:0004386', 'HP:0002829', 'HP:0001433']
ADAM17 deficiency_ADAM17_AR	ADAM17 deficiency	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	614328	ADAM17	ADAM17	6868	Early onset diarrhea and skin lesions	Normal	Normal	Normal	Normal	Leukocytes and epithelial cells	['Aderbasib: D09320', 'Apratastat: D08859']	['hsa04330  Notch signaling pathway', 'hsa05010  Alzheimer disease', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0002014', 'HP:0000007', 'HP:0004387', 'HP:0002721']
ALPI deficiency_ALPI_AR	ALPI deficiency	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	171740	ALPI	ALPI	248	Inflammatory bowel disease	Normal	Normal	Normal	Normal	Intestinal epithelial cells	['Ilofotase alfa: D12277']	['hsa00730  Thiamine metabolism', 'hsa00790  Folate biosynthesis', 'hsa01100  Metabolic pathways', 'hsa01240  Biosynthesis of cofactors']	['HP:0000007', 'HP:0002037', 'HP:0002721']
AP1S3 deficiency_AP1S3_AR	AP1S3 deficiency	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	615781	AP1S3	AP1S3	130340	Pustular psoriasis	Normal	Normal	Normal	Normal	Keratinocytes	[]	['hsa04142  Lysosome', 'hsa05170  Human immunodeficiency virus 1 infection']	['HP:0000007', 'HP:0003765', 'HP:0002721']
CAMPS (CARD14 mediated psoriasis)_CARD14_AD	CAMPS (CARD14 mediated psoriasis)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD	602723	CARD14	CARD14	79092	Psoriasis	nan	nan	nan	nan	Mainly in keratinocytes	[]	['hsa04064  NF-kappa B signaling pathway']	['HP:0000006', 'HP:0003765', 'HP:0002721']
COPA defect_COPA_AD	COPA defect	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD	6011924	COPA	COPA	1314	Autoimmune inflammatory arthritis and interstitial lung disease with Th17 dysregulation and autoantibody production	nan	nan	nan	nan	PMN and tissue specific cells	[]	[]	['HP:0000006', 'HP:0002088', 'HP:0002960', 'HP:0002721', 'HP:0006530', 'HP:0001369']
Tim-3 deficiency_HAVCR2_AR	Tim-3 deficiency	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	606652	HAVCR2	HAVCR2	84868	T-cell lymphoma, subcutaneous panniculitis-like, HLH	Normal	Normal	Normal	Normal	Leukocytes	['Cobolimab: D11377', 'Sabatolimab: D12164', 'Surzebiclimab: D12429']	[]	['HP:0002665', 'HP:0000007', 'HP:0012490', 'HP:0002721']
HCK disease_HCK_AD GOF	HCK disease	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD GOF		HCK	HCK	3055	Cutaneous vasculitis and chronic pulmonary inflammation/fibrosis. Inflammatory leukocyte infiltration of the lungs and skin, anemia, hepatosplenomegaly, death due to respiratory failure. Clinical improvement with ruxolitinib	nan	nan	nan	nan	nan	[]	['hsa04062  Chemokine signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection']	['HP:0000006', 'HP:0001903', 'HP:0200029', 'HP:0001433', 'HP:0002633', 'HP:0002878']
DIRA (Deficiency of the Interleukin 1 Receptor Antagonist)_IL1RN_AR	DIRA (Deficiency of the Interleukin 1 Receptor Antagonist)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	612852	IL1RN	IL1RN	3557	Neonatal onset of sterile multifocal osteomyelitis, periostitis and pustulosis.	Normal	Normal	Normal	Normal	PMNs, Monocytes	[]	['hsa04060  Cytokine-cytokine receptor interaction']	['HP:0030314', 'HP:0033605', 'HP:0000007', 'HP:0002721', 'HP:0003765', 'HP:0002754']
DITRA (Deficiency of IL-36 receptor antagonist)_IL36RN_AR	DITRA (Deficiency of IL-36 receptor antagonist)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	614204	IL36RN	IL36RN	26525	Pustular psoriasis	Normal	Normal	Normal	Normal	Keratinocytes, leukocytes	[]	['hsa04060  Cytokine-cytokine receptor interaction']	['HP:0000007', 'HP:0003765', 'HP:0002721']
Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia  (Majeed syndrome)_LPIN2_AR	Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia  (Majeed syndrome)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	609628	LPIN2	LPIN2	9663	Chronic recurrent multifocal osteomyelitis, transfusion-dependent anemia, cutaneous inflammatory disorders	Normal	Normal	Normal	Normal	Neutrophils, bone marrow cells	[]	['hsa00561  Glycerolipid metabolism', 'hsa00564  Glycerophospholipid metabolism', 'hsa01100  Metabolic pathways', 'hsa04150  mTOR signaling pathway', 'hsa04936  Alcoholic liver disease']	['HP:0001903', 'HP:0000007', 'HP:0002721', 'HP:0002754']
HEM1 (NCKAPIL) deficiency_NCKAPIL_AR	HEM1 (NCKAPIL) deficiency	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR		NCKAPIL	NCKAP1L	3071	Infections, skin rashes, ulcers, SLE-like, fever, HLH-like, FTT.  High Th1 cytokines	Normal T cell counts but high TCM, decreased prolfieration	Normal	Normal to high	nan	nan	[]	['hsa04810  Regulation of actin cytoskeleton', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05132  Salmonella infection']	['HP:0010702', 'HP:0001508', 'HP:0000007', 'HP:0002721', 'HP:0002037', 'HP:0001945', 'HP:0000988']
Blau syndrome_NOD2_AD	Blau syndrome	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD	186580	NOD2	NOD2	64127	Uveitis, granulomatous synovitis, camptodactyly, rash and cranial neuropathies, 30% develop Crohn colitis	Normal	Normal	Normal	Normal	Monocytes	['Inarigivir soproxil: D11385', 'Mifamurtide: D06619']	['hsa04621  NOD-like receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa05152  Tuberculosis', 'hsa05321  Inflammatory bowel disease']	['HP:0012385', 'HP:0000006', 'HP:0002583', 'HP:0000554', 'HP:0002721', 'HP:0000988', 'HP:0009830', 'HP:0100769']
Otulipenia/ORAS_OTULIN_AR	Otulipenia/ORAS	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	615712	OTULIN	OTULIN	90268	Fever, diarrhea , dermatitis	nan	nan	nan	nan	Leukocytes	[]	[]	['HP:0001954', 'HP:0002014', 'HP:0000007', 'HP:0002721', 'HP:0001945', 'HP:0011123']
PLAID (PLCg2 associated antibody deficiency and immune dysregulation) or familial cold autoinflammatory syndrome 3  or APLAID (c2120A>C)_PLCG2_AD GOF	PLAID (PLCg2 associated antibody deficiency and immune dysregulation) or familial cold autoinflammatory syndrome 3  or APLAID (c2120A>C)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD GOF	614468	PLCG2	PLCG2	5336	Cold urticaria hypogammaglobulinemia, autoinflammation	Normal	Normal	Normal	Normal	B cells, NK, Mast cells	[]	['hsa00562  Inositol phosphate metabolism', 'hsa01100  Metabolic pathways', 'hsa01521  EGFR tyrosine kinase inhibitor resistance', 'hsa04012  ErbB signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04020  Calcium signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04066  HIF-1 signaling pathway', 'hsa04070  Phosphatidylinositol signaling system', 'hsa04072  Phospholipase D signaling pathway', 'hsa04360  Axon guidance', 'hsa04370  VEGF signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04611  Platelet activation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa04670  Leukocyte transendothelial migration', 'hsa04722  Neurotrophin signaling pathway', 'hsa04750  Inflammatory mediator regulation of TRP channels', 'hsa04919  Thyroid hormone signaling pathway', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa04935  Growth hormone synthesis, secretion and action', 'hsa05110  Vibrio cholerae infection', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05131  Shigellosis', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05205  Proteoglycans in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05214  Glioma', 'hsa05223  Non-small cell lung cancer', 'hsa05225  Hepatocellular carcinoma']	['HP:0001954', 'HP:0000006', 'HP:0410135', 'HP:0002721', 'HP:0001025', 'HP:0004313']
CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy)_PSMB8_AR	CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	256040	PSMB8	PSMB8	5696	Contractures, panniculitis, ICC, fevers	nan	nan	nan	nan	nan	[]	['hsa03050  Proteasome']	['HP:0012490', 'HP:0000007', 'HP:0002721', 'HP:0001945', 'HP:0002514']
CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy)_PSMB8_AD	CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD	256040	PSMB8	PSMB8	5696	Contractures, panniculitis, ICC, fevers	nan	nan	nan	nan	nan	[]	['hsa03050  Proteasome']	['HP:0000006', 'HP:0012490', 'HP:0002721', 'HP:0001945', 'HP:0002514']
PRAAS -like condition_PSMB9_AD GOF	PRAAS -like condition	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD GOF		PSMB9	PSMB9	5698	Severe autoinflammatory phenotype (neonatal-onset fever, a chilblain-like skin rash, myositis, severe pulmonary hypertension, basal ganglia calcification), periodic inflammatory exacerbation.  Immunodeficiency. Elevated levels of inflammatory cytokines (IL-6, IL-18, IP-10, IFN-a) and in blood and CSF.  High LFTs. Hyperactivation of IFN-a, pSTAT1.	Mild pancytopenia	Mild pancytopenia	Variable	Mild pancytopenia	nan	[]	['hsa03050  Proteasome']	['HP:0000006', 'HP:0100614', 'HP:0000822', 'HP:0002721', 'HP:0002135', 'HP:0001945', 'HP:0000988', 'HP:0001876']
CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy)_PSMG2_AR	CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	609702	PSMG2	PSMG2	56984	Panniculitis, lipodystrophy, autoimmune hemolytic anemia	Normal	Normal	Normal	Normal	nan	[]	[]	['HP:0012490', 'HP:0002960', 'HP:0001890', 'HP:0009125', 'HP:0001903', 'HP:0000007', 'HP:0002721', 'HP:0001878']
Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome, hyperzincemia and hypercalprotectinemia_PSTPIP1_AD	Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome, hyperzincemia and hypercalprotectinemia	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD	604416	PSTPIP1	PSTPIP1	9051	Destructive arthritis, inflammatory skin rash, myositis	Normal	Normal	Normal	Normal	Hematopoietic tissues, upregulated in activated T-cells	[]	['hsa04621  NOD-like receptor signaling pathway']	['HP:0001954', 'HP:0000006', 'HP:0100614', 'HP:0002721', 'HP:0000988', 'HP:0001369']
Cherubism_SH3BP2_AD	Cherubism	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD	118400	SH3BP2	SH3BP2	6452	Bone degeneration in jaws	nan	nan	nan	nan	Stroma cells, bone cells	[]	['hsa04650  Natural killer cell mediated cytotoxicity']	['HP:0000277', 'HP:0000006', 'HP:0002721']
Hyperpigmentation hypertrichosis, histiocytosis-lymphadenopathy plus syndrome SLC29A3 mutation_SLC29A3_AR	Hyperpigmentation hypertrichosis, histiocytosis-lymphadenopathy plus syndrome SLC29A3 mutation	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	602782	SLC29A3	SLC29A3	55315	Hyperpigmentation, hypertrichosis, histiocytosis, lymphadenopathy , clinodactyly, short stature, red cell aplasia	nan	nan	nan	nan	Leukocytes, bone cells	[]	['hsa05034  Alcoholism']	['HP:0004322', 'HP:0100727', 'HP:0000998', 'HP:0030084', 'HP:0000007', 'HP:0002721', 'HP:0012410', 'HP:0002716']
SYK disease_SYK_AD GOF	SYK disease	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD GOF		SYK	SYK	6850	Immune deficiency/recurrent infections, multi-organ inflammatory disease (colitis, arthritis, dermatitis), inflammation in multiple tissues (gut, skin, CNS, lung, liver). Diffuse large B cell lymphoma. High WBC counts, CRP	nan	nan	Low IgG, IgM	nan	nan	['Entospletinib: D11209', 'Fostamatinib (DG01419): D09347 D09348<US>', 'Gusacitinib (DG03080): D11676 D11677', 'Mivavotinib (DG03106): D11789 D11790', 'Tuspetinib: D12476']	['hsa04064  NF-kappa B signaling pathway', 'hsa04072  Phospholipase D signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04380  Osteoclast differentiation', 'hsa04611  Platelet activation', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04650  Natural killer cell mediated cytotoxicity', 'hsa04662  B cell receptor signaling pathway', 'hsa04664  Fc epsilon RI signaling pathway', 'hsa04666  Fc gamma R-mediated phagocytosis', 'hsa05152  Tuberculosis', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05203  Viral carcinogenesis']	['HP:0000006', 'HP:0002583', 'HP:0012191', 'HP:0002665', 'HP:0002850', 'HP:0001369', 'HP:0011123', 'HP:0004315']
A20 deficiency_TNFAIP3_AD	A20 deficiency	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD	616744	TNFAIP3	TNFAIP3	7128	Arthralgia, mucosal ulcers, ocular inflammation	nan	nan	nan	nan	Lymphocytes	[]	['hsa04064  NF-kappa B signaling pathway', 'hsa04217  Necroptosis', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa05162  Measles', 'hsa05169  Epstein-Barr virus infection']	['HP:0100533', 'HP:0000006', 'HP:0002829', 'HP:0002721']
NEMO-NDAS_IKBKG c. 671+3 G > C_XL females can be affected	NEMO-NDAS	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	XL females can be affected		IKBKG c. 671+3 G > C	IKBKG	8517	Panniculitis, fevers, lipodystrophy, conical teeth, arthritis, CNS inflammation	nan	nan	Low IgG	nan	nan	[]	['hsa01523  Antifolate resistance', 'hsa04010  MAPK signaling pathway', 'hsa04014  Ras signaling pathway', 'hsa04062  Chemokine signaling pathway', 'hsa04064  NF-kappa B signaling pathway', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04380  Osteoclast differentiation', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04625  C-type lectin receptor signaling pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04658  Th1 and Th2 cell differentiation', 'hsa04659  Th17 cell differentiation', 'hsa04660  T cell receptor signaling pathway', 'hsa04662  B cell receptor signaling pathway', 'hsa04668  TNF signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05120  Epithelial cell signaling in Helicobacter pylori infection', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05135  Yersinia infection', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05200  Pathways in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05208  Chemical carcinogenesis - reactive oxygen species', 'hsa05212  Pancreatic cancer', 'hsa05215  Prostate cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05221  Acute myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer', 'hsa05340  Primary immunodeficiency', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0012490', 'HP:0100533', 'HP:0009125', 'HP:0002721', 'HP:0000698', 'HP:0001945', 'HP:0001369', 'HP:0004315']
TBK1 disorder_TBK1_AR	TBK1 disorder	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR		TBK1	TBK1	29110	Arthritis, vasculitis, fever, rash, developmental delay, basal ganglia calcification	nan	nan	nan	nan	nan	[]	['hsa04014  Ras signaling pathway', 'hsa04137  Mitophagy - animal', 'hsa04140  Autophagy - animal', 'hsa04620  Toll-like receptor signaling pathway', 'hsa04621  NOD-like receptor signaling pathway', 'hsa04622  RIG-I-like receptor signaling pathway', 'hsa04623  Cytosolic DNA-sensing pathway', 'hsa04657  IL-17 signaling pathway', 'hsa04936  Alcoholic liver disease', 'hsa05014  Amyotrophic lateral sclerosis', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05131  Shigellosis', 'hsa05135  Yersinia infection', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05417  Lipid and atherosclerosis']	['HP:0100533', 'HP:0000007', 'HP:0002721', 'HP:0001263', 'HP:0002135', 'HP:0001945', 'HP:0000988', 'HP:0001369', 'HP:0002633']
TNF receptor-associated periodic syndrome (TRAPS)_TNFRSF1A_AD	TNF receptor-associated periodic syndrome (TRAPS)	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AD	142680	TNFRSF1A	TNFRSF1A	7132	Recurrent fever, serositis, rash, and ocular or joint inflammation	Normal	Normal	Normal	Normal	PMNs, monocytes	['Tasonermin: D08562']	['hsa04010  MAPK signaling pathway', 'hsa04060  Cytokine-cytokine receptor interaction', 'hsa04061  Viral protein interaction with cytokine and cytokine receptor', 'hsa04064  NF-kappa B signaling pathway', 'hsa04071  Sphingolipid signaling pathway', 'hsa04150  mTOR signaling pathway', 'hsa04210  Apoptosis', 'hsa04215  Apoptosis - multiple species', 'hsa04217  Necroptosis', 'hsa04380  Osteoclast differentiation', 'hsa04668  TNF signaling pathway', 'hsa04920  Adipocytokine signaling pathway', 'hsa04931  Insulin resistance', 'hsa04932  Non-alcoholic fatty liver disease', 'hsa04936  Alcoholic liver disease', 'hsa05010  Alzheimer disease', 'hsa05014  Amyotrophic lateral sclerosis', 'hsa05022  Pathways of neurodegeneration - multiple diseases', 'hsa05130  Pathogenic Escherichia coli infection', 'hsa05131  Shigellosis', 'hsa05132  Salmonella infection', 'hsa05142  Chagas disease', 'hsa05145  Toxoplasmosis', 'hsa05152  Tuberculosis', 'hsa05160  Hepatitis C', 'hsa05163  Human cytomegalovirus infection', 'hsa05164  Influenza A', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05170  Human immunodeficiency virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0001954', 'HP:0000006', 'HP:0002721', 'HP:0045073', 'HP:0001945', 'HP:0001369', 'HP:0000988']
TRIM22_TRIM22_AR	TRIM22	Table 7 Autoinflammatory Disorders	Subtable 3 Non-Inflammasome Related Conditions	AR	606559	TRIM22	TRIM22	10346	Granulomatous colitis	Normal	Normal	Normal	Normal	Macrophages, intestinal epithelial cells	[]	[]	['HP:0000007', 'HP:0002037', 'HP:0002583', 'HP:0002721']
C1q deficiency due to defects in C1QA_C1QA_AR	C1q deficiency due to defects in C1QA	Table 8 Complement Deficiencies	nan	AR	120550	C1QA	C1QA	712	SLE, infections with encapsulated organisms	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04936  Alcoholic liver disease', 'hsa05020  Prion disease', 'hsa05133  Pertussis', 'hsa05142  Chagas disease', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C1q deficiency due to defects in C1QB_C1QB_AR	C1q deficiency due to defects in C1QB	Table 8 Complement Deficiencies	nan	AR	120570	C1QB	C1QB	713	SLE, infections with encapsulated organisms	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04936  Alcoholic liver disease', 'hsa05020  Prion disease', 'hsa05133  Pertussis', 'hsa05142  Chagas disease', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C1q deficiency due to defects in C1QC_C1QC_AR	C1q deficiency due to defects in C1QC	Table 8 Complement Deficiencies	nan	AR	120575	C1QC	C1QC	714	SLE, infections with encapsulated organisms	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04936  Alcoholic liver disease', 'hsa05020  Prion disease', 'hsa05133  Pertussis', 'hsa05142  Chagas disease', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C1r deficiency_C1R_AR	C1r deficiency	Table 8 Complement Deficiencies	nan	AR	613785	C1R	C1R	715	SLE, infections with encapsulated organisms, Ehlers Danlos phenotype	Normal	Normal	Normal	Normal	nan	['Conestat alfa: D10845<US>']	['hsa04145  Phagosome', 'hsa04610  Complement and coagulation cascades', 'hsa05133  Pertussis', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C1r Periodontal Ehlers Danlos_C1R_AD GOF	C1r Periodontal Ehlers Danlos	Table 8 Complement Deficiencies	nan	AD GOF	613785	C1R	C1R	715	Normal CH50, Hyperpigmentation, skin fragility	Normal	Normal	Normal	Normal	nan	['Conestat alfa: D10845<US>']	['hsa04145  Phagosome', 'hsa04610  Complement and coagulation cascades', 'hsa05133  Pertussis', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0001030', 'HP:0000006', 'HP:0000704', 'HP:0002721']
C1s deficiency_C1S_AR	C1s deficiency	Table 8 Complement Deficiencies	nan	AR	120580	C1S	C1S	716	SLE, infections with encapsulated organisms, Ehlers Danlos phenotype	Normal	Normal	Normal	Normal	nan	['Conestat alfa: D10845<US>', 'Sutimlimab: D11530<JP/US>']	['hsa04610  Complement and coagulation cascades', 'hsa05133  Pertussis', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C1s Periodontal Ehlers Danlos_C1S_AD GOF	C1s Periodontal Ehlers Danlos	Table 8 Complement Deficiencies	nan	AD GOF	613785	C1S	C1S	716	Normal CH50, Hyperpigmentation, skin fragility	Normal	Normal	Normal	Normal	nan	['Conestat alfa: D10845<US>', 'Sutimlimab: D11530<JP/US>']	['hsa04610  Complement and coagulation cascades', 'hsa05133  Pertussis', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0001030', 'HP:0000006', 'HP:0000704', 'HP:0002721']
C2 deficiency_C2_AR	C2 deficiency	Table 8 Complement Deficiencies	nan	AR	217000	C2	C2	717	SLE, infections with encapsulated organisms, atherosclerosis	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04936  Alcoholic liver disease', 'hsa05133  Pertussis', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721', 'HP:0002621']
C3 deficiency (LOF)_C3_AR	C3 deficiency (LOF)	Table 8 Complement Deficiencies	nan	AR	120700	C3	C3	718	Infections , glomerulonephritis, atypical hemolytic-uremic syndrome with GOF mutations.	Normal	Normal	Normal	Normal	nan	['Pegcetacoplan: D11613']	['hsa04080  Neuroactive ligand-receptor interaction', 'hsa04145  Phagosome', 'hsa04610  Complement and coagulation cascades', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04936  Alcoholic liver disease', 'hsa05131  Shigellosis', 'hsa05133  Pertussis', 'hsa05134  Legionellosis', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05150  Staphylococcus aureus infection', 'hsa05152  Tuberculosis', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05203  Viral carcinogenesis', 'hsa05322  Systemic lupus erythematosus']	['HP:0002718', 'HP:0000007', 'HP:0002721', 'HP:0000099', 'HP:0005575']
C3 GOF_C3_AD GOF	C3 GOF	Table 8 Complement Deficiencies	nan	AD GOF	120700	C3	C3	718	Atypical hemolytic-uremic syndrome , dense deposit disease	Normal	Normal	Normal	Normal	nan	['Pegcetacoplan: D11613']	['hsa04080  Neuroactive ligand-receptor interaction', 'hsa04145  Phagosome', 'hsa04610  Complement and coagulation cascades', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04936  Alcoholic liver disease', 'hsa05131  Shigellosis', 'hsa05133  Pertussis', 'hsa05134  Legionellosis', 'hsa05140  Leishmaniasis', 'hsa05142  Chagas disease', 'hsa05150  Staphylococcus aureus infection', 'hsa05152  Tuberculosis', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05203  Viral carcinogenesis', 'hsa05322  Systemic lupus erythematosus']	['HP:0000006', 'HP:0002718', 'HP:0002721', 'HP:0004746', 'HP:0005575']
Complete C4 deficiency_C4A_AR	Complete C4 deficiency	Table 8 Complement Deficiencies	nan	AR	120810	C4A	C4A	720	SLE, infections with encapsulated organisms , partial deficiency is common (either C4A or C4B) and appears to have a modest effect on host defense	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04936  Alcoholic liver disease', 'hsa05133  Pertussis', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
Complete C4 deficiency_C4B_AR	Complete C4 deficiency	Table 8 Complement Deficiencies	nan	AR	120810	C4B	C4B	721	SLE, infections with encapsulated organisms , partial deficiency is common (either C4A or C4B) and appears to have a modest effect on host defense	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04936  Alcoholic liver disease', 'hsa05133  Pertussis', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C5 deficiency_C5_AR	C5 deficiency	Table 8 Complement Deficiencies	nan	AR	120900	C5	C5	727	Disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	['Avacincaptad pegol sodium: D11748', 'Crovalimab: D11696', 'Eculizumab: D03940<JP/US>', 'Gefurulimab: D12208', 'Nomacopan: D11473', 'Olendalizumab: D11331', 'Pexelizumab: D10023', 'Pozelimab: D11477', 'Ravulizumab: D11054<JP/US>', 'Vilobelimab: D11838', 'Zilucoplan (DG03224): D12356 D12357']	['hsa04080  Neuroactive ligand-receptor interaction', 'hsa04610  Complement and coagulation cascades', 'hsa04613  Neutrophil extracellular trap formation', 'hsa04810  Regulation of actin cytoskeleton', 'hsa04936  Alcoholic liver disease', 'hsa05020  Prion disease', 'hsa05133  Pertussis', 'hsa05150  Staphylococcus aureus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C6 deficiency_C6_AR	C6 deficiency	Table 8 Complement Deficiencies	nan	AR	217050	C6	C6	729	Disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C7 deficiency_C7_AR	C7 deficiency	Table 8 Complement Deficiencies	nan	AR	217070	C7	C7	730	Disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C8a deficiency_C8A_AR	C8a deficiency	Table 8 Complement Deficiencies	nan	AR	120950	C8A	C8A	731	Disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05146  Amoebiasis', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C8bï deficiency_C8B_AR	C8bï deficiency	Table 8 Complement Deficiencies	nan	AR	120960	C8B	C8B	732	Disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05146  Amoebiasis', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C8g deficiency_C8G_AR	C8g deficiency	Table 8 Complement Deficiencies	nan	AR	120930	C8G	C8G	733	Disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05146  Amoebiasis', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
C9 deficiency_C9_AR	C9 deficiency	Table 8 Complement Deficiencies	nan	AR	120940	C9	C9	735	Mild susceptibility to disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04810  Regulation of actin cytoskeleton', 'hsa05020  Prion disease', 'hsa05146  Amoebiasis', 'hsa05171  Coronavirus disease - COVID-19', 'hsa05322  Systemic lupus erythematosus']	['HP:0000007', 'HP:0002718', 'HP:0002721']
Membrane Cofactor Protein (CD46) deficiency_CD46_AD	Membrane Cofactor Protein (CD46) deficiency	Table 8 Complement Deficiencies	nan	AD	120920	CD46	CD46	4179	Atypical hemolytic-uremic syndrome, infections, preeclampsia	Normal	Normal	Normal	Normal	nan	[]	['hsa03267  Virion - Adenovirus', 'hsa04610  Complement and coagulation cascades', 'hsa05162  Measles']	['HP:0000006', 'HP:0100602', 'HP:0005575', 'HP:0002721']
CD55 deficiency (CHAPEL disease)_CD55_AR	CD55 deficiency (CHAPEL disease)	Table 8 Complement Deficiencies	nan	AR	125240	CD55	CD55	1604	Protein losing enteropathy, thrombosis	Normal	Normal	Low	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04640  Hematopoietic cell lineage', 'hsa05416  Viral myocarditis']	['HP:0000007', 'HP:0002721', 'HP:0004313', 'HP:0002243', 'HP:0002242']
Membrane Attack Complex Inhibitor (CD59) deficiency_CD59_AR	Membrane Attack Complex Inhibitor (CD59) deficiency	Table 8 Complement Deficiencies	nan	AR	107271	CD59	CD59	966	Hemolytic anemia, polyneuropathy, thrombosis	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04640  Hematopoietic cell lineage']	['HP:0001271', 'HP:0001903', 'HP:0000007', 'HP:0002721', 'HP:0001878']
Factor B GOF_CFB_AD GOF	Factor B GOF	Table 8 Complement Deficiencies	nan	AD GOF	138470	CFB	CFB	629	Atypical Hemolytic-uremic syndrome	Normal	Normal	Normal	Normal	nan	['Iptacopan (DG03207): D12251 D12252']	['hsa04610  Complement and coagulation cascades', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000006', 'HP:0005575', 'HP:0002721']
Factor B LOF_CFB_AR	Factor B LOF	Table 8 Complement Deficiencies	nan	AR	138470	CFB	CFB	629	Infections with encapsulated organisms	Normal	Normal	Normal	Normal	nan	['Iptacopan (DG03207): D12251 D12252']	['hsa04610  Complement and coagulation cascades', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000007', 'HP:0005575', 'HP:0002721']
Factor D deficiency_CFD_AR	Factor D deficiency	Table 8 Complement Deficiencies	nan	AR	134350	CFD	CFD	1675	Neisserial infections	Normal	Normal	Normal	Normal	nan	['Danicopan: D11641', 'Lampalizumab: D10440', 'Vemircopan: D12481']	['hsa04610  Complement and coagulation cascades', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0000007', 'HP:0002718', 'HP:0002721']
Factor H deficiency_CFH_AR	Factor H deficiency	Table 8 Complement Deficiencies	nan	AR	134370	CFH	CFH	3075	Infections, disseminated neisserial infections, atypical Hemolytic-uremic syndrome, preeclampsia, dense deposit disease	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa05150  Staphylococcus aureus infection']	['HP:0002718', 'HP:0000007', 'HP:0002721', 'HP:0100602', 'HP:0004746', 'HP:0005575']
Factor H deficiency_CFH_AD	Factor H deficiency	Table 8 Complement Deficiencies	nan	AD	134370	CFH	CFH	3075	Infections, disseminated neisserial infections, atypical Hemolytic-uremic syndrome, preeclampsia, dense deposit disease	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa05150  Staphylococcus aureus infection']	['HP:0000006', 'HP:0005381', 'HP:0002721', 'HP:0100602', 'HP:0004746', 'HP:0005575']
Factor H ârelated protein deficiencies_CFHR1_AR	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AR	134371, 600889, 605336, 605337, 608593	CFHR1	CFHR1	3078	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000007', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR2_AR	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AR	134371, 600889, 605336, 605337, 608593	CFHR2	CFHR2	3080	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000007', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR3_AR	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AR	134371, 600889, 605336, 605337, 608593	CFHR3	CFHR3	10878	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000007', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR4_AR	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AR	134371, 600889, 605336, 605337, 608593	CFHR4	CFHR4	10877	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000007', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR5_AR	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AR	134371, 600889, 605336, 605337, 608593	CFHR5	CFHR5	81494	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000007', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR1_AD	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AD	134371, 600889, 605336, 605337, 608593	CFHR1	CFHR1	3078	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000006', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR2_AD	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AD	134371, 600889, 605336, 605337, 608593	CFHR2	CFHR2	3080	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000006', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR3_AD	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AD	134371, 600889, 605336, 605337, 608593	CFHR3	CFHR3	10878	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000006', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR4_AD	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AD	134371, 600889, 605336, 605337, 608593	CFHR4	CFHR4	10877	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000006', 'HP:0005575', 'HP:0002721']
Factor H ârelated protein deficiencies_CFHR5_AD	Factor H ârelated protein deficiencies	Table 8 Complement Deficiencies	nan	AD	134371, 600889, 605336, 605337, 608593	CFHR5	CFHR5	81494	Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades']	['HP:0000006', 'HP:0005575', 'HP:0002721']
Factor I deficiency_CFI_AR	Factor I deficiency	Table 8 Complement Deficiencies	nan	AR	217030	CFI	CFI	3426	Infections, disseminated neisserial infections, atypical Hemolytic-uremic syndrome, preeclampsia	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa05150  Staphylococcus aureus infection']	['HP:0002718', 'HP:0000007', 'HP:0002721', 'HP:0100602', 'HP:0005575']
Properdin deficiency_CFP_XL	Properdin deficiency	Table 8 Complement Deficiencies	nan	XL	300383	CFP	CFP	5199	Neisserial infections	Normal	Normal	Normal	Normal	nan	[]	['hsa05168  Herpes simplex virus 1 infection']	['HP:0001417', 'HP:0002718', 'HP:0002721']
Ficolin 3 deficiency_FCN3_AR	Ficolin 3 deficiency	Table 8 Complement Deficiencies	nan	AR	604973	FCN3	FCN3	8547	Respiratory infections, abscesses	Normal	Normal	Normal	Normal	nan	[]	[]	['HP:0002718', 'HP:0011947', 'HP:0000007', 'HP:0002721', 'HP:0025615']
MASP2 deficiency_MASP2_AR	MASP2 deficiency	Table 8 Complement Deficiencies	nan	AR	605102	MASP2	MASP2	10747	Pyogenic infections, inflammatory lung disease, autoimmunity	Normal	Normal	Normal	Normal	nan	['Narsoplimab: D11531']	['hsa04610  Complement and coagulation cascades', 'hsa05150  Staphylococcus aureus infection', 'hsa05171  Coronavirus disease - COVID-19']	['HP:0002718', 'HP:0002088', 'HP:0002960', 'HP:0000007', 'HP:0002721']
C1 inhibitor deficiency_SERPING1_AD	C1 inhibitor deficiency	Table 8 Complement Deficiencies	nan	AD	606860	SERPING1	SERPING1	710	Hereditary angioedema	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa05133  Pertussis']	['HP:0100665', 'HP:0000006', 'HP:0002721']
Thrombomodulin deficiency_THBD_AD	Thrombomodulin deficiency	Table 8 Complement Deficiencies	nan	AD	188040	THBD	THBD	7056	Atypical hemolytic-uremic syndrome	Normal	Normal	Normal	Normal	nan	[]	['hsa04610  Complement and coagulation cascades', 'hsa04933  AGE-RAGE signaling pathway in diabetic complications', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0005575', 'HP:0002721']
DKCA6_ACD_AD	DKCA6	Table 9 Bone marrow failure	nan	AD	616553	ACD	ACD	65057	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	[]	['HP:0000006', 'HP:0005528', 'HP:0007427', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
Fanconi Anemia Type S_BRCA1_AR	Fanconi Anemia Type S	Table 9 Bone marrow failure	nan	AR	617883	BRCA1	BRCA1	672	normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa01524  Platinum drug resistance', 'hsa03440  Homologous recombination', 'hsa03460  Fanconi anemia pathway', 'hsa04120  Ubiquitin mediated proteolysis', 'hsa04151  PI3K-Akt signaling pathway', 'hsa05206  MicroRNAs in cancer', 'hsa05224  Breast cancer']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type D1_BRCA2_AR	Fanconi Anemia Type D1	Table 9 Bone marrow failure	nan	AR	605724	BRCA2	BRCA2	675	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03440  Homologous recombination', 'hsa03460  Fanconi anemia pathway', 'hsa05200  Pathways in cancer', 'hsa05212  Pancreatic cancer', 'hsa05224  Breast cancer']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type J_BRIP1_AR	Fanconi Anemia Type J	Table 9 Bone marrow failure	nan	AR	609054	BRIP1	BRIP1	83990	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03440  Homologous recombination', 'hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Coats plus syndrome due to CTC1 deficiency_CTC1_AR	Coats plus syndrome due to CTC1 deficiency	Table 9 Bone marrow failure	nan	AR	613129	CTC1	CTC1	80169	Intrauterine growth retardation, sparse graying hair, dystrophic nails, trilinear bone marrow failure, osteopenia, gastrointestinal hemorrhage due to vascular ectasia, retinal telangiectasia, intracranial calcification, abnormal telomeres	Normal	Normal	nan	nan	nan	[]	[]	['HP:0000938', 'HP:0002239', 'HP:0005528', 'HP:0000007', 'HP:0002721', 'HP:0008404', 'HP:0001510', 'HP:0001009', 'HP:0007763', 'HP:0001511', 'HP:0002514']
DKCX1_DKC1_XL	DKCX1	Table 9 Bone marrow failure	nan	XL	305000	DKC1	DKC1	1736	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03008  Ribosome biogenesis in eukaryotes']	['HP:0005528', 'HP:0007427', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0001417', 'HP:0005403']
Fanconi Anemia Type Q_ERCC4_AR	Fanconi Anemia Type Q	Table 9 Bone marrow failure	nan	AR	615272	ERCC4	ERCC4	2072	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03420  Nucleotide excision repair', 'hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type A_FANCA_AR	Fanconi Anemia Type A	Table 9 Bone marrow failure	nan	AR	227650	FANCA	FANCA	2175	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type B_FANCB_XLR	Fanconi Anemia Type B	Table 9 Bone marrow failure	nan	XLR	300514	FANCB	FANCB	2187	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0002721', 'HP:0040012', 'HP:0001419', 'HP:0005403']
Fanconi Anemia Type C_FANCC_AR	Fanconi Anemia Type C	Table 9 Bone marrow failure	nan	AR	227645	FANCC	FANCC	2176	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type D2_FANCD2_AR	Fanconi Anemia Type D2	Table 9 Bone marrow failure	nan	AR	227646	FANCD2	FANCD2	2177	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type E_FANCE_AR	Fanconi Anemia Type E	Table 9 Bone marrow failure	nan	AR	600901	FANCE	FANCE	2178	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type F_FANCF_AR	Fanconi Anemia Type F	Table 9 Bone marrow failure	nan	AR	603467	FANCF	FANCF	2188	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type I_FANCI_AR	Fanconi Anemia Type I	Table 9 Bone marrow failure	nan	AR	609053	FANCI	FANCI	55215	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type L_FANCL_AR	Fanconi Anemia Type L	Table 9 Bone marrow failure	nan	AR	614083	FANCL	FANCL	55120	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway', 'hsa04120  Ubiquitin mediated proteolysis']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type M_FANCM_AR	Fanconi Anemia Type M	Table 9 Bone marrow failure	nan	AR	618096	FANCM	FANCM	57697	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type V_MAD2L2_AR	Fanconi Anemia Type V	Table 9 Bone marrow failure	nan	AR	617243	MAD2L2	MAD2L2	10459	normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa04110  Cell cycle', 'hsa04114  Oocyte meiosis', 'hsa04914  Progesterone-mediated oocyte maturation', 'hsa05100  Bacterial invasion of epithelial cells']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
EVI1, MECOM deficiency_MECOM_AD	EVI1, MECOM deficiency	Table 9 Bone marrow failure	nan	AD		MECOM	MECOM	2122	Somatic features:  radioulnar synostosis, clinodactyly, cardiac and renal malformations, late onset hearing loss. Genotype-phenotype correlation with B cell deficiency associated with C-terminal mutations. Phenocopies HOXA11 deficient patients	Pancytopenia with thrombocytopenia most common	B cell deficiency variable	Variable	Pancytopenia	nan	[]	['hsa00310  Lysine degradation', 'hsa01100  Metabolic pathways', 'hsa04010  MAPK signaling pathway', 'hsa05200  Pathways in cancer', 'hsa05220  Chronic myeloid leukemia']	['HP:0000006', 'HP:0010976', 'HP:0012210', 'HP:0000365', 'HP:0002974', 'HP:0030084', 'HP:0001876']
DKCB2_NHP2_AR	DKCB2	Table 9 Bone marrow failure	nan	AR	613987	NOLA2	NHP2	55651	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03008  Ribosome biogenesis in eukaryotes']	['HP:0005528', 'HP:0007427', 'HP:0000007', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
DKCB1_NOP10_AR	DKCB1	Table 9 Bone marrow failure	nan	AR	224230	NOLA3	NOP10	55505	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03008  Ribosome biogenesis in eukaryotes']	['HP:0005528', 'HP:0007427', 'HP:0000007', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
Fanconi Anemia Type N_PALB2_AR	Fanconi Anemia Type N	Table 9 Bone marrow failure	nan	AR	610832	PALB2	PALB2	79728	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03440  Homologous recombination', 'hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
DKCB6_PARN_AR	DKCB6	Table 9 Bone marrow failure	nan	AR	616353	PARN	PARN	5073	developmental delay, microcephaly, and cerebellar hypoplasia	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03018  RNA degradation']	['HP:0005528', 'HP:0001321', 'HP:0000007', 'HP:0002721', 'HP:0001263', 'HP:0000252', 'HP:0005403']
Fanconi Anemia Type R_RAD51_AR	Fanconi Anemia Type R	Table 9 Bone marrow failure	nan	AR	617244	RAD51	RAD51	5888	normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03440  Homologous recombination', 'hsa03460  Fanconi anemia pathway', 'hsa05200  Pathways in cancer', 'hsa05212  Pancreatic cancer']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type O_RAD51C_AR	Fanconi Anemia Type O	Table 9 Bone marrow failure	nan	AR	613390	RAD51C	RAD51C	5889	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03440  Homologous recombination', 'hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconia Anemia Type W_RFWD3_AR	Fanconia Anemia Type W	Table 9 Bone marrow failure	nan	AR	617784	RFWD3	RFWD3	55159	normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	[]	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
DKCA4_RTEL1_AD	DKCA4	Table 9 Bone marrow failure	nan	AD	615190	RTEL1	RTEL1	51750	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	[]	['HP:0000006', 'HP:0005528', 'HP:0007427', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
DKCB5_RTEL1_AR	DKCB5	Table 9 Bone marrow failure	nan	AR	615190	RTEL1	RTEL1	51750	nail dystrophy, leukoplakia, bone marrow failure, severe B-cell immunodeficiency, intrauterine growth retardation, growth retardation, microcephaly, cerebellar hypoplasia, and esophageal dysfunction	normal to low	low	nan	nan	Hematopoietic stem cell	[]	[]	['HP:0005528', 'HP:0001321', 'HP:0000007', 'HP:0002721', 'HP:0001510', 'HP:0008404', 'HP:0000252', 'HP:0001511', 'HP:0005403']
SAMD9 (GOF)_SAMD9_AD GOF	SAMD9 (GOF)	Table 9 Bone marrow failure	nan	AD GOF	617053	SAMD9	SAMD9	54809	IUGR with gonadal abnormalities, adrenal failure, MDS with chromosome 7 aberrations, predisposition to infections, enteropathy, absent spleen	Not reported	Not reported	nan	nan	nan	[]	[]	['HP:0002863', 'HP:0000006', 'HP:0001746', 'HP:0005528', 'HP:0002719', 'HP:0002721', 'HP:0001510', 'HP:0001511', 'HP:0002242']
Ataxia Pancytopenia Syndrome_SAMD9L_AD	Ataxia Pancytopenia Syndrome	Table 9 Bone marrow failure	nan	AD	611170	SAMD9L	SAMD9L	219285	MDS, neurological features	nl	low	nan	nan	Hematopoietic stem cell, myeloid cells	[]	[]	['HP:0002863', 'HP:0000006', 'HP:0002721', 'HP:0005528']
Fanconi Anemia Type P_SLX4_AR	Fanconi Anemia Type P	Table 9 Bone marrow failure	nan	AR	613951	SLX4	SLX4	84464	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
BMFS1 (SRP72-deficiency)_SRP72_AD	BMFS1 (SRP72-deficiency)	Table 9 Bone marrow failure	nan	AD	602122	SRP72	SRP72	6731	Bone marrow failure and congenital nerve deafness	nan	nan	nan	nan	Hematopoietic stem cell	[]	['hsa03060  Protein export']	['HP:0000006', 'HP:0000365', 'HP:0002721', 'HP:0005528']
Coats plus syndrome due to STN1 deficiency_STN1_AR	Coats plus syndrome due to STN1 deficiency	Table 9 Bone marrow failure	nan	AR	613128	STN1	STN1	79991	Intrauterine growth retardation, premature aging, pancytopenia, hypocellular bone marrow, gastrointestinal hemorrhage due to vascular ectasia, intracranial calcification, abnormal telomeres	Variable	Variable	nan	nan	nan	[]	[]	['HP:0002239', 'HP:0005528', 'HP:0000007', 'HP:0001510', 'HP:0002721', 'HP:0001511', 'HP:0001876', 'HP:0002514']
DKCA1_TERC_AD	DKCA1	Table 9 Bone marrow failure	nan	AD	127550	TERC	TERC	7012	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa05200  Pathways in cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer']	['HP:0000006', 'HP:0005528', 'HP:0007427', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
DKCA2_TERT_AD	DKCA2	Table 9 Bone marrow failure	nan	AD	187270	TERT	TERT	7015	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	['Imetelstat: D09629', 'Imetelstat sodium: D09630']	['hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer']	['HP:0000006', 'HP:0005528', 'HP:0007427', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
DKCB4_TERT_AR	DKCB4	Table 9 Bone marrow failure	nan	AR	613989	TERT	TERT	7015	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	['Imetelstat: D09629', 'Imetelstat sodium: D09630']	['hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05200  Pathways in cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer']	['HP:0005528', 'HP:0007427', 'HP:0000007', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
DKCA3_TINF2_AD	DKCA3	Table 9 Bone marrow failure	nan	AD	604319	TINF2	TINF2	26277	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	[]	['HP:0000006', 'HP:0005528', 'HP:0007427', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
BMFS5_TP53_AD	BMFS5	Table 9 Bone marrow failure	nan	AD	618165	TP53	TP53	7157	Erythroid hypoplasia, B-cell deficiency	nan	Low	nan	nan	Hematopoietic stem cell	['Cenersen sodium: D08887']	['hsa01522  Endocrine resistance', 'hsa01524  Platinum drug resistance', 'hsa04010  MAPK signaling pathway', 'hsa04071  Sphingolipid signaling pathway', 'hsa04110  Cell cycle', 'hsa04115  p53 signaling pathway', 'hsa04137  Mitophagy - animal', 'hsa04151  PI3K-Akt signaling pathway', 'hsa04210  Apoptosis', 'hsa04211  Longevity regulating pathway', 'hsa04216  Ferroptosis', 'hsa04218  Cellular senescence', 'hsa04310  Wnt signaling pathway', 'hsa04722  Neurotrophin signaling pathway', 'hsa04919  Thyroid hormone signaling pathway', 'hsa05012  Parkinson disease', 'hsa05014  Amyotrophic lateral sclerosis', 'hsa05016  Huntington disease', 'hsa05131  Shigellosis', 'hsa05160  Hepatitis C', 'hsa05161  Hepatitis B', 'hsa05162  Measles', 'hsa05163  Human cytomegalovirus infection', 'hsa05165  Human papillomavirus infection', 'hsa05166  Human T-cell leukemia virus 1 infection', 'hsa05167  Kaposi sarcoma-associated herpesvirus infection', 'hsa05168  Herpes simplex virus 1 infection', 'hsa05169  Epstein-Barr virus infection', 'hsa05200  Pathways in cancer', 'hsa05202  Transcriptional misregulation in cancer', 'hsa05203  Viral carcinogenesis', 'hsa05205  Proteoglycans in cancer', 'hsa05206  MicroRNAs in cancer', 'hsa05210  Colorectal cancer', 'hsa05212  Pancreatic cancer', 'hsa05213  Endometrial cancer', 'hsa05214  Glioma', 'hsa05215  Prostate cancer', 'hsa05216  Thyroid cancer', 'hsa05217  Basal cell carcinoma', 'hsa05218  Melanoma', 'hsa05219  Bladder cancer', 'hsa05220  Chronic myeloid leukemia', 'hsa05222  Small cell lung cancer', 'hsa05223  Non-small cell lung cancer', 'hsa05224  Breast cancer', 'hsa05225  Hepatocellular carcinoma', 'hsa05226  Gastric cancer', 'hsa05230  Central carbon metabolism in cancer', 'hsa05417  Lipid and atherosclerosis', 'hsa05418  Fluid shear stress and atherosclerosis']	['HP:0000006', 'HP:0010976', 'HP:0005528', 'HP:0002721', 'HP:0012133']
Fanconi Anemia Type T_UBE2T_AR	Fanconi Anemia Type T	Table 9 Bone marrow failure	nan	AR	616435	UBE2T	UBE2T	29089	normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
DKCB3_WRAP53_AR	DKCB3	Table 9 Bone marrow failure	nan	AR	613988	WRAP53	WRAP53	55135	Bone marrow failure, pulmonary and hepatic fibrosis, nail dystrophy, leukoplakia, reticulate skin pigmentation; microcephaly, neurodevelopmental delay	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	[]	['HP:0005528', 'HP:0007427', 'HP:0000007', 'HP:0008404', 'HP:0002721', 'HP:0012758', 'HP:0001395', 'HP:0000252', 'HP:0005403']
Fanconi Anemia Type U_XRCC2_AR	Fanconi Anemia Type U	Table 9 Bone marrow failure	nan	AR	617247	XRCC2	XRCC2	7516	normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03440  Homologous recombination']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
Fanconi Anemia Type G_FANCG_AR	Fanconi Anemia Type G	Table 9 Bone marrow failure	nan	AR	614082	XRCC9	FANCG	2189	Normal to low NK, CNS, skeletal, skin, cardiac, GI, urogenital anomalies, increased chromosomal breakage	normal to low	Normal to low	nan	nan	Hematopoietic stem cell	[]	['hsa03460  Fanconi anemia pathway']	['HP:0005528', 'HP:0000119', 'HP:0000007', 'HP:0002721', 'HP:0040012', 'HP:0005403']
